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Cancer Research Center 
Framework for Progress 
How long will your patients wait 
whileyouYe waiting for repairs? 
At Healthco, we not only deliver the equipment 
and merchandise on t ime, we also deliver on 
service. Because, unless the products you buy 
are ful ly backed by service, you'd better have 
a lot of patience and a lot of patients with 
patience. 
Your practice and its product ivi ty depend on 
your ski l ls, and on consistent, dependable 
service to your patients. Our business depends 
on seeing to it that your chair t ime is not 
interrupted by breakdown of equipment or delays 
in delivery of merchandise, inother words, along 
with dental supplies we supply assurance that 
when you're ready to treat a patient, you have 
everything you need when you need it. 
H e a l t h c o . . . next order, every order and between orders, if necessary. 
r 
- H e a l t h G O 0̂ DENTAL SUPPLY 
25 Stuart Street, Boston, Mass. 02116. (617) 423-6045 
77 full-service branches in the United States and Canada 
Newswatch 
A quick Hip through a tew oi the many 
newsclips that have recently featured 
the words and works of fJledical Cen-
ter professionals: 
Literally hundreds of American 
newspapers in January carried arti-
cles based cn the f indings cf a BUMC 
research study that l inked major 
heart abnormalit ies in infants tc the 
exposure cf their mothers tc female 
sex hormones early in pregnancy. 
The stories were based cn a study by 
Olli P. Heincnen, M.D.. Dennis SIcne, 
M.D., and Samuel Shapiro, M.B., 
F.R.C.P.,' cf the Medical Center's 
Drug Epidemiology Unit. The team 
had reported its f indings in the New 
England Journal of Medicine. In most 
cases, the newspapers had picked up 
an Associated Press story, although 
a substantial number had used a New 
York Times News Service article. The 
cl ippings we have seen show notable 
differences in editing styles, some of 
them downright unconscious. An ex-
ample: the Cleveland Plain Dealer, a 
fairly well known and presumably 
professionally run newspaper, 
carried a large two-column headline 
over this story about hormones and 
heart defects, proclaiming, "Baby 
brain f laws/blamed on the Pil l." No 
wonder the public gets con-
fused. . . . 
An editorial in the Providence (R.I.) 
Journal, urging community support 
for the Rhode Island Black Heritage 
Society, underscored its endorse-
ment of the project by quoting School 
of Medicine professor of psychiatry 
Charles A. Pinderhuges, M.D., who 
wrote in The Black Amer ican 
Reference Bock, "The majority of 
black people today make it clear that 
they will no longer be defined by 
someone else. . . . On the one 
hand, blacks want to join ranks, or 
build a 'nation'; but at the same time, 
they want to retain 'soul', being 
faithful to their individual selves, with 
each person defining what con-
stitutes 'good' and what constitutes 
'bad ' in his or her experience.". . . 
Otto McClarrin's "Happiness 
Through Health" column in the Des 
Moines, Iowa, Bystander, recently ex-
amined the problem of alcoholism 
among women, and reported on 
testimony that BUSM's Henry L. 
Rcsett, M.D., had given before the 
U.S. Senate subcommittee on 
alcoholism and narcotics. Rosett, a 
professor of psychiatry, had told 
senators of one study that showed 
that "of 42 infants born to heavy 
drinking women, 69 percent present-
ed at least one abnormality, as com-
pared with 36 percent of those born 
to moderate drinking women and 35 
percent of those born to rare drinking 
women," the columnist reported. (For 
more on Rosett's study, see Kalei-
doscope in the Winter 1976/77 
Centersccpe.) 
Like their counterparts in the 
United States, major publications 
throughout South America, including 
El Nacicnal of Caracas and 
Resumen, a newsweekly, carried ex-
tensive articles on the findings of 
School of Medicine researcher Ana 
G. Colmenares, Ph.D., on malnu-
tr i t ion-induced retardation in 
chi ldren. Colmenares, who became 
interested in the problem of malnutr i-
tion in her native Venezuela, reported 
in a paper that drew wide attention 
last fall that she had found evidence 
that early malnutrit ion may only delay 
brain development, rather than leave 
irreversible damage. 
U.S. News and World Report and 
such major news agencies as the 
Associated Press, the New York 
Times News Service and the Los 
Angeles Times/Washington Post 
News Service gave broad distribution 
to articles based on a recent report of 
Jane Porter and Hershel Jick, M.D., 
of the Medical Center's Boston 
Collaborative Drug Surveillance 
Program. The researchers' report in 
the Journal of the American Medical 
Associat ion updates their previous 
f indings that adverse reactions to 
prescription drugs in the hospitals 
caused the deaths of 29,000 hospital 
patients a year. The researchers now 
say that 24 of the 26,462 patients in 
their study — or 0.9 per 1,000 — were 
considered to have died as the result 
of one drug or combination of drugs. 
In a previous study of 6,200 patients, 
they found the rate to be 4.0 per 
1,000. 
Numerous health and science 
writers picked up on quotes by Eli 
Shapiro, M.D., a BUSM assistant 
clinical professor of medicine, in the 
Family Physician, a journal published 
by the American Academy of Family 
Physicians. Shapiro captured a great 
deal of press interest with his opin-
ions on the dangers of cuit ism, "a 
sociopathic illness which is rapidly 
spreading throughout the United 
States." 
Psychology Today carried an arti-
cle on a method developed by BUSM 
researchers which has helped epilep-
tic patients whose attacks may be 
emotionally triggered learn to control 
their seizures. Robert Feldman, M.D., 
and Norman Paul, M.D., of the 
Department of Neurology, use 
videotape to record the moments just 
before a patient's attack, which am-
nesia usually causes the patient to 
forget. They later show the tape to the 
patient, allowing him or her to see 
what emotional "tr igger" preceded 
the attack. The patient can then un-
derstand what situations contribute to 
causing the seizures, and can even-
tually learn to control the attacks. 
Two Connecticut papers, the New 
London Day and the Hartford 
Gourant, ran stories on a survey done 
by Edward Gaensler, M.D., a 
physiology professor at the School, of 
employees at General Dynamics-
Electric Boat in Groton. Gaensler's 
study showed that only 6 to 8 percent 
of workers examined showed signs of 
asbestosis, a chronic lung disease 
caused by exposure to asbestos. 
Gaensler was hired by the company 
after studies done by another medical 
team last year showed that almost 50 
percent of the workers had signs of 
the disease. 
Readers in Santa Rosa, California, 
saw a News-Herald article on beards, 
in which professor of dermatology 
Herbert Mescon, M.D., cited the 
growth of an average beard as 0.017 
inch per day, or roughly half an inch 
per month. Mescon was also quoted 
on a little-known benefit of obesity: 
that "fat men usually get smoother 
shaves because the large amount of 
fatty tissue gives the facial skin 
greater resiliency under the pressure 
of a razor." 
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THE COVER: Photo made 
from color slide shows 
tumor cell in the process 
of rarely seen pentapolar 
mitosis, or five-way cell 
division, in which cell 
about to divide has five 
complements of chro-
mosomes instead of the 
usual two. Abnormal size, 
shape or staining of the 
nucleus is one of the 
identifying characteristics 
of the cancer cell. 
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Peter J. Mozden, M.D., chief of surgical oncology, and 
Teresa Rudiowski, M.D., a radiation oncology fellow, 
check the progress of a patient on the surgical on-
cology unit. The many dimensions of cancer research, 
patient care and education are highlighted in this 
special issue on the Cancer Research Center beginning 




a possible solution to 
the hospital crisis? 
b y J o h n I. S a n d s o n , M.D. 
D e a n , B U S M 
a n d 
J o h n H. B e t j e m a n n 
A d m i n i s t r a t o r , 
Un i ve r s i t y H o s p i t a i 
(The following article appeared in a 
slightly modified form in the Boston 
Sunday Globe on Apr/ /24, 1977. The 
Globe described the proposal as "a 
radical new solution for financially 
beleaguered teaching hospitals." The 
article has stirred interest in both the 
public and the hospital-admin-
istration sectors. We invite the com-
ment of Centerscope's readers. 
Editor) 
The double-digit inflation of health-
care costs is producing a crisis in 
academic medical centers, especially 
those that are private institutions. 
Because Boston is renowned for its 
constellation of medical schools and 
teaching hospitals, it seems es-
pecially crucial to find a creative solu-
tion to the hospital-cost problem here 
and now. 
Most of the nation's private 
academic medical centers are in ur-
ban areas and consist of a medical 
school (and sometimes other health-
professional schools) closely 
associated with one or more teaching 
hospitals. The teaching hospitai is 
sometimes part of the same cor-
porate entity as the medical school, 
but is most often an independent en-
tity, with separate fiscal account-
ability. 
Centers for special ized care. Urban 
teaching hospitals have become 
referral medical centers that deliver 
very specialized care, such as open-
heart surgery or renal transplanta-
t ion. This third level of care, that 
which is beyond the primary care 
delivered by private physicians and 
the secondary level provided most of-
ten in community hospitals. Is "ter-
tiary," or highly specialized care. 
In the midst of the general escala-
tion of health-care costs, the added 
cost of delivering such tertiary care, 
plus the expenditures involved in 
teaching, have driven the per-unit 
cost of health care in urban teaching 
hospitals to extraordinarily high 
levels. Both Medicaid and Medicare 
are now refusing to pay the full costs 
for their beneficiaries in these 
hospitals. This stance, coupled with 
the costs incurred through an in-
creasing amount of free care, has led 
to bigger and bigger deficits, placing 
some of the leading teaching 
hospitals in the country in critical 
financial straits. It has also placed a 
serious strain on the Medicaid 
budgets of those states, including 
Massachusetts, that purchase 
primary- and secondary-care ser-
vices, as well as tertiary medical-care 
services f rom high-cost teaching 
hospitals. 
Traditionally, society has counted 
on the academic medical center to 
educate and train its health 
professionals, provide the advances 
in knowledge upon which medical 
care depends, and undertake the 
care and treatment of patients suffer-
ing from advanced and unusual dis-
eases. Now, there is a question: Is the 
academic medical center worth the 
cost? Government regulators seem to 
be answering no, not unless costs 
can be moderated and innovative 
ways to support this system can be 
found. 
Of the possible solutions, a method 
for distributing the high costs of ter-
tiary care more equitably throughout 
the heaith-care system seems to hold 
the greatest potential. A large step 
could be made in that direction by 
decentralizing tertiary care to com-
munity hospitals through an alliance 
with academic medical centers, thus 
creating a "multi-hospital system." 
This system would distribute the cost 
of tertiary care without lowering the 
quality of care. 
Teaching hospitals, under internal 
and external pressures to lower the 
very high costs of tertiary care, are 
developing more efficient manage-
ment, but so far with little or no effect 
on the high unit cost. 
Who is 'someone else'? The teaching 
hospitals are also getting the 
message that they should isolate 
eductional costs and have someone 
else pick up that bill. But who might 
this "someone else" be? The federal 
government could choose to pay all 
teaching costs; since it pays many of 
the teaching costs now, through its 
reimbursement programs, the in-
creased expenditure would not be 
overwhelming. The total cost of the 
salaries for all interns and residents 
(hospital house staff) in the country is 
probably less than $1 bill ion. About 
50 percent of house staff costs is 
already being paid by Medicaid and 
Medicare. To pay the difference 
would increase the total federal ex-
penditure in health by only one per-
cent. Since these salaries are already 
being paid by the total health-care 
dollar, such a payment would repre-
sent a shift—but not a net increase— 
in total health expenditures. That shift 
would serve to decrease the fiscal 
pressure on the teaching hospitals. 
This solution, although apparently 
feasible, is not likely to be realized, 
since our congressional represen-
tatives do not now appear eager to 
assign more of the total health dollar 
to the federal budget. 
The decentralization of tertiary 
care to community hospitals might be 
the best possible approach, under 
these circumstances. By extending 
house-staff and medical-student 
education to these hospitals, we 
would not only be distributing 
educational costs more equitably, but 
also be helping to alleviate the 
geographic and specialty maldis-
tribution of physicians. 
Could improve quality. Such decen-
tralization, unless it were done 
carefully, could be undesirable from 
the perspective of quality health care. 
But the multi-hospital system ap-
proach, linking an academic medical 
center with a group of community 
hospitals, could maintain and even 
improve the quality of care. 
The average per-diem cost 
throughout the multi-hospital system 




report link between 
hormones, birth defects 
Women who take female sex hor-
mones while pregnant have twice as 
much chance of bearing babies with 
heart abnormalit ies as women who 
do not take those hormones, ac-
cording to a report in the New 
England Journal of Medicine by three 
researchers f rom the Medical Cen-
ter's Drug Epidemiology Unit. The ar-
ticle, published in January, was by 
Olli P. Heincnen, M.D., Dennis Slone, 
M.D., and Samuel Shapiro, M.D., all 
associate professors at the School of 
Medicine. 
50,000 women studied. Studying 
more than 50,000 pregnant women 
between 1958 and 1965, the 
researchers determined that among 
1,042 women in the study who took 
hormones during the first four 
months of pregnancy, there were 19 
children born with heart defects— 
18.2 per 1,000 births. This compares 
with a 7.8 per 1,000 cardiovascular 
abnormality rate among 49,240 
children not exposed to the hor-
mones. 
In addit ion, six children with heart 
defects were born to a subgroup of 
278 women who used birth-control 
pills during early pregnancy—a rate 
of 21.5 per 1,000. The findings sup-
port previous data that link prenatal 
exposure to birth-control pills with 
various birth defects. The women in 
the Drug Epidemiology Unit study 
and earlier ones, however, took the 
older type of oral contraceptives 
which contained much higher 
amounts of progesterone and es-
trogen than piHs in use today. The 
Drug Epidemiology Unit study did not 
examine the effects that current oral 
contraceptives have on prenatal 
development. 
Evidently, some women who took 
the older type of oral contraceptives 
were unaware that they were preg-
nant. Also, a decade ago, physicians 
more widely used progesterone and 
estrogen to test for pregnancy or to 
forestall miscarriage. Subsequently, 
the hormones were found to have lit-
tle value in protecting the pregnancy, 
and the synthetic estrogen DES has 
been linked directly to vaginal cancer 
during adolescence in the daughters 
of some women who used the drug. 
Gould to coordinate 
joint Boston center 
for perinatal care 
The School of Medicine will be one 
of five Boston-area health institutions 
involved in a major joint venture to 
provide optimal care to high-risk 
newborns. The program will be 
launched in midsummer by the in-
stitutions in conjunction with Boston's 
Department of Health and Hospitals 
(DHH). 
The program, the Boston Perinatal 
Center, will be a consortium of 
Boston City Hospital (BCH), Boston 
Floating Hospital (Tufts-New England 
Medical Center), St. Margaret's 
Hospitai, BUSM and Tufts University 
School of Medicine. 
Requires no construct ion. Jeffrey B. 
Gould, M.D., a BUSM associate 
professor of pediatrics and obstetrics 
and gynecology, and director of New-
born Services at BCH, has been 
named program coordinator for the 
Boston Perinatal Center, and will be 
responsible for the center's overall 
design and operation. The program 
will not require the outlay of any 
funds for construction of facilities, 
since existing hospital units will be 
used. 
Joel J. Alpert, M.D., professor and 
chairman of pediatrics at BUSM and 
pediatrician-in-chief at BCH, was 
among those leading the 
collaborative effort that brought 
about the new service; the others 
were Sydney S. Gellis, M.D., 
professor and chairman of pediatrics 
at Tufts University School of Medicine 
and pediatrician-in-chief, Tufts-New 
England Medical Center; and Joseph 
Kennedy, M.D., associate professor 
of pediatrics and assistant professor 
of obstetrics-gynecology at Tufts and 
chief of neonatology at St. Margaret's 
Hospital. 
Interhospital effort. The program 
represents an interhospital and in-
terinstitutional effort to improve 
already excellent services available at 
Rose O'Leary, L.P.N., tielps a motfier feed fier premature baby in the Special 
Care Nursery for newborns at Boston City Hospital. 
BCH and St. Margaret's Hospital 
(both designated as perinatal cen-
ters) and at the neonatal intensive 
care unit at Boston Floating Hospital, 
which has no inpatient maternity ser-
vice, but is one of the few pediatric 
hospitals in the state. The chiefs of 
pediatrics and obstetrics in the three 
hospitals feel that by combining and 
coordinating their efforts, they will be 
able to develop a greater flexibility for 
patient care by offering their total 
resources to patients in need. 
Perinatal medicine deals with the 
expectant mother after her seventh 
month of pregnancy and with both 
mother and child until one month af-
ter the child is born. 
BUSM awarded grant 
of $3.5 mill ion for 
lung-disease study 
A large-scale, multidisciplinary in-
vestigation into the mechanisms of 
various kinds of lung disease will be 
carried out under a $3.5-mill ion grant 
recently awarded to BUSM. The 
award is the second largest currently 
held by BUSM, the largest being the 
$4.5-mill ion SCOR (specialized cen-
ter of research) hypertension grant 
awarded a year ago. 
Carl Franzblau, Ph.D., a professor 
of biochemistry, is principal in-
vestigator under the five-year 
National Heart, Lung and Blood In-
stitute grant, and Gordon L. Snider, 
M.D., a professor of medicine, is co-
principal investigator. The depart-
ments of Biochemistry, Pathology, 
Medicine, Surgery and Phar-
macology, as well as the Department 
of Biology on the Charles River 
campus, will all be significantly in-
volved in the program project. 
The broadly-based study, entitled 
"The Response of the Lung to Injury," 
will focus on the pathogenesis of 
emphysema and interstitial lung dis-
ease, but will also explore the 
response of the lung to foreign sub-
stances, such as asbestos. In addi -
t ion, the growth and development of 
the lung, and its response to 
pneumonectomy, will be Investigated. 
These phenomena will be studied 
biochemically, physiologically, phar-
macologically and ultrastructurally. 
Work on the study will be done not 
only at BUSM, but also on the 
Charles River campus, at the Boston 
VA Hospital, at the Evans Memorial 
Department of Clinical Research at 
University Hospital, and at the 
Thorndike Laboratory and the 
Mallory Institute of Pathology of 
Boston City Hospital. 
Large-bowel cancers 
found higher in rats on 
polyunsaturated fat diet 
Rats fed a diet high in polyun-
saturated fat developed more large-
bowel cancers than either of two 
groups of rats fed a diet containing 
saturated fat, when all three groups 
were given a cancer-inducing 
chemical, according to BUSM scien-
tists. 
The findings, reported at the an-
nual meeting of the American Society 
for Microbiology, may have possible 
implications for persons who have 
switched to polyunsaturated fats in 
their diets to reduce the risk of 
developing heart disease. Polyun-
saturated fats are more often found in 
foods derived from vegetables, such 
as corn oil margarine and safflower 
oil; saturated fats are more often 
found in animal-derived foods, such 
as beef, butter and cream. 
All diets high in choiesteroi. Among 
the rats fed saturated fat, those 
receiving a high-fat diet developed 
175 percent more tumors than those 
given a low-fat diet. But in both 
saturated-fat groups, the number of 
rats developing tumors and the num-
ber of tumors per rat were lower than 
in the group fed polyunsaturated fat. 
Diets in all three groups were high in 
cholesterol. 
"Extrapolating f rom animal to 
human studies always entails some 
difficulties, but the findings would 
suggest that diets high in polyun-
saturated fats aimed at reducing 
cholesterol levels in the blood might 
conceivably increase the risk of 
developing cancer of the large 
bowel," Seiwyn A. Broitman, Ph.D., a 
BUSM professor of microbiology, 
said. 
In recent years Americans have 
been urged to switch f rom saturated 
fats to polyunsaturated fats in their 
diets to reduce the risk of car-
diovascular disease. While the results 
of the Boston study seem to suggest 
that persons who do so may be 
avoiding heart disease at the cost of 
increasing their risk of developing 
cancer of the colon, the BU 
researchers emphasized that the far 
smaller incidence of the latter disease 
makes it substantially less a risk than 
heart disease for most people. 
The findings were reported at the 
ASM meeting May 11 in New Orleans 
by Sara W. Rothman, Ph.D., an assis-
tant research professor of micro-
biology at BUSM, and Broitman. Ap-
proximately 8,000 scientists attended 
the six-day meeting, which brought 
together microbiologists, molecular 
biologists, and other scientists from 
across the country. 
The colon oanoer oonneotion. A con-
nection between diet and colon can-
cer has been established through 
epidemiological studies showing that 
in Western countries, such as the 
United States, where a diet high in fat 
and cholesterol is common, there is a 
high incidence of large-bowel cancer, 
while in countries where a diet low in 
fat and cholesterol is the rule, such as 
Japan, people are much less likely to 
develop the disease. 
In the Rothman-Broitman study, 
rats were divided into four groups, 
each receiving a different diet; one 
high in saturated fat (20 percent of 
the total diet); another low in 
saturated fat (5 percent); a third high 
in polyunsaturated fat (20 percent); 
and the fourth low in polyunsaturated 
fat (5 percent). All of the diets were 
high in cholesterol. All four groups of 
rats were then injected with 
dimethylhydrazine (DMH), a chemical 
known to cause cancer in the large 
and small bowel. 
All of the animals on the high 
polyunsaturated fat diet developed 
colonic cancer, with an average of 3.8 
tumors for each rat. Eighty-five per-
cent of the rats on the high saturated 
fat diet developed the disease 
(average 2.2 tumors per rat), com-
pared with only half the rats on the 
low saturated fat diet (average 0.8 
tumors each). The rats in the fourth 
group, those on the low polyun-
saturated diet, ail died, apparently of 
some dietary inadequacy, and could 
not be used in the study. 
In a control group of rats receiving 
no DMH, no tumors developed. 
The specific focus of the study was 
to determine whether the effect of 
diet on tumor incidence might be tied 
to its role in changing the level of a 
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particular bacterial enzyme, beta-
glucuronidase, in the large intestine. 
The chemical carcinogen DMH, which 
Rothman and Broitman gave their 
rats, is detoxified in the liver, which 
disarms the chemical by hooking it to 
a sugar molecule, making it harm-
less. However, beta-glucuronidase 
splits the sugar off, leaving the 
chemical free to be converted to a 
tumor-causing product. 
Enzyme level measured. Theorizing 
that a high-fat diet might cause 
tumors by causing the bacteria to 
produce more of this enzyme, the two 
BUSM scientists measured the levels 
of the enzyme in ail their subject rats, 
but could find no correlation between 
levels of enzymes and incidence of 
tumors. 
"it is safe to say that the enzyme 
level is not the factor that shifts with 
diet to cause cancer," Rothman said. 
The study was supported by the 
National Large Bowel Cancer Project, 
of the National Cancer Institute. 
Rothman and Broitman are currently 
looking at the role of other intestinal 
enzymes in cancer product ion, and 
are expanding their studies to include 
a comparison of the effects of diets 
with and without choiesteroi, and with 
varying ratios of polyunsaturated to 
saturated fats. 
Williams Is named 
to top BUSM, Hospital 
surgery positions 
Lester F. Williams, Jr., M.D. 
Lester F. Will iams, Jr., M.D., an 
associate dean and a professor of 
surgery at the School of Medicine, 
has been named surgeon-in-chief of 
University Hospital and chairman of 
the Division of Surgery of the School 
of Medicine. 
The appointment was announced 
May 25 by Richard H. Egdahl, M.D., 
director of the Medical Center, and 
was effective immediately. 
Will iams, 46, is a general surgeon 
known for his clinical and research 
work in the field of gastrointestinal 
disease. He has been vice-chairman 
of the Division of Surgery since 1973, 
and chief of the gastrointestinal sur-
gical section, University Hospital, 
since 1971. As an associate dean, 
Will iams has been responsible for im-
plementing the School of Medicine's 
relationship with Boston's Depart-
ment of Health and Hospitals (DHH). 
The School of Medicine is responsi-
ble for the provision of medical ser-
vices for DHH. Will iams is also direc-
tor of the Sears Surgical Research 
Laboratory. 
Abil i t ies as surgeon ci ted. In 
announcing the School of Medicine 
and University Hospitai appoint-
ments, Egdahl called attention to 
Williams's effectiveness as an 
academic surgeon and manager. 
"Lester Will iams is well known and 
highly regarded by his peers as a 
gastrointestinal surgeon, and he is 
one of the most active surgical 
researchers in Boston. His principal 
current research, an investigation of 
the formation of gallstones, repre-
sents a continuation of earlier work in 
collaboration with Dr. Donald M. 
Small, a professor of medicine at the 
School of Medicine, in which a 
primate model was developed for the 
study of gallbladder function. 
"Earlier in his career," Egdahl said, 
"Dr. Will iams and several colleagues 
at the School of Medicine, including 
Dr. Robert L. Berger, chief of car-
diovascular surgery, did important 
work on the effects of myocardial in-
farction on blood flow in the intestine. 
"in addit ion," Egdahl continued, 
"Dr. Will iams's ability as an ad-
ministrator of a complex medical 
system has been shown in his 
development of the Boston University 
Medical Center Surgical Residency 
Program, which brings under one 
management structure three formerly 
separate training programs." 
As the surgical chairman, Will iams 
will fill two important posts: chairman 
of the School of Medicine's Division 
of Surgery, in which he will hold the 
James B. Utiey Professorship; and 
surgeon-in-chief of the 373-bed 
University Hospital. The Division of 
Surgery includes the Departments of 
General Surgery, Plastic Surgery, 
Cardiothoracic Surgery, 
Neurosurgery, Orthopedic Surgery, 
Otolaryngology, Oral Surgery and 
Stomatology, and Urology. 
The Division of Surgery is respon-
sible for the education and training of 
520 medical students and 78 
postgraduate trainees. Faculty mem-
bers of the Division coordinate 
education and training programs at 
University Hospital, the Boston 
Veterans Administration Hospital, 
Boston City Hospital, and Brookline, 
Brockton, Cape Cod, Carney, 
Framingham Union, Maiden and 
Norwood Hospitals, and Pawtucket 
Memorial Hospital in Rhode Island. 
A Brockton native. A native of 
Brockton, Mass., Will iams received 
his B.A. from Brown University in 
1952 and his M.D. from the School of 
Medicine in 1956. After spending a 
decade receiving his postgraduate 
training and then serving in the 
medical corps of the U.S. Air Force, 
Will iams was appointed an assistant 
professor of surgery at BUSM in 
1965. He became an associate 
professor in 1967 and was promoted 
to professor of surgery in 1971. 
Williams's current interest in the 
role of the gallbladder in the develop-
ment of gallstones is supported by a 
five-year grant from the National in-
stitutes of Health (NIH). His earlier 
research interest, the relationship 
between myocardial function and 
blood flow in the intestine, was sup-
ported by research funding f rom the 
NIH and the United States Army. 
A prestigious post. The surgery 
chairmanship at the School of 
Medicine and University Hospital is 
considered an especially prestigious 
post in academic surgery. A 
predecessor, John A. Mannick, M. D., 
is now Mosley Professor of Surgery at 
Harvard Medical School and chief of 
surgery at Peter Bent Brigham 
Hospital. Mannick was preceded by 
Egdahl, now the director of BUMC 
and academic vice-president for 
health affairs of the University. 
Egdahl is a former president of the 
Society of University Surgeons. 
Williams is a member of the 
American Surgical Association, the 
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American College of Surgeons, the 
Society of University Surgeons and 
the American Federation for Clinical 
Research. He has published more 
than 80 reports on his research in-
vestigations. He has been cited 
several t imes as an outstanding 
teacher at the School of Medicine. He 
holds appointments as a consultant 
in surgery at Maiden Hospital, Carney 
Hospital and Brockton Hospitai. 
Wil l iams resides in Shrewsbury, 
Mass., with his wife, Sara Jayne, who 
is a lieutenant coionei (ret.) in the 
nurse corps of the U.S. Air Force. 
Mrs. Wil l iams, currently director of 
nursing at the Hubbard Regional 
Hospital in Webster, Mass., will soon 
assume the position of associate 
director of ambulatory care at the 
Hospital of the University of Mass-
achusetts Medical Center, Worcester. 
Will iams succeeds John R. Benfield, 
M.D., in the top surgery posts. 
Benfield, who was appointed to 
succeed Mannick on Jan. 1, 1977, 
resigned shortly thereafter for per-
sonal reasons. 
Cohen is named 
president-elect of 
rheumatism group 
Alan S. Cohen, M.D., Conrad 
Wesselhoeft Professor of Medicine at 
BUSM, was named president-elect of 
the American Rheumatism Associa-
t ion, the medical-scientif ic compo-
nent of the Arthrit is Foundation, at 
the group's recent annual meeting in 
San Francisco. 
Cohen is chief of medicine at 
Boston City Hospital and director of 
the Thorndike Memorial Laboratory 
there. He has been chief of the 
arthritis section of the Evans 
Memorial Department of Clinical 
Research and Preventive Medicine at 
University Hospital since 1960 and 
has recently been engaged in 
developing an organizational struc-
ture for the coordination of all 
arthrit is-related work at Boston Uni-
versity and its related health institu-
tions. 
Cohen has been active in the 
American Rheumatism Association 
for a number of years and has served 
on its executive committee and 
chaired a number of other working 
committees. While he was chairman 
of the ARA's criteria committee, the 
commonly used Classification 
Alan S. Cohen, M.D. 
Criteria for Systemic Lupus Erythe-
matosus were established. He is a 
member of the Editorial Board of 
Arthritis and Rheumatism, has written 
or edited several books, including 
Laboratory Diagnostic Procedures in 
the Rheumatic Diseases, now in its 
second edit ion, and the recently 
published Medical Emergencies, 
Diagnostic and Management 
Procedures from the Boston City 
Hospital. He is the author of more 
than 300 publications and abstracts 
in the field of arthritis. 
Pioneer in amyloid research. His ma-
jor research has been in studies of 
systemic lupus erythematosus and of 
amyloidosis. The latter, a disorder 
previously thought to be rare, has 
been shown to be an accompaniment 
of many infections or inflammatory 
disorders, to occur along with aging, 
and to appear as a unique entity or as 
part of a hereditary syndrome. Cohen 
was the first to establish that amyloid 
is a unique protein that can be 
isolated and characterized, and he 
has performed with his associates 
many pioneer studies of its 
chemistry, immunology, and 
biophysical and clinical aspects. 
Based on his research, a new method 
of treating patients with amyloid dis-
ease has been developed and is 
currently being studied at the 
Thorndike Memorial Laboratory. 
Recently, Cohen was in Spain to 
address the Spanish Rheumatology 
Society on the latest developments in 
amyloidosis at a symposium on 
rheumatologic diseases. He was one 
of three Americans invited to address 
the two-part symposium, which took 
place in Madrid and Barcelona, at-
tracting several hundred rheuma-
tologists and internists. 
Cohen has served as a consultant 
to the National Academy of Sciences, 
as chairman of the Arthritis Graduate 
Training Grant Committee, and as a 
member of General Medicine Study 
Section A of the National Institutes of 
Health. He has been active with the 
Massachusetts Chapter of the 
Arthrit is Foundation and is currently 
chairman of its medical and scientific 
committee and on its Board of 
Trustees. 
An outstanding alumnus. The new 
president-elect has been honored as 
one of the "Four Outstanding Young 
Men in Massachusetts," and as one 
of the 21 "Outstanding Alumni of 
Boston University School of 
Medicine" in the School's 100-year 
history. He is the current president of 
the Alumni Association of Boston 
University School of Medicine. He 
received his undergraduate degree 
f rom Harvard University. 
SGD's Kapala to head 
Pedodontics Dept. 
Jon T. Kapaia, D.M.D., associate 
professor of pedodontics at the 
School of Graduate Dentistry and 
chairman of the School's Department 
of Predoctoral Pedodontics-
Orthodontics, has been named chair-
man of the Department of Pedodon-
tics. Kapaia will continue to serve as 
the School's director of predoctoral 
admissions and student affairs. 
Kapaia succeeds Spencer N. 
FrankI, D.D.S., who resigned from the 
chairmanship last spring after 
holding that post for 12 years. FrankI 
became the School's dean July 1, 
1977, upon the retirement of the for-
mer dean, Henry M. Goldman, D.M.D. 
Kapaia, who earned both his B.S. 
and his D.M.D. degrees from Tufts 
University, received an M.Sc.D. in 
pedodontics from the School of 
Graduate Dentistry in 1968. He has 
been a full-t ime member of that 
department since that t ime. 
Kapaia was instrumental in es-
tablishing SGD's office of Predoctoral 
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Matching 
Day, 1977 
Matching Day, an annual event at which 
fourth-year medical students learn of their 
residency assignments, went well for 
BUSM students this year, with 38 of them 
receiving their first-choice internship. 
Some of the reactions registered at that 
long-awaited moment were caught by the 
Centerscope camera. Counterclockwise, 
from top left, Michael Gilio mops brow in 
apparent relief as he learns he is going to 
the University of South Florida Attiiiated 
Hospitals, Tampa; Victoria Cargill, who 
seconds later erupted with a happy shout, 
reads that she's being assigned to Peter 
Bent Brigham Hospital, Boston; Myron 
Maron opens his mailbox to learn his 
assignment (Southside Hospital, Bay-
shore, N. Y.); Charles F. Sanzone holds his 
letter up to the light, learns he has to open 
It to find out that he Is going to New York's 
Presbyterian Hospital. 
Admissions and Student Affairs, has 
lectured in the Department of Orai 
Biology, and the Department of 
Anatomy at the School of Medicine, 
and has taught preventive dentistry in 
University Hospital's Home Medical 
Service (then a part of the Schooi of 
Medicine). 
He is also active in professional 
organizations on both a national and 
state level. He is a diplomate of the 
American Board of Pedodontics and 
has been nominated to the board of 
directors of the American Academy 
of Pedodontics. He is chairman of the 
ad hoc committee on the survey of 
regional groups for that organization 
and is currently serving as the presi-
dent of the Massachusetts Society of 
Dentistry for Children. He has been 
elected secretary to the Council of 
Sections of the American Association 
of Dental Schools. He is also a mem-
ber of the Academy of Dentistry for 
the Handicapped. 
Drug study given 
$1.2-mlllion renewal 
A $1.2-mill ion, three-year renewal 
of a grant to study drug toxicity has 
been awarded to the Medical Cen-
ter's Boston Collaborative Drug Sur-
veillance Program, headed by 
Herschel Jick, M.D., an associate 
professor of medicine at BUSM. 
Researchers involved in the study will 
use clinical data to measure the acute 
and long-term toxicity of ail drugs 
commonly used in medicine. A goal 
of the study is to provide such precise 
data to physicians as an aid to their 
practice of therapeutics. 
The grant, "Acute and Long-term 
Ciinical Toxicity of Drugs," is funded 
by the National Institute of General 
Medical Sciences and by the Food 
and Drug Administrat ion. 
In a study stemming from the first 
part of this research, Jick and his 
colleague, Jane Porter, determined 
that the number of drug-attr ibuted 
deaths in a series of 26,500 patients 
was not "substantially different" from 
that of a series of 6,200 patients 
studied five years earlier, and that "it 
was quite low in both series, con-
sidering the large number of drugs 
which were prescribed and the 
serious illnesses being treated." 
Jick and Porter published their 
results in a paper entitled "Drug-
Related Deaths Among Medical In-
patients," in the Feb. 28 issue of 
JAMA. 
Seven BUSM students 
chosen to receive 
new Mass. subsidy 
Seven Massachusetts residents 
who are first-year students at the 
School of Medicine have been selec-
ted by lot from among nine qualified 
applicants to receive a new subsidy 
f rom the Commonwealth that will 
allow the students to pay only $2,000 
in tuition this year. 
Nine of 23 qualify. Nine of the 23 first-
year students who applied for the 
subsidy were found to be qualified on 
the basis of certifiable residency, in-
dividual merit, and a demonstrated 
financial need of at least $3,300 in the 
academic year 1976-77. 
Under terms of a contract between 
BUSM and the New England Board of 
Higher Education, the Common-
wealth agreed to subsidize the cost of 
educating seven first-year students 
who are Massachusetts residents. 
The contract makes possible a tuition 
reduction for participating students of 
$3,300, and allows the School to 
recover the approximate net cost of 
educating these students. 
The seven students had to agree to 
serve in a medical capacity within the 
state for a period of six months for 
every one year of state support 
received. It is expected that support 
for the seven selected students will 
continue for the next three years. 
BUSM friends cheer 
Tory ' Lunette's 50th 
Salvatore Lunetta, a technician in 
the Department of Anatomy, was 
honored recently with a surprise 
party in the Dean's Office in recogni-
tion of his 50th anniversary as a 
BUSM employee. 
Faculty members, department 
heads, and friends crowded into the 
Dean's office for the party, at which 
Dean Sandson presented Lunetta 
with a rocking chair bearing the 
School of Medicine seal. The 73-
year-old Lunetta has been granted 
eight employment extensions to allow 
him to stay on the job past the normal 
retirement age. He still has no im-
mediate retirement plans. 
Lunetta is primarily responsible for 
the maintenance of the collection of 
slides that are loaned to students, ac-
cording to William F. McNary, Jr., 
Ph.D., associate dean for student af-
fairs. "Tory has a talent for preparing 
excellent neurological and histoiog-
ical slides," McNary said. 
Salvatore Lunetta, who has worked for BUSM for 50 years, and his wife, 
Louise, receive congratulations from B.U. President John R. Silberat the 
University's annual Service Recognition Dinner in May. Sllber made a 






cases show difference 
by George J. Annas, J.D., M.P.H. 
One column In this series dealt with a 
patient who sued his surgeon and the 
hospital for cremating his amputated leg.' 
In that case the court found in favor of the 
defendants, noting that the method of dis-
posal was standard and reasonable, and 
that the plaintiff had not specifically objec-
ted to it." 
The two cases that are discussed in this 
column are similar to that case in that they 
Involve bizarre fact patterns, but different 
In that In each case the hospital was held 
liable, In the first for negligence in not 
making a proper patient Identification, 
and in the second for the tort of "out-
rageous conduct." Since this latter tort 
is of relatively recent origin, the cases 
also serve to Illustrate the difference be-
tween conduct that Is negligent and con-
duct that can be legally viewed as 
"outrageous." 
Case #1—The death of Emma Johnson. In 
the first case, from New York,^ the Hudson 
River State Hospital sent the following 
telegram to Emma Johnson's sister: 
REGRET TO INFORM YOU OF 
DEATH OF EMMA JOHNSON 
PLEASE NOTIFY RELATIVES 
MAKE BURIAL ARRANGEMENTS 
HAVE UNDERTAKER CONTACT 
HOSPITAL BEFORE COMING FOR 
BODY HOSPITAL WISHES TO 
STUDY ALL DEATHS FOR SCIEN-
TIFIC REASONS PLEASE WIRE 
POST MORTEM CONSENT 
HUDSON RIVER STATE HOSPITAL 
The sister informed Ms. Johnson's 
daughter that her mother had died. The 
daughter accordingly made funeral 
arrangements. On the afternoon of the 
wake she and the sister went to the 
funeral home to observe the body and 
both mentioned that Ms. Johnson's ap-
pearance had changed remarkably. That 
evening, becoming more agitated, they 
examined the body more carefully and 
verified that it was not their relative. At 
that point the daughter became "very, 
very hysterical" and had to be helped 
from the funeral chapel. 
Mistake confirmed. The hospital was 
called, and confirmed the fact that a dif-
ferent Emma Johnson had died and that 
plaintiff's mother was alive and well In 
George J. Annas is director of tfie Center 
for Law and Heaitfi Sciences, Boston Uni-
versity Sctiooi of Law. "Legal Signs" is a 
continuing feature of Centerscope and ttie 
Center for Law and Health Sciences. 
another wing of the hospital. The daughter 
did not work for 11 days and had 
"recurrent nightmares, terrifying dreams 
of death, seeing the cofflti. . . difficulty in 
concentrating, Irritability, Inability to func-
tion properly, general tenseness and anx-
iety." 
The New York Court of Appeals, revers-
ing a lower court, found that under these 
circumstances the daughter could recover 
not only out-of-pocket funeral expenses, 
but also damages arising from mental dis-
tress because such damages, proximately 
caused by the defendant hospital's 
negligence, were substantial, and were 
suffered under such circumstances that 
they were likely to be genuine. The total 
award in the case was $7,500. 
Case #2—The unburied infant. In the 
second case, from Tennessee," the plain-
tiff sought damages for outrageous con-
duct. The appeals court concluded that 
the jury could have found the following 
facts: The plaintiff, Ms. Rita Johnson, was 
experiencing a difficult pregnancy and 
was hospitalized sometime during her 
sixth month of pregnancy. Shortly thereaf-
ter she gave birth to a premature Infant 
who died within an hour of birth. The floor 
nurse advised her that the hospital would 
take care of the final disposition of the 
body. (Ms. Johnson, who wanted very 
much to have a son, had viewed the body, 
and It was a perfectly formed male Infant.) 
Six weeks later, while Ms. Johnson was 
waiting for her routine examination by her 
physician, she noted a pathologist's report 
in her records which read that because of 
the size and age of the fetus it could not 
be used as a surgical specimen. Ms. 
Johnson asked the doctor what It meant, 
and he advised her to go to the hospital 
with his nurse to see one Ms. Chaney 
about it. When they got to the hospital, 
Ms. Chaney said she had been looking tor 
Ms. Johnson and that she had preserved 
her Infant's body. She then took Ms. 
Johnson to a refrigerator, opened the 
door, took out a jar of formaldehyde con-
taining the "floating, shrivelled body" of 
her infant, and handed it to Ms. Johnson. 
As a result of this incident, Ms. Johnson 
suffered from nightmares, Insomnia, and 
depression when around children. She 
also had a pseudo-pregnancy which even-
tually necessitated exploratory surgery 
followed by psychiatric treatment for an 
indefinite period. 
'Outrageous conduct' defined. The jury 
awarded Ms. Johnson and her husband a 
total of $300,000, which the trial judge 
reduced to $175,000; $50,000 of this 
amount was for punitive damages. The 
court explained the intentional tort of 
"outrageous conduct" by noting that such 
conduct must be "so extreme in degree as 
to go beyond all bounds of decency and to 
be regarded as atrocious and utterly In-
tolerable In a civilized community." The 
court further noted that "liability clearly 
does not extend to mere insults, In-
dignities, threats, annoyances, petty op-
pression, or other trivialities. Rather the 
case is one In which the recitation of the 
facts to an average member of the com-
munity would arouse his resentment 
against the actor and lead him to exclaim 
'outrageous'." 
The court found that the defendant 
physican himself never contracted to bury 
the child and never engaged In any out-
rageous conduct, and accordingly re-
versed the verdict against him. It was the 
hospital, and the hospital alone, the court 
found, that agreed to bury the Infant, 
breached that contract, and then, through 
Its employees, outrageously and inten-
tionally, displayed the dead child to its 
mother. 
The hospital argued that, for out-
rageous conduct, damages could only be 
awarded for actual injuries sustained and 
that punitive damages (or "punishment" 
damages) could not be awarded. The 
Tennessee court, however, disagreed with 
this contention (which had been accepted 
In Illinois), saying the nature of the con-
duct Itself would determine whether or not 
punitive damages are allowable and that 
there was no logical reason to permit such 
damages to be awarded In a case Involv-
ing willful and wanton negligence but not 
to permit the recovery in one Involving an 
even higher degree of misconduct. 
An instructive simiiarity. While similar, the 
two cases are Instructive in their dif-
ferences. In the first, the question was one 
of negligence in not verifying a patient's 
Identity, while In the second it was out-
rageous conduct In Intentionally display-
ing a dead child to a mother who believed 
It had long since been buried. Not only 
does the degree of culpability in the 
second case explain why the damages 
were almost 25 times higher, but It Is also 
relevant that the plaintiff's emotional harm 
led to both an operation and permanent 
mental damages. Moreover, while the 
daughter was put through an emotionally 
draining experience in planning for her 
mother's funeral, the fact that her mother 
was still alive and had not herself been 
harmed In any way by the hospital 
probably played a part in keeping the 
damages awarded by the jury low. On the 
other hand, in the second case not only 
was the mother treated in an outrageous 
manner, but so also was the body of her 
dead son, and the jury may also have had 
this in mind in awarding damages. 
The fundamental lesson from both 
cases, however, is the same. Hospitals will 
be held liable for the emotional harm In-
flicted on patients and their relatives 
whether it Is inflicted negligently or inten-
tionally. Hospitals should take positive 
steps to insure that their employees un-
derstand and respect the rights of patients 
and their relatives—for the protection of 
both their patients and themselves. 






T he s e a r c h for a n s w e r s to t h e cance r puzz le b e c o m e s m o r e u rgen t as c a n c e r e m e r g e s as an i nc reas ing l y i m p o r t a n t th rea t to l i fe a n d 
hea l th . A t p resen t ra tes of i n c i d e n c e , 51 mi l l i on 
A m e r i c a n s l iv ing t o d a y wi l l d e v e l o p s o m e f o r m of 
cancer , a n d 34 mi l l i on wi l l d ie f r o m the d isease. 
Yet, d e s p i t e the u rgency , a n s w e r s r e m a i n e lus ive . 
O n e r e a s o n is tha t c a n c e r is not one d isease , bu t 
many , a f fec t ing e a c h of the m o r e t han 100 d i f fe ren t 
k i nds of b o d y ce l ls in a d i f fe ren t way. Its causes are 
m a n y a n d d i ve rse , a n d i n c l u d e c h e m i c a l s , v i ruses 
and rad ia t i on ; its o c c u r r e n c e can be In f l uenced by 
h o r m o n e s , nu t r i t i on , i nhe r i t ance a n d e n v i r o n m e n t . 
T r e a t m e n t of cance r m a y invo lve , s ing ly or in c o m -
b ina t i on , su rge ry , r ad i o the rapy , c h e m o t h e r a p y , a n d 
i m m u n o t h e r a p y . 
Cancer Research Center 's f irst task. No w o n d e r , 
t h e n , tha t c a n c e r is a p p r o a c h e d f r o m so m a n y di f -
fe ren t pe rspec t i ves by r esea rche rs in so m a n y di f-
f e ren t sc ien t i f i c d i sc ip l i nes . W h e n the Bos ton Un i -
vers i ty C a n c e r Resea rch Cen te r was f o u n d e d In 
1974, its f i rs t t ask w a s to p r e p a r e an inven to ry of 
c a n c e r - r e l a t e d resea rch act iv i t ies at t he Med i ca l 
Cen te r a n d Cha r l es River c a m p u s e s of the Un iver -
sity. So m a n y , so sca t t e red , a n d , in s o m e cases , so 
f r a g m e n t e d , w e r e these act iv i t ies tha t no one c o u l d 
be su re of the i r s c o p e or r ange . 
The C a n c e r Research Cen te r has c h a n g e d th is 
s i tua t ion by seek i ng ou t t hese d i ve rse ef for ts , 
o rgan i z ing t h e m into mu l t i d i sc ip l i na ry g r o u p s w h o s e 
Peter J. Deckers, M.D., surgical oncologist and director 
of ttie University Hospitai - Cancer Research Center 
Regional Oncology Program, examines patient records 
in the early morning quiet on BC-5. 
f ocus is on cancer , and p r o v i d i n g s u p p o r t to e x p a n d 
the i r e f for ts and inc rease the i r e f fec t iveness. 
These pages , t h e n , are all abou t the m e n and 
w o m e n of the Bos ton Un ivers i ty Cance r Research 
Center a n d the i r i n d o m i t a b l e ques t for answers to 
the u rgen t h u m a n p r o b l e m that Is cancer . 
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A framework for progress 
F ^ I V E years ago, a "grass-roots" movement was launched by eight Boston University and Univer-sity Hospital cancer specialists to explore the 
potential for forming a university-wide cancer center. 
The voluntary efforts of those individuals, and an in-
creasing number of interested colleagues, soon received 
the backing of the Medical Center. The original infor-
mal group of eight grew into an official Medical Center 
Cancer Coordinating Committee of 18 members ap-
pointed by the Medical Center director. 
Today, the Cancer Research Center is a federally 
designated national Cancer Center; it involves the ex-
pertise of more than 60 cancer and cancer-related 
specialists on the Charles River and Medical Center 
campuses; its activities are supported by a Cancer Cen-
ter support grant from the National Cancer Institute, 
and it serves as the focal point for more than $4,220,000 
annually in grants and contracts for cancer research, 
clinical care, and education. 
1 
Sidney R. Cooperband, M.D., director of the Cancer 
Research Center. 
F o c u s e s r e s o u r c e s o n cance r . The development and 
growth of the Cancer Research Center has brought into 
being a major vehicle for focusing the full range of Uni-
versity and Hospital resources on the causes, treatment 
and prevention of cancer. The CRC's strong inter-
disciplinary programs of research, education and 
clinical care are disseminated well beyond the Univer-
sity's borders through a series of active outreach 
programs aimed at improving the quality of cancer care 
delivered by local physicians and community hospitals, 
facilitating the rapid referral of patients with special 
needs, and broadening patient participation in clinical 
research involving new therapies. 
In devising the administrative structure and charter 
of the CRC, the coordinating group's executive com-
mittee organized the numerous existing clinical and 
basic research efforts of medical scientists and other 
health professionals throughout the University into 
functional groups whose central interest is cancer. As a 
result, previously uninvolved faculty have developed in-
creased interests in the cancer field, and activity on the 
part of all concerned faculty has been heightened, 
resulting in the generation of many new grant and con-
tract proposals to government and private funding 
sources. 
Overall funding for independent cancer research and 
investigation, excluding that received for CRC planning 
and support from the National Cancer Institute and for 
large multidisciplinary programs, now averages be-
tween $3 million and $4 million per year, up from less 
than $1 million five years ago. In the past year the CRC 
participated in the preparation and review of 56 in-
dependent research proposals, and applications for 33 
new grants and contracts are pending. 
C o o p e r b a n d n a m e d d i r ec to r . The CRC formally 
came to life in January, 1974, when the president and 
trustees of the University approved the CRC charter 
and the selection of the Center's director, Sidney R. 
Cooperband, M . D . , a professor of microbiology and 
medicine. The charter set forth the CRC's ambitious 
objectives as follows: 
"—To stimulate and support goal-oriented mul-
tidisciplinary programs in cancer research in the 
basic and clinical sciences involving all relevant 
departments at the University; 
"—To encourage and accelerate the application of 
research results to patient care, including 
physical, social, mental, and occupational 
rehabilitation involving services reaching out into 
the community, and 
"—To extend the results of research to hospitals, the 
medical schools, the dental schools, and other in-
stitutional and training programs at a level of in-
tensity appropriate to the mainstream of educa-
tional activities in the Medical Center, at the 
University, and in the community." 
Obviously, the multidisciplinary nature of this CRC 
charter is in strong evidence at the Medical Center, with 
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activities in cancer education, clinical care, and research 
bridging the School of Medicine, the School of 
Graduate Dentistry, and University Hospital. Many of 
these activities are also linked firmly to programs at the 
University's Charles River campus, in the Departments 
of Mathematics, Biology and Chemistry of the College 
of Liberal Arts and in such diverse schools as Nursing, 
Theology, Social Work, Law a.nd the Sargent College of 
the Allied Health Professions. But the CRC has also es-
tablished strong ties with community health institutions 
in both clinical care and education through a Regional 
Oncology Program. And in line with its mandate to ex-
tend the results of its research to patient care and 
education, the CRC is cooperating with area medical 
schools and health institutions. 
An example of this cooperative effort is the CRC's 
membership on the Regional Cancer Control Commit-
tee under the aegis of Boston's Sidney Farber Com-
prehensive Cancer Center. This cooperative effort is 
more than a year old now, and includes the submission 
of a joint Cancer Control Grant application in concert 
with Tufts-New England Medical Center, Massachu-
setts General Hospital, and the Farber Cancer Center. 
The proposal has been approved, and funding began as 
of June 1, 1977. I t supports the Regional Oncology 
Program and other similar programs at the other 
cooperating institutions. 
A m a g n e t for t a l e n t e d p ro fess iona l s . The creation 
and development of the CRC, culminating in the Mul -
tidisciplinary Cancer Center designation by the N C I in 
November, 1976, has not only stimulated new activities 
on the part of cancer specialists at the Medical Center, 
but has served as a magnet for a number of other tal-
ented professionals. The CRC, working with the medical 
school's deans and department and division chairmen, 
has been instrumental in the hiring of 15 new full-time 
faculty members for positions in otolaryngology, 
medicine, surgery, biochemistry, microbiology, 
pathology, socio-medical sciences, radiotherapy and 
statistics. 
The impact of the Cancer Research Center's mem-
bers on education and training has been significant in 
recent years through the stimulation and coordination 
of multidisciplinary research and investigation projects. 
That accomplishment wil l become evident to the reader 
in the pages that follow, through articles that highlight 
some, but certainly not all, of the cancer activities at the 
Medical Center, the University, and in the community. 
In its commitment to organize and stimulate the 
faculty, to improve their ability to diagnose cancer. 
A typical tumor board meeting. 
treat it effectively, and eventually control it , the CRC 
has set for itself a number of specific tasks, and has 
designed programs to carry them out: 
—The Center coordinates and integrates the basic 
research programs of scientists within the Boston 
University family; 
— i t recruits, stimulates and guides scientists and 
clinicians to form cancer and cancer-related inter-
disciplinary research groups; 
— i t seeks to encourage the rapid expansion of these 
joint research groups so that the communications 
between bench scientists and patient-oriented 
physicians wil l lead to the application of 
laboratory research results to clinical practice at an 
accelerated rate; 
— i t works to spur the development of new programs, 
pilot studies, and demonstration projects in cancer 
research, diagnosis, treatment, education and ser-
vice; 
— i t encourages, lends aid and support, and seeks to 
integrate community programs in all aspects of 
cancer management; 
— i t communicates approved new developments in 
cancer diagnosis, therapy and rehabilitation to the 
community and to affiliated institutions; 
— i t develops and disseminates information related to 
cancer epidemiology in the region, in affiliated 
hospitals and in the Medical Center in order to 
evaluate and improve the modalities of cancer 
diagnosis, treatment and control; 
— i t develops programs to continue improvement in 
the training and education of students, established 
physicians, and allied health professionals. 
M o r e t h a n 60 m e m b e r s . In its four years of planning 
and seven months since designation as a national Can-
cer Center, the CRC has developed a membership of 
more than 60 cancer specialists involved in a broad 
variety of research, teaching and service functions. 
In addition to its planning and Cancer Center sup-
port grants, the CRC and its members have initiated a 
number of large multidisciplinary program grants from 
the National Cancer Institute, the American Cancer 
Society, and private foundations, including the follow-
ing: new approaches to tumor immunotherapy; a mul-
tidisciplinary approach to head and neck cancer; 
cellular kinetics of clinical cancer chemotherapy; deter-
mination of optimal screening frequencies for early 
detection of cervical cancer; measurement of the cost of 
cancer care; etiologic and prognostic factors in breast 
cancer; and lipid nutrition and cancer. 
Training grants which members of the CRC have 
received from the N C I include the Center's enterosto-
mal therapy education program and the oncology 
nurses' training program located at the School of Nurs-
ing, a clinical cancer training grant, and training in on-
cologic immunology at University Hospital and the 
School of Medicine. 
As mentioned above, the CRC has been involved in 
the preparation and review of 56 grants instituted by in-
dependent investigators. More than 70 funded projects 
are now under way. 
W i d e s p e c t r u m of r esea rch in te res ts . In the area of 
research interests, CRC members are active in a wide 
spectrum of cancer-related areas. Groupings, by in-
terests, are in basic tumor immunology, chemical and 
environmental carcinogenesis, endocrine aspects of can-
cer, nutrition and cancer, tumor cell biology, tumor cell 
kinetics, clinical and basic pharmacology, tumor 
virology, and cancer epidemiology. 
Teaching activity by members of the CRC ranges 
through the undergraduate, graduate and postgraduate 
levels. On the undergraduate level, CRC staff take 
part in education courses in 11 of the 15 schools that 
make up the University, in addition to the School of 
Medicine. Additional cancer-related teaching is carried 
out by faculty of the various schools who are not on the 
CRC staff. After surveying all undergraduate education 
at the University that may be related to cancer, the 
CRC has offered to provide expert assistance to a num-
ber of courses on an "as-needed" basis. Examples of 
CRC involvement in the undergraduate programs may 
be seen in Sargent College, which offers a brief course 
on cancer diagnosis and rehabilitation; in the School of 
Nursing, which offers a block on special nursing 
problems with cancer patients; and in the School of 
Social Work, which has a course on loss, grief, and 
emotional reactions to body deterioration. 
On the graduate level, cancer-related subjects are also 
taught in a number of the schools of the University: 
Nursing offers two graduate-level courses; Sargent 
College, the School of Theology, and the School of 
Graduate Dentistry ail have one course on the graduate 
level. The School of Medicine has a broad offering of 
courses in which the cancer content has been enlarged 
Frederick Moolten, M.D., CRC associate director for the 
Carcinogenesis Program, and microbiology graduate 
student Barbara Schreiber purify toxin for tests against 
tumor cells. 
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and strengthened through the participation of the 
CRC's Education Committee. In addition, there are a 
large number of clinical clerkships and electives in sur-
gical, medical and radiotherapeutic oncology, and in 
many basic science labs. 
M e e t i n g s , c o n f e r e n c e s , s e m i n a r s . On the 
postgraduate level, there are educational opportunities 
for resident house staff and staff physicians through 
tumor board meetings, tumor conferences, cancer 
seminars, and tumor pathology conferences, all held 
weekly, and through the biweekly oncology staff 
meetings, and the annual visiting professor program. 
Nursing staff education and training opportunities 
are provided through nursing oncology workshops at 
University Hospital and in affiliated hospitals, and in a 
nursing oncology lecture series offered 20 hours per 
year in outreach and affiliated hospitals. 
Continuing education for practicing physicians is 
available through the CRC's outreach program: Tumor 
boards and tumor conferences are held in outreach 
hospitals on a biweekly or monthly basis; tumor clinics 
are held weekly or biweekly; cancer seminars are pre-
sented bimonthly or three times a year; specialized 
block courses are offered once a year. 
In the area of clinical investigation, the CRC's 
programs are conducted primarily at University 
Hospital, Boston City Hospital and the Boston 
'Veterans Administration Hospitai and, to a lesser ex-
tent, through the more than 20 affiliated community 
hospitals. The center of this clinical activity is on Uni-
versity Hospital's two specialized cancer patient 
floors—the Medical Oncology unit of 40 beds and the 
Surgical Oncology ward of 30 beds. More than 1,200 
new cancer patients are seen at the three hospitals per 
year. 
C l i n i c a l r e s e a r c h i n c l u d e s c h e m o t h e r a p y . Clinical 
cancer investigation includes new methods in the use of 
drug chemotherapy, utilizing a basic understanding of 
tumor cell kinetics; adjuvant tumor immunotherapy in 
cooperation with the basic immunology group; the ef-
fect of nutrition on cancer; endocrine therapy for breast 
and ovarian cancer in cooperation with the basic en-
docrine groups of the Department of Biochemistry; ad-
juvant chemotherapy for lung cancer; urological cancer 
studies; chromosomal research of malignant cells; 
Sharon Seweic, a nurse on the surgical oncology floor, 
notes a patient's condition. 
hematological cancers and the possible use of bone 
marrow transplantation; and the development of new 
pharmacological agents. There is extensive cooperation 
between the clinical and basic research groups in 
developing new protocols and treatment regimens. 
In addition, the medical, surgical and radiotherapy 
groups participate in national cooperative group studies 
in chemotherapy with the Eastern Clinical Oncology 
group, the National Surgical Adjuvant Breast group, 
the Radiotherapy Oncology group, and specialized 
groups interested in prostate and bladder cancer. These 
groups place patients from different institutions on a 
common protocol of treatment so a large patient 
population can be treated at the same time and the 
results tabulated and analyzed by a central data 
management group which speeds the process of 
evaluating new drugs and treatment plans. 
The two cancer patient floors are staffed with ex-
perienced and specially trained oncology nurses and on-
cologic specialists; cancer patient management is 
a cooperative and multidisciplined effort. Their ap-
proach includes taking care not only of the patient, but 
also of the family, for cancer affects everyone associated 
with the patient. Thus, the team includes radiothera-
pists, medical and surgical oncologists, psychiatrists, 
nurses, social workers, theologians, and many other 
allied health professionals. Finally, the many specialists 
available at the Medical Center and Cancer Research 




Seeking the answers 
j j * The research efforts of CRC members 
Cell surface may yield clues 
to mystery of uncontrolled 
tumor cell growth 
make contact with surrounding cells is called contact in-
hibition, and this process, along with other kinds of 
Asher D. Kelman, M.D., Ph.D., a key research member 
of the CRC and an assistant professor of microbiology, 
and graduate student Steve Edmonds observe the ef-
fects of platinum complexes on DNA. 
cell-growth controls, is thought to be mediated in some 
way by the cell surface. Frederick L . Moolton, M . D . , 
an associate professor of biochemistry and associate 
director of the CRC, explains: "We don't know what 
causes a normal cell to stop growing, but we think the 
cell surface may play a quite crucial role. After all, the 
cell receives information, including controlling in-
fluences that might come from outside, through its sur-
face." 
Consequently, Moolten explains, a great deal of 
scientific interest has focused on the possibility that 
tumor cells behave abnormally because their surface is 
altered. That the surface of tumor cells is indeed altered 
is supported by an abundance of evidence. The problem 
lies in the fact that, to date, no single alteration has 
been found to be universal in tumor cells, and it is not 
yet clear which alterations may play a role in causing 
the cell's uncontrolled growth, and which may be sim-
ply secondary effects. 
In a recently completed study of the carbohydrate 
molecules that are associated with the cell surface, 
Moolten and his associates found differences in car-
bohydrates between normal and tumor cells. "Certain 
carbohydrates which were part of the membrane of the 
normal cells were produced in much smaller amounts 
by the tumor cell," Mollten explains. "What one has to 
try to do with these and other changes found in tumor 
cells is to find some way to determine whether they are 
the cause of the abnormal behavior of these cells." 
W h e n c e the m i s b e h a v i o r ? In another, ongoing study, 
Moolten's laboratory is looking at changes in the cell's 
ability to take up materials from its environment. In an 
effort to elucidate what Moolten calls "the mechanisms 
by which tumor cells misbehave," the researchers are 
studying in particular the ability of the cell surface to 
transport sugars from outside to inside the cell, since 
evidence has been found that tumor cells usually take 
up sugars, like glucose, at a faster rate than normal 
cells. What they hope to find is that this change may 
somehow be related to the cell's uncontrolled growth. 
What they have, in fact, found so far seems to indicate 
that it is not the sugar uptake itself, but the membrane 
by Lorraine Loviglio 
W H E N a normal cell is transformed into a cancer cell—whether because of exposure to chemical carcinogens, cancer-producing 
viruses. X-rays, or other agents—it acquires certain 
characteristics, the most striking of which is loss of the 
ability possessed by normal cells to stop multiplying at 
the appropriate time. When you cut your finger, the 
cells surrounding the wound begin to divide more 
rapidly to heal the wound. When the incision has been 
covered over with new skin and tissue, the cells stop 
multiplying. They know, somehow, when to stop. 
Cancer cells don't know when to stop. They continue 
to multiply out of control, piling up on one another and 
forming a tumor. Further, they invade surrounding 
normal tissues, and can migrate to distant sites in the 
body through metastasis. 
I n f o r m a t i o n c o m e s t h r o u g h su r face . The braking ef-
fect on cell multiplication that occurs when normal cells 
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change of which the sugar uptake is only a reflection, 
that is probably the crucial factor. 
"We think that the membrane change which is reflec-
ted in increased sugar uptake probably does a lot of 
other things also, and it is some of these other things 
which may be crucial to the development of a tumor," 
Moolten says. 
As to what actually triggers the transformation of the 
cell in the first place, Moolten believes that the most im-
portant way in which human tumors arise is probably 
as a result of exposure to chemicals. "Some people 
believe that chemicals may activate viruses to cause can-
cer, but I don't think it's necessary to invoke that com-
plicated a mechanism, in most cases. I think we can 
assume that, in most cases, the chemicals act on the 
D N A of the cell to cause a mutation. This change in the 
hereditary properties of the cell causes a change in the 
behavior of that cell and of all its progeny." 
N o e v i d e n c e of d i r e c t l i nk . What is not known is exac-
tly what the change consists of and what cellular func-
tions are primarily affected by it . "We can speculate, 
for example, that maybe in some cases what is changed 
is the D N A that controls certain aspects of the cell sur-
face," Moolten continues. "We don't have evidence for 
a direct link between the causal agent in a tumor— 
whether it be a chemical, a virus. X-rays, or something 
else—and the specific changes that have been observed 
biochemically, like changes in the membranes. 
"We haven't completed the chain of evidence linking 
the agents which cause tumors to the observed results of 
uncontrolled behavior. We know what some of the 
things that cause tumors are. We know what the final 
result is. We have some observations along the way. 
What we have to try to find out is whether these obser-
vations are really the crucial ones." • 
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Ryser group studies the way 
materials move by pinocytosis, 
hoping to pinpoint difference 
between normal, tumor cells 
r • T HE process by which large molecules move 
I from outside the cell, across the cell membrane 
- A . and into the interior of the cell itself, and what 
happens to those materials once they are inside the cell, 
might provide a clue to the fundamental differences be-
tween the surface of a cancer cell and that of a normal 
cell, according to Hugues J.-P. Ryser, Dr. Med., a 
BUSM professor of pathology and pharmacology and a 
CRC member. 
Attention to such molecular processes is extremely 
important in cancer research, Ryser maintains. "One of 
the major problems in cancer research is to find a basic 
difference between normal cells and tumor cells," Ryser 
says. "That has been the wish, the hope, the drive of, 
let's say, 80 percent of cancer research." 
Process c o u l d m e a n m u c h t c c h e m o t h e r a p y . 
Elucidation of this particular molecular process, called 
pinocytosis, can help scientists develop a tool for deter-
mining these basic differences, and the process itself can 
also be employed as a means for administering 
therapeutic chemicals within the cell, Ryser says. 
Water, nutrients and other elements can flow freely, 
or diffuse, into normal cells and tumor cells alike. These 
materials, he explains, are small molecules and com-
pounds. Ryser is studying the ability of certain 
macromolecules—substances that could be thousands, 
or perhaps millions, of times the size of the small 
molecules—to cross the membrane into the cell as well. 
In the pinocytotic process, a macromolecule attaches 
to the outer surface of the cell membrane. A t that point, 
a small pocket, or crypt, begins to form around the 
macromolecule on the interior of the surface as the 
macromolecule moves across the membrane and inside 
the cell. In almost all cases, at the end of the several-
step process, the macromolecule is broken up and is 
released, as bits and pieces, into the interior of the cell. 
Pinocytosis is significant, Ryser says, because scien-
tists have determined that certain substances can be 
"complexed" as Ryser puts it, with the macromolecules 
that are known to be taken up by the cell. Through this 
piggybacking of substances, scientists can introduce 
whatever materials they want directly into the cell. 
P e r m i t s l ow d r u g c o n c e n t r a t i o n . Chemotherapy is 
one important practical application of this principle. 
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Sidney R. Cooperband, M.D., director of the Cancer Research Center, discusses some 
research results with Elinor Levy, Ph.D., a member of the CRC and an instructor in 
microbiology, while graduate students John Corvese (left) and Michael Allen (right) 
listen. Levy is doing experiments to purify some of the cells involved in immune regula-
tion, particularly the M cell. 
Microscopic slide shows bladder tumor (lower right) in-
vading small blood vessel. Cells about to detach at 
edge of tumor illustrate one of mechanisms by which 
cancer can spread: once the tumor cells enter the 
bloodstream, they can be carried to a distant part of 
the body, where they may lodge and begin to grow 
another tumor. 
Because the chemotherapeutic agents are introduced, 
along with certain macromolecules, directly into the 
cell, Ryser explains, the concentration of the free drug 
administered can be relatively low, since the drug is 
working from within the cell itself. This type of chemo-
therapy has been used in both animals and humans. 
Ryser is interested in determining what factors wi l l 
increase the penetration of macromolecules into the 
cell. He has already determined that a strong positive 
electrical charge in the macromolecule, the size of the 
macromolecule, and the way certain macromolecules 
tend to " f i t " particular areas on the cell surface all have 
this effect. 
Ryser explains that he and his colleagues have 
isolated some differences in the responses of normal 
cells and of tumor cells to the same stimulus. 
"However," he says, "these differences are not across 
the board. We are looking for differences in membrane 
properties that are constant." 
Ryser is also working with Albert L . Politoff, M . D . , 
an assistant professor of physiology at BUSM, on 
causes for cell division, and particularly the role the 
electric membrane properties play in this process. 
"Something must happen for a cell to divide," Ryser 
comments. "There must be a trigger. This question is of 
fundamental importance since cancer is, after all, a dis-
ease of uncontrolled cell division." • N . H . 
Cell-killing teamwork by 
tumor antibodies and power-
ful toxins shows an 
encouraging potential 
CANCER cells—being the body's own cells, however transformed—often evoke a less powerful counterattack by the immune system 
than such clearly foreign agents as bacteria and viruses. 
In addition, they tend to be more resistant to the im-
munity that they do evoke. Tumor antibodies are 
produced and attack the tumor cells, but they are nor-
mally too weak to eradicate the tumor. 
What i f a powerful toxic agent could be linked to the 
tumor antibodies and thus transported to the tumor 
cell, which it would then destroy? Working with two 
powerful toxins—diphtheria toxin and ricin, a potent 
plant protein—Frederick L . Moolten, M . D . , an 
associate professor of microbiology, is turning antibody 
into a killer substance by chemically linking antibody 
molecules with substances so highly toxic that as few as 
two or three molecules will k i l l a cell. His results so far 
with animals have been encouraging. 
T h e a n t i b o d y as a veh i c l e . "These agents by them-
selves would attack a whole variety of cells, including 
normal cells, but by linking them to antibodies, we are 
trying to use the antibody as a vehicle for attaching 
these toxins selectively to the tumor cell," Moolten 
says. 
He started work with Sidney Cooperband, M . D . , on 
this imaginative approach in 1970, and is continuing the 
work largely on his own at the present time. Using the 
technique, he has successfully eliminated some tumors 
in hamsters, but technical problems involving the 
potency of the toxins remain to be solved before the 
method wil l be safe enough for human 
application. • L . L . 
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Immunotherapy's anti-cancer 
value is still unproven, but 
studies give rise to important 
new understanding 
by Susan Gertman and 
Lorraine Loviglio 
S CIENTISTS have long been puzzled by an apparent short-circuit in the body's cancer-fighting mechanism: Why does the immune 
system, so successful in protecting against infection, 
fail to recognize a tumor as a foreign substance and 
reject it? 
Scientists in the developing field of tumor im-
munology and its clinical branch, immunotherapy, are 
trying to combat tumors by manipulating the immune 
system to enhance its ability to kil l cancer cells. "The 
conundrum in tumor immunology is that tumors grow 
despite the fact that there is host immunity," says Sid-
ney R. Cooperband, M . D . , director of the Boston 
University Cancer Research Center. "No one has ever 
fully understood this. What is crazy about the whole 
thing is that tumors somehow evade immunity." 
Not j u s t o n e s y s t e m . A breakthrough in immunology 
occurred with the discovery that immunity is not one, 
but at least two, and possibly three or four systems 
working together. One system, called humoral im-
munity, protects against infection by producing an-
tibodies. Antibodies, however, do not ki l l many tumor 
cells, i f they ki l l any at all. In fact, according to Cooper-
band, a professor of medicine and microbiology at 
BUSM, they act in some circumstances to enhance 
tumor growth. 
A second system, known as cellular immunity, is 
capable of rejecting tumor cells by producing sub-
stances called T-lymphocytes, or T-cells, a sub-group of 
white blood cells. Recently other reactions that are 
neither of these two have been discovered. 
"For example," Cooperband explains, "macrophages 
(large white blood cells that engulf and consume foreign 
bodies and debris) appear to have the ability to kil l 
tumor cells directly, and there now appears to be com-
ing out of research at the Cancer Research Center 
recognition of yet another system for rejecting tumor 
cells that are present in the bone marrow, the so-called 
M-cell" (see story elsewhere in this section). 
Studying the ways in which tumors evade immunity, 
and attempting to block them, are among the most im-
portant activities of Cooperband's lab. One way tumors 
evade immunity is by provoking an antibody response 
that tends to block the ability of the host to reject 
tumor cells. A second way appears to be by producing 
or stimulating regulatory cells which act to shut off the 
immune response. These so-called T-suppressor cells 
are part of a complex regulatory mechanism that nor-
mally prevents immunity from running amok by 
shutting off the immune response after it reaches a cer-
tain optimum level. 
I m m u n o s u p p r e s s i v e f ac to r s . The third way is by 
producing humoral factors—factors that circulate in the 
blood—which inhibit the ability of the cells to ki l l 
tumor cells. One of these immunosuppressive factors 
produced by cancer cells was discovered in Cooper-
band's laboratory, and is still the subject of major in-
vestigation. Cooperband and his associates discovered 
that in the blood of cancer patients, and in the fluids 
that bathe tumors, there is a substance that inhibits the 
ability of T-cells to kil l tumors. The scientists are 
currently in the process of isolating and purifying that 
factor and attempting to learn where it comes from. 
They will then attempt to find a way to inhibit its sup-
pressing activity, thus allowing T-cells to do their job of 
knocking out tumor cells. 
" I t may well be that everyone develops cancer, but 
only those cancers that develop a mechanism for sup-
pressing immunity continue to grow, while those that 
don't are wiped out by the person's normal immune 
reaction," speculates Cooperband. 
Although antibodies are not effective in killing tumor 
cells, they can be made effective if they are modified in 
such a way that they carry a killer substance. Frederick 
Moolten's modified antibody (described elsewhere in 
this section) has been able to cure animal leukemias. 
Cooperband, in collaboration with Peter Deckers and 
Stanley Leong, is currently extending that methodology 
to a human cancer system, malignant melanoma. They 
are isolating tumor antigens from the surface of 
melanoma cells as a preliminary to making an antibody 
to those antigens. The antibody wil l be linked to 
diphtheria toxin, a very potent killer molecule, which 
wil l then be used to treat melanoma patients who have 
microscopic metasteses. However, the daring new 
therapy won't be ready for use on patients for a number 
of years, Cooperband predicts. 
Since antibodies can block the action of T-lympho-
cytes in attacking tumor cells, there is reason to think 
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that i f one removes anti-tumor antibodies, one may 
enhance the host's ability to destroy his tumor cells. In 
a system currently being developed by Richard Rome, a 
medical student working with Cooperband, blood from 
the host would be taken out of the body and passed 
over a plastic surface containing tumor antigens. Using 
malignant melanoma as an example, Cooperband ex-
plains the procedure: "One isolates the purified antigen 
from the melanoma cells and then chemically links it to 
a plastic surface—in this case, a series of small tubes— 
so that the plasma passes over the surface of the tubes. 
As the circulating antibodies in the blood pass an an-
tigen that they recognize, they grab hold of it, as they 
would when they pass a tumor cell. On a tumor cell, 
they block the surface antigens so the lymphocytes can 
no longer see them and understand that there is a 
foreign antigen. As you remove antibodies from the 
bloodstream, the ability of antibody to bind on the 
tumor cell surface is markedly reduced, and therefore 
T-lymphocytes can now find and see that surface an-
tigen and attack i t . " 
T h e use o f a d j u v a n t s . Immunotherapy procedures, the 
newest branch of clinical cancer care, may work to 
stimulate one immune system, while they suppress 
another that is counter-productive. One method of 
stimulating immune reactions is by administering drugs, 
called adjuvants. "The hope is that i f the patient has 
some immunity to his tumor and is given an adjuvant, 
one that wi l l stimulate cell-mediated immunity more 
than humoral immunity, then the therapy wil l augment 
the patient's own immunological reaction to the 
tumor," Cooperband explains. 
Three substances are currently under investigation at 
the Cancer Center, although none thus far has 
demonstrated a significant ability to prolong survival of 
cancer patients. They include two bacterial adjuvants— 
BCG, a live tubercle bacillus, and C. parvum, a bacteria 
that stimulates bone marrow growth—and a chemical 
agent, levamisol. 
The tubercle bacillus used in these experiments is a 
modified and less pathogenic form of the bacteria that 
causes tuberculosis. Once a patient receives a BCG in-
jection, the body produces an intense immune reaction 
that kills the bacteria and stimulates the production and 
activity of T-cells. BCG was first used in human studies 
at the Pasteur Institute in Paris, where it resulted in 
prolonged survival in patients with myelocytic 
leukemia. However, only one other institution has had 
similar results. 
T h e use o f C . p a r v u m . C. parvum is being used in a 
University Hospital trial in patients who first undergo 
radiotherapy. Since radiotherapy depresses bone 
marrow production, C. parvum has the dual advantage 
of stimulating cell-mediated immunity as well as en-
couraging bone-marrow growth. The bone marrow 
manufactures white blood cells, themselves part of the 
host's resistance to cancer. 
Levamisol, first used to treat worm infestation, has 
been found to stimulate production of tumor-killing 
lymphocytes in patients with severe cancer. Two 
levamisol studies are about to begin at University 
Hospital: one involves patients with advanced lung can-
cer; the other, patients who recently have undergone 
cancer surgery. 
The development of immunotherapy with adjuvant 
drugs is moving toward specific drugs that act upon T-
cells, such as levamisol, and away from non-specific ad-
juvants, such as BCG and C. parvum. Cooperband 
comments: "As our knowledge of drug adjuvants 
becomes more sophisticated, the therapy will become 
more effective. . . . The advantage of adjuvants is that 
you just have to give patients a shot or a tablet and it's 
standardized therapy; it's a mode of treatment that does 
not involve any separate technology." 
Several immunotherapy investigations in animals and 
man that do involve the development of new technology 
are currently under way at the Medical Center. They in-
clude: 
—Transfer factor, a name for a substance extractable 
from blood lymphocytes of an immune donor which 
confers immune reactivity on a non-immune recipient. 
—Exposing T-cells to ribonucleic acid. In this 
procedure, RNA from the lymphoid tissue of an im-
munized rabbit is extracted and incubated with blood 
cells from a patient with cancer. The blood cells pick up 
the immune information that is present in the RNA, 
and are rendered immune. The cells are then reinfused 
into the patient. 
M u c h s t i l l t o b e d o n e . Cooperband compares the 
progress of immunology so far with the early history of 
chemotherapy. "What's happening with immuno-
therapy is that there now seems to be a slight prolonga-
tion of survival, but, with rare exceptions, no cures. The 
early experience with chemotherapy was almost the 
same—early reports were very dramatic about 
prolongation of life, and then, as people started using it 
in all kinds of tumor systems, they had very disap-
pointing early results. As more combinations of drugs 
came into play, and as the tolerance for more drug-
induced toxicity was increased, the symptom-free inter-
vals, or remissions, got longer." Now, of course, 
chemotherapy is recognized as being able to extend sur-
vival in many cancers, and in a limited number of can-
cers, to effect a cure. 
"The trouble is," Cooperband says, "we don't have 
all the pieces of knowledge about the interrelationships 
between tumors and the host's immune response. 
Almost every day, people are discovering other im-
munologic effects, other regulatory mechanisms, other 
cell involvements in immunology which have never 
been fully understood before. 
" I n the long run, I think tumor immunity wil l play a 
major role in treatment of cancer. But it will take 
years." • 
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Bennett identifies M cell: 
guardian against leukemia and 
killer of tumor cells 
A newly discovered group of immune cells, identified by CRC researcher Michael Bennett, M . D . , in 1973 and already 
demonstrated to be effective in surveillance against 
leukemia, may hold the key to the deepening riddle of 
cancer's complex relationship with immunity. 
The cells, called M cells because they depend on the 
bone marrow for their differentiation, are distinct from 
the other lymphocytes—the T cells, B cells, and 
macrophages—already known to make up the cellular 
components of the body's immune system. They may or 
may not be related to the macrophage system, ac-
cording to Bennett, who is an associate professor of 
pathology. 
S p e c i f i c a l l y k i l l t u m o r ce l l s . M cells include a group 
of cells called natural killer cells, which arise naturally, 
without immunization, in humans and animals, and 
which specifically ki l l tumor cells without killing nor-
mal cells. Bennett explains, "We all have these cells, 
which are neither T cells nor B cells nor the usual type 
of macrophage, and they are able to ki l l tumor cells in 
vivo as well as in vitro." 
M cells appear to be specifically toxic for primitive 
cells, and, since tumors usually arise from the more 
primitive elements of a given tissue, " i t may be that 
these cells are much more important than the classical T 
cells and B cells," Bennett believes. 
Bennett had been working since the early sixties with 
Gustavo Cudkowicz, M . D . , a pioneer of bone marrow 
transplantation at State University of New York in Buf-
falo, studying the mechanism of the rejection of bone 
marrow allografts (grafts of tissue taken from a donor 
of the same species as the recipient). In 1973, he dis-
covered that i f he administered strontium 89 to mice, 
they lost the ability to reject bone marrow allografts, 
but still had T cells, B cells and macrophages. From this 
he deduced the existence of another immunocompetent 
cell, one that was responsible for the allograft rejec-
tions, and that failed to develop when the bone marrow 
was destroyed. He called it the M cell. 
Using animal models, Bennett has found that 
eliminating M cells makes animals much more suscepti-
ble to leukemia induction by viruses. Eliminating T cells 
or B cells or macrophages, on the other hand, does not 
change the susceptibility to leukemia significantly. " A t 
Researcher Michael Bennett, M.D. 
least experimentally, the M cell is very important in sur-
veillance against leukemia," Bennett concludes. 
C o n t r o l s i m m u n o s u p p r e s s i o n . One of the effects of 
the leukemia virus is to profoundly suppress the im-
mune system of the host, through the agency of T sup-
pressor cells—thymus-dependent cells which function 
to suppress immune reactions rather than to augment 
them. Bennett and his colleague, Vinay Kunar, M . D . , 
discovered that the M cell, in addition to its role in sur-
veillance against leukemia virus, also controls this 
process of immunosuppression, by regulating and 
limiting the numbers of T suppressor cells in the body. 
Thus, by preventing the suppression of the immune 
reaction through T suppressor cells, the M cell has the 
added beneficial effect of allowing the T cells and B 
cells to function against the cancer cells, too. 
The long-range aim of Bennett's research is to 
develop a way to treat neoplasms—"leukemia would be 
the most logical one, but we'll also include solid 
tumors"—by treating with total body irradiation, with 
or without chemotherapy, to eliminate the tumor as 
much as possible; then to repopulate the immune 
system of the tumor-bearing or leukemic patient by 
means of a bone marrow transplant from a donor who 
is genetically resistant. 
Bone marrow transplants are currently being done 
for acute leukemia, and at one center with considerable 
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experience in this procedure, according to Bennett, "ap-
proximately 30 percent of the patients are being cured, 
whereas normally, using chemotherapy, you would be 
lucky to get 8 or 10 percent." However, bone marrow 
transplantation, at present, is a dangerous procedure; 
not only does it render the patient susceptible to infec-
tion, but it can also lead to a graft-versus-host syn-
drome, in which the donor bone-marrow cells, as they 
grow in the host, react as i f the host were foreign and 
attack him, sometimes with fatal results. Solutions to 
these problems are currently being sought by 
researchers. 
C a n c e r - c a u s i n g agen t s s t u d i e d . Unt i l recently, most 
of Bennett's research has involved virus-induced cancer. 
Recently, he received a new grant to study the develop-
ment of chemically induced cancers, specifically the 
relationship of immunity to the development of precan-
cerous changes in very young animals whose mothers, 
while pregnant, are given cancer-causing agents. Recent 
evidence tends to suggest, Bennett points out, that can-
cer may be related to changes that occur long before the 
disease develops. In the new study, after giving car-
cinogens to the pregnant animals, Bennett wil l study the 
mother animals and their offspring as cancer develops 
in the animals, while paying particular attention to the 
immune system and the role of the M cell. 
"This is a way to see, in chemically induced tumors, 
whether the immune system is important or not," Ben-
nett explains. " A n d the big advantage of the 
transplacental approach is that you can separate in time 
the administration of the carcinogenic agent and 
manipulations of the immune system," because the im-
mune system develops in the infant animal at least 
several weeks after administration of the transplacental 
carcinogen. 
Even after it was discovered four years ago that a cell 
existed that depended upon the marrow for its differen-
tiation, interest in the new M cell was limited. However, 
with the realization that M cells are critical in function-
ing against leukemia, and also that they include natural 
killer cells for neoplastic cells, interest in M cells has 
begun to develop very rapidly, especially in the past 
year. 
" A lot of investigators are now turning their labs 
over to the study of natural killer cells," Bennett ob-
serves. 
i m m u n e sys tem ' s i m p o r t a n c e . On the other hand, 
some scientists—even a number of immunologists— 
believe that tumor immunology doesn't have much to 
offer against cancer. Bennett disagrees. " I think that the 
immune system is important, but that it starts with the 
problem of the M cell." 
There are, however, difficult problems to be solved, 
Bennett concedes. "Every time we learn about a new 
type of antitumor immune cell or antibody, we also 
learn that the tumor cell knew about it long before we 
did, and has figured out a way to escape. That is 
definitely a problem, a big problem." • L . L . 
Platinum compounds studied 
in search for more effective, 
less toxic cancer treatment 
P L A T I N U M , a precious metal perhaps most often associated in the public mind with wedding rings, is the subject of studies at the CRC aimed at un-
derstanding and exploiting its potential value as an ef-
fective anticancer drug. 
Research conducted elsewhere in experimental 
animals and with small numbers of patients has 
demonstrated that certain platinum compounds can be 
effective against cancer, but have side effects that in-
clude possible kidney damage and severe nausea. A t 
B U M C , Asher Kelman, M . D . , Ph.D., an assistant 
professor of microbiology and CRC member, is at-
tempting to determine the molecular basis for the an-
ticancer effects of these compounds in order to devise 
more effective and less toxic analogous drugs for use in 
treating cancer patients. 
"We feel pretty certain that platinum acts by attack-
ing the chromosomes of tumor cells, by linking together 
adjacent bases of D N A and also by linking together the 
two complementary strands which constitute D N A , " 
Kelman explains. 
D u p l i c a t i n g D N A . In order for a cell to divide, the 
D N A must be duplicated, so that each new cell wi l l 
have its own complement of genes. To accomplish this, 
each strand of D N A must be separated and then copied 
to produce two double strands. " I f the strands cannot 
come apart because of drug action, then there's inter-
ference with D N A duplication," Kelman explains. 
Since platinum appears to make tumor tissue more 
sensitive to radiation damage, Kelman's group is also 
investigating the possible benefits of combining 
platinum drug treatment with radiation therapy. 
In a related study, Kelman and his coworkers are 
studying platinum drugs and their effectiveness against 
herpes-virus-infected cells. They are attempting to pre-
vent the herpes virus from multiplying by using 
platinum compounds to alter the structure of its nucleic 
acid. The platinum drug he is working with is known to 
be selective for attack on D N A ; the chemical composi-
tion of herpes virus D N A , because it is particularly rich 
in certain chemical bases, is such that it is likely to be 
very sensitive to inactiviation by platinum drugs. • 
L . L . 
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Sidney Kibrick, M.D., Ph.D., aims his research at the possible link between viruses 
and cancer in humans. , . 
what role do viruses play 
in cancer in humans? 
Kibrick and Kelman attempt 
to discover the link 
the spinal cord. The virus remains there in noninfec-
tious form, and then it responds to various stimuli— 
fever, colds, the sun." 
Another member of the herpes virus group that can 
lie in wait inside the cells until the circumstances are 
right for a repeat performance is chicken pox, which 
can recur years later, in a person who has lost most of 
his initial immunity, as shingles. 
I t has long been noted by epidemiologists that certain 
characteristics of cervical cancer strongly imply that it 
might be caused by an infectious agent. Most strongly 
implicated, on the basis of a variety of evidence, is the 
herpes virus. 
"Herpes and carcinoma of the cervix have a number 
of epidemiological features in common," Kibrick states. 
"But the evidence indicating that one is unequivocally 
responsible for the other is still the million-dollar ques-
t ion." 
A s e a r c h fo r e v i d e n c e . Work in Kibrick's laboratory 
is directed toward the search for some evidence that 
herpes virus is involved in malignant or premalignant 
cervical tissue. Specifically, Kibrick, Kelman and their 
colleagues are looking inside cancer cells either for 
genetic material of the virus or for some sign that this 
material is being expressed—what Kelman calls the 
"fingerprints" of the virus. 
Viruses are, in effect, tiny bits of genetic material sur-
rounded by a protective coat of protein. When they 
multiply in a cell, they must not only reproduce their 
own genetic material, but also manufacture protein 
material to furnish the coat. Traces of these viral 
proteins are the clues to the presence of the virus in can-
cer cells that the BUSM researchers are seeking. 
"From the results we've gotten so far, we believe that 
a number of cervical cancers do, in fact, have evidence 
of herpes virus having been there at one time or another 
in the cells," Kelman says. 
P i n n i n g d o w n a c u l p r i t . In their discussion of the role 
of viruses in cancer, both Kibrick and Kelman empha-
size the interplay of various causative agents and the 
difficulty of pinning down a single culprit. 
"Viruses are really strings of genes, and a very simple 
way of altering the gene content of the cell, as you must 
do i f you are to change a normal cell to a cancer cell, is 
to simply bring in new genes," Kelman points out. "But 
we know we can alter the existing gene by ingesting car-
cinogens, by solar radiation. X-rays, and so on. We 
don't know what the combination is. We do know there 
is overwhelming circumstantial evidence that viruses 
play important roles in carcinogenesis in man." • 
L . L . 
B E G I N N I N G in 1911, when Peyton Rous produced a malignant tumor in a chicken by injecting it with a filtered extract of a tumor from 
another chicken, the fact that viruses cause cancer in 
animals—from birds and frogs all the way up to mam-
mals, including monkeys—^has been well established by 
researchers. 
In spite of intense research activity, however, scien-
tists still have not come up with unequivocal proof link-
ing viruses with cancer in humans. 
E v i d e n c e , in m a n , m u s t b e i n d i r e c t . One of the dif-
ficulties of establishing a viral etiology of cancer in man 
is that one obviously cannot do to a human being what 
Rous did to the chicken. The evidence, when i t comes, 
must be indirect. Another difficulty, points out Sidney 
Kibrick, M . D . , Ph.D., arises from the possibility that 
viruses may not be specific for cancer, but may, under 
appropriate conditions, and in an appropriate host, 
produce malignancy years after an initial infection. 
"The incubation period between the infection and the 
malignancy may be so long that it is very difficult to 
associate the virus with the malignancy," explains 
Kibrick, a professor of microbiology and pediatrics and 
associate director of the CRC for biohazards. 
Asher Kelman, M . D . , Ph.D., an assistant professor 
of microbiology, adds, "Some cancers may be caused 
by an ordinary infectious disease which, in 99.9 percent 
of the cases, does not have a neoplastic outcome. But 20 
or 30 or 40 years later, people with the right genetic 
predispositions, the right cofactors that have occurred 
subsequently—and bad luck—will get cancer." 
One virus suspected of such a delayed-action role is 
the virus responsible for cold sores and fever blisters, 
the herpes simplex virus. Kibrick explains that, once in-
fected with this virus, a person carries i t , very likely, for 
life. As illustration he cites the common sun blister. 
R e m a i n s , in n o n i n f e c t i o u s f o r m . "The sun doesn't 
give you the blister; the virus does," Kibrick points out. 
" I t apparently has the ability to traverse the sensory 
nerves from the site where the initial infection was ac-
quired and it ends up in the sensory ganglia, which lie 
just outside of and connect with the sensory portions of 
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Relationship between breast 
cancer and hormone 
imbalance focus of 
2-pronged $1-million study 
b y C y n t h i a C a r t e r 
r • 1 HE theory that hormone imbalance, partic-
I ularly during the childbearing years, is 
J*- related to the development in later life of breast 
cancer in one out of nine women is currently being 
studied by researchers at the Cancer Research Center. 
I f such a relationship could be proved, it would lead 
to the possibility that simple screening, followed by 
treatment with the appropriate hormone, might prevent 
cancer from developing. This theory is being in-
vestigated as part of a three-year study funded by more 
than $1 million in grants from the National Cancer 
Institute. 
Herbert H . Wotiz, Ph.D., a professor of biochemistry 
at the Schooi and an associate director of the CRC, is 
principal investigator of a $490,000 study of the effect 
of female hormones on the development of breast can-
cer in animal models, and hormone balance and follow-
up treatment of women who have undergone mastec-
tomies. He wil l conduct these studies with James C. 
Melby, M . D . , a professor of medicine and physiology. 
In another aspect of the study, Wotiz will work with 
Marc J. Straus, M . D . , an associate professor of 
medicine and chief of the University Hospital Section of 
Medical Oncology. Straus is principal investigator of 
the three-year, $650,000 study, which, among other 
things, seeks to help physicians determine which 
mastectomy patients wil l respond to hormone treatment 
of recurring tumors. He is associate director of the 
CRC for clinical research. 
C o u l d l e a d t o s c r e e n i n g m e t h o d . I f this concept of 
the etiology of breast cancer can be sufficiently verified 
to make it acceptable to the scientific community, 
Wotiz said, one could conceive of screening all young 
women, especially those coming from cancer-prone 
families, to test for a proper balance of the two female 
steroids: estradiol, the active hormone, and estrioi, an 
anti-hormone, which is antagonistic to the former. 
A variety of data suggests that when the balance of 
these two steroids is in favor of estradiol for a long 
period of time, the risk of breast cancer at menopause is 
increased. I t is possible to determine from testing what 
the ratio is; i f there is not enough estrioi, it may be 
possible to treat women periodically with the anti-
hormone—which has been proven to be safe, even i f 
given in large doses—and perhaps prevent cancer in the 
future. 
The study could also help the many women who do 
not respond to hormone treatment after mastectomies. 
I f it can be determined, by examining tissue, that a 
patient wil l not respond to hormonal treatment, then 
that treatment may be eliminated, saving the patient 
from unnecessary delays in the initiation of proper 
therapy. 
" I f we can verify that hormone imbalance is one of 
the bases for formation of tumors, then we have the 
means of preventing the formation of cancers in some 
women at least," says Wotiz. "Breast cancer is so 
prevalent that i f we are even 10 percent successful, this 
study will have had a major impact." • 
Can one's own voice betray 
the presence of cancer? 
Studies of flow of air in 
vocal tract may be key 
r r i H E smoke from his own cigarette led BUSM 
I research professor Herbert M . Teager, Sc.D., to 
a notable discovery about the way the human 
vocal tract works, a finding that could become the basis 
for a method of using the voice itself as an early detec-
tor of cancer. 
Teager, who has been studying the voice for more 
than five years and the ear for about 15, found that the 
smoke he exhaled was a good example of "separation," 
a concept he had worked with for some time. The 
smoke was not smooth and uniform; rather, it appeared 
to be contained in a jet. 
W h e r e s o u n d is g e n e r a t e d . Scientists, Teager ex-
plained, have long assumed that speech is produced by 
uniform, or laminar, air flow. But Teager, following 
through on his cigarette-smoke observations, thought 
the air flow in the vocal tract might be separated to 
form an unstable jet. " I f this were true," Teager says, 
" i t would mean you generate sound not just at your 
larynx, but all the way up the vocal tract as well." The 
existence of this extended site for sound production 
provides the basis for a diagnostic tool for cancer and 
other abnormalities, he maintains. 
I t is a principle of physics that fluid or air flowing 
through any sort of constriction or making a change in 
direction produces separation. 
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Teager, who is head of biomedical engineering in 
University Hospital's Evans Department of Clinical 
Research, uses ocean currents as an illustration to ex-
plain separated flow. " A t the surface of the ocean," 
Teager says, "you have the current going in one direc-
ti6n, and down below, you can have currents moving in 
entirely different directions." 
His theory about the vocal tract proved valid. Using 
tiny hot-wire anemometers inserted into the mouth and 
throat, Teager located a separate "jet stream" in the air 
flow, and measured how different speech sounds 
changed the direction of the flow. Ninety percent of the 
air flow was exhaled in about 10 percent of the available 
cross-sectional space. 
"This jet," Teager explains, "is very sensitive to the 
conditions around it. When it goes past a cavity in the 
mouth or the throat, i t wil l interact with that cavity, 
and change its flow pattern. Similarly, when it comes 
close to a wall, i t wi l l interact with that wal l ." 
S o u n d s a n d d i r e c t i o n s . The jet stream, Teager says, 
changes direction, depending upon the vocal sound the 
person is making. " ' U h ' sounds and 'ah' sounds are 
due to the jet's deflection in perpendicular directions. 
"Because you are making sounds all the way through 
your vocal tract by changing the direction and am-
plitude of this jet stream, the condition of your vocal 
chords, the inner tract surface and all the cavities, are 
important in the sound you produce." 
Any change in the configuration of these elements 
wil l affect the sound the person produces, according to 
Teager. Cancerous growth and other neoplasms, he 
theorizes, wil l thus alter the sound of a person's voice. 
"The trouble with detecting most of these changes is 
the human ear," the researcher comments. " I f you hear 
someone you know very well, and they have some 
alteration in these cavities, you'll know they sound dif-
ferent. But for the most part, unless you have a tape 
recording of how a person sounded last week, you 
might miss it . Even so, the information is all there in the 
sound that is produced." 
V o i c e t a p e par t of m e d i c a l r e c o r d ? Thus, a taped 
record of a person's voice, perhaps as a part of his or 
her medical record, might, when compared to subse-
quent recordings, enable a physician to detect cancer or 
other growths in the vocal tract at a very early stage. 
" A good part of curing cancer," Teager comments, 
"is catching things early. Normally, when we try to 
gather information about a person's body, we are 
limited to probes; you can inject a dye in a per-
son . . . that kind of thing. But those methods can be 
kind of violent. Here, you have a built-in probe—the 
voice. I f we learn to use it properly, 1 think it could be 
very important in the early detection of cancer and 
other diseases of the vocal-pulmonary tract." • N . H . 
Air flow in vocal tract as a possible means of detecting the presence of tumors is a 
special research interest of Herbert M. Teager, Sc.D. 
ĵli;̂  Improving the odds 
The CRC's clinical programs 
Humane clinical care 
stands at the hub of 
a multitude of CRC 
programs on cancer 
by Owen J . McNamara 
H U M A N E clinical cancer care, whether it is aimed at curing the disease, controlling it, or rehabilitating the patient, stands at the hub 
of the multitude of cancer research, education and 
training activities at the Cancer Center. Most of the 
programs of a clinical nature are located at University 
Hospital, Boston City Hospital and the Boston 
Veterans Administration Hospital, the principal af-
filiates of the School of Medicine. There are also 
clinical activities at a growing number of community 
hospitals involved in the Regional Oncology Program. 
Clinical faculty from the School of Medicine, staffing 
University Hospital, BCH and the V A , see some 1,200 
new cancer patients each year. The patients for the most 
part come from the New England area, although some 
do come from other parts of the country and from 
abroad, as was the case several weeks ago, when a 
Greek physician sent his wife here for breast cancer 
treatment. 
Fi rs t s e p a r a t e p a t i e n t un i t . The Cancer Center's 
clinical oncology program is based on strong sections of 
medical oncology and surgical oncology and an active 
radiation medicine department. Peter Mozden, M . D . , 
associate director for cancer education and training of 
the CRC, headed the Hospital's first oncology section, 
which was one of the first in the nation. The section in-
cluded both medicine and surgery when it was opened 
in 1965, although administratively it came under the 
Division of Surgery. The medical/surgical oncology 
patient unit that opened on the fifth floor of the 
Hospital's Robinson Building that same year was the 
first such unit in the country in a university teaching 
hospital. 
Because of the demonstrated success of the Surgical 
Division's oncology section in developing a systematic 
approach to cancer care, and spurred by the increasing 
admissions of cancer patients, the Division of Medicine 
in 1974 created a separate section of medical oncology 
and appointed Marc J. Straus, M . D . , as its chief. 
The 30-bed surgical cancer unit was designed to meet 
the varied requirements of effective clinical manage-
ment of cancer patients, and the psychosocial needs of 
the patients and their families, as well as the needs dic-
tated by the education and training programs that 
would be part of the unit. The Hospital willingly 
reduced the "bed density" so that the unique needs of 
this cancer care unit could be met. 
The medical cancer unit, a 34-bed facility in the F 
Building, was opened in September, 1974, under the 
direction of Straus. Approximately two-thirds of the 
patients on this floor have solid tumors, while the 
remaining third have hematologic diseases. Like the 
surgical oncology unit on BC-5, the medical oncology 
floor has been designed to provide conference rooms 
and spaces suitable for teaching and clinical research. 
The medical oncology inpatient unit is also the locale 
for an outpatient oncology clinic, where an increasing 
number of patients are receiving chemotherapy treat-
ment. 
T r a d i t i o n a l s t a n d p r o v e s w r o n g . There had been a 
traditional feeling in medicine that having several or 
many cancer patients together in a common area was 
bad, that is, i t was depressing for cancer patients and 
their families. Actually, nothing could be further 
from the truth, according to Mozden. "This was 
demonstrated years ago," he says, " i n institutions that 
specialized in cancer care. I t was found that cancer 
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staff physicians gather for weekly multidisciplinary tumor conferen 
clinical cases. 
patients actually derived added security from sharing 
their concerns with others who had similar problems, or 
by talking with physicians and nurses who could speak 
openly and frankly about cancer, its special problems 
and the various treatments that can be brought to 
bear." 
The oncology unit "experiment" at University 
Hospital showed clearly that the concept of a "cancer 
floor" in a general teaching hospital was not only 
desirable, but was eminently successful in terms of bet-
ter patient care and better patient-family-staff relations. 
According to Mozden and Straus, the special units 
have proven their value, primarily in the special 
emphasis they allow oncology personnel to place on the 
psychological needs of the patient and his family, the 
way the units lend themselves to specialized training 
programs for nurses and other oncology specialists, and 
the ease with which the latest research advances can be 
applied directly at the patient's bedside, thus helping to 
close the traditional "gap" between research and 
clinical care. 
R a d i a t i o n m e d i c i n e ' s ro le . The Department of Radia-
tion Medicine, headed by Merri l l Feldman, M . D . , CRC 
associate director for radiotherapy, participates actively 
in the medical and surgical oncology sections' clinical 
for discussion of difficult 
activities, as well as educational and research programs. 
The department's facilities include a 42-million-
electron-volt Siemens Betatron and a Toshiba cobalt 
unit. Approximately 600 new patients are seen annually 
in the department. 
Information-sharing crucial 
Because cancer cuts across medical specialty lines, 
research and education are closely tied to clinical care 
through a variety of information-sharing sessions keyed 
to problem cases or new treatment modes. 
Oncology rounds are held twice daily on both the 
medical and surgical oncology units, and involve 
medical students, the assigned residents and interns, at 
least one staff oncologist, and nurses from the floors. A 
weekly cancer seminar is geared especially to the un-
dergraduate medical students and residents, and is con-
ducted in small-group sessions by members of the on-
cology staff. 
T h e m u l t i d i s c i p l i n a r y a p p r o a c h . Tumor board 
meetings, held each week, are aimed especially at the 
practicing staff physicians, with students and junior 
house staff able to observe the multidisciplinary ap-
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proach being employed for decision-making in difficult 
clinical cases. Staff members from throughout the 
Medical Center are encouraged to present problem 
cases for discussion by a group that includes medical 
and surgical oncologists, radiotherapists, pathologists, 
psychiatrists and social workers. This approach to the 
management of cancer problems has worked well; the 
oncology staff leadership expects that as concepts of 
treatment guidelines and clinical-care review 
mechanisms become more firmly established, the con-
cept of the tumor board wil l be even more widely accep-
ted in cancer management. 
Yet another clinical evaluation mode is the weekly 
conference centered on patients who have been newly 
admitted to the oncology units and have been examined 
by house staff and students on the oncology services. 
The aim of this conference is to demonstrate that there 
is a method and discipline to the systematic evaluation 
of a cancer problem, and that it is important to have the 
input of several disciplines during the initial planning of 
evaluation and therapy. 
A tumor conference is held weekly for the presenta-
tion to students, house staff and active medical and sur-
gical staff of a pertinent topic in the cancer field by 
Cancer Center specialists and experts from other 
teaching institutions in Boston and elsewhere. 
I n t e r a c t i o n b r i n g s resu l t s . The varied specialties 
engaged in clinical cancer activities come together at a 
cancer research conference once each month to discuss 
research with the Cancer Center's basic scientists in 
such fields as biochemistry, virology and immunology. 
These meetings, although not directly tied to clinical 
cases, enhance the continuing cross-fertilization of 
ideas, as groups with common goals but different dis-
ciplines and approaches have an opportunity to learn of 
each other's work and problems. Such interaction is 
more and more frequently resulting in joint research ef-
forts into the causes, cure and treatment of cancer. 
The adjuvant modes of therapy 
The one-to-one setting developed for oncology 
patients at the Cancer Center helps to reduce the ten-
sion and anxieties that usually surround cancer. The 
nurses on F-4 and BC-5 get to know the cancer patient 
and his family from the first day. 
"Our new treatments and the toxic and powerful 
drugs being used are explained to the patient in great 
detail," according to Mozden. "One of the lessons we 
have well learned is that when the patient and his family 
are well informed, many anxieties and tensions are 
curbed." 
One c o n c e r t e d a t t ack . Responsibility for the cancer 
patient no longer belongs to any single doctor, he 
pointed out. "Our stress is on getting a number of 
disciplines—surgery, chemotherapy and hormone 
therapy, radiation medicine, and immunology—^joined 
in a concerted attack. The cancer patient is presented 
with a collaborative effort, a plan involving a combina-
tion of treatment modalities to treat his disease from 
the outset. The team approach is the name of the 
game." 
Mozden explains that, nationally, 35 to 40 percent of 
cancer patients are being cured. "Wi th our present 
technology, we soon should be able to cure 50 to 60 per-
cent. With this group, the answer lies in how well we 
employ the technology and resources we have on hand. 
"Now," Mozden says, "assuming we are able to cure 
50 percent of the cancer patients—what about the 50 
percent who cannot be cured? Our aim is to allow them 
as much time as possible, with the disease under con-
trol, with as good a quality of life as is possible. We 
arrive at this control through the use of drugs, hor-
mones and immunology. 
"The curative modes of treatment for cancer are sur-
gery and radiation medicine. But there is a growing 
realization that, since cancer in most cases is a systemic 
disease, it should be attacked systemwide, right from 
the first sign. And, although surgery and radiation 
medicine are the curative agents in cancer, they are in-
adequate when the disease is systemic, since they are ap-
plied locally. A patient can have surgery or radiation 
therapy at a localized site, but 50 percent of the time, 
the patient wil l be back a year or so later, with 
symptoms in another site. The disease had begun 
spreading from day one." 
R e a c h a l l b o d y a reas . " A t University Hospital, we 
treat the patient from day one with systemic ther-
apy, through the use, along with surgery or radia-
tion procedures, of 'adjuvant' modes of therapy— 
chemotherapy, hormone therapy or immunotherapy. 
These adjuvant modes formerly were used only to con-
trol cancer after the patient came back showing new 
signs. Now, we use them to support the curative modes 
of therapy from the outset, for they possess the poten-
tial the curative modes lack— they can reach all areas 
of the body." 
Also, chemotherapeutic agents, hormones and im-
munotherapeutic agents are maximally effective when 
the tumor burden is small, as it would be immediately 
after surgery or radiation therapy. Once the cancer cells 
have become well established, and have grown to visible 
size, these "adjuvant" modalities are less effective, and 
temporary remission or control can usually be achieved 
only for a comparatively short period of time. 
Radiotherapy: Sklii oniy haif battie 
Radiation medicine, an integral part of the cancer-
treatment armamentarium, obviously requires staff 
members who are highly skilled in carrying out the 
treatment plans devised by radiotherapists. But, in the 
view of department chief Feldman, skill is only half the 
battle; radiation medicine personnel have to be much 
more than technicians. 
Radiation medicine brings out strong emotional reac-
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tions in patients, and technicians in Feldman's depart-
ment, like the oncology nursing staff, "have to be em-
pathetic people, have to really be the kind of people 
who can carry the ball. Our people have a one-to-one 
relationship with patients, and sometimes it can really 
be tough. We are dealing with only one specific 
diagnosis—cancer—and a lot of patients have advanced 
cases, and they know they are going to die, even as they 
go into therapy; so from day to day, they have their 
emotional problems, too, and their own defenses." 
600 n e w p a t i e n t s a year . The department's staffers see 
the full gamut of such emotions, for they see 50 to 60 
patients every weekday, and there are approximately 
600 new radiation-therapy patients each year. 
"Some people feel that i f they've been referred for 
radiation therapy, that means they have advanced 
cases, or terminal disease. This was the stigma in the 
past, that when you had to have radiotherapy, it meant 
that your cancer was really serious and advanced, 
because the surgeons couldn't cure it, and no one else 
could, so you were going to die." 
Feldman says he thinks some of that stigma remains, 
although patients are better educated about their dis-
ease now and radiotherapy has advanced to a more 
definitive role as primary, as well as adjuvant, treat-
ment. 
"The other thing is the fear of the diagnosis per se. A 
lot of people wi l l deny the diagnosis of cancer; a lot of 
other people will confront it, live with it, start to deal 
with it . I t varies from patient to patient, family to 
family, from one variety of the disease to another." 
Another emotional situation Feldman's staff must 
deal with involves excessive fear of treatment "side ef-
fects." There are occasional side effects, ranging from 
nausea to diarrhea or hair loss, but Feldman points out 
that they all depend upon the body area being treated, 
so they can be anticipated and treated. 
"These things are minimal and transient, and they are 
mostly controlled by drugs. We have patients who come 
in expecting to get sick because one of their neighbors 
had a treatment once and got nauseous—but in 99 per-
cent of those cases, the patient receives treatment 
without getting sick. Our technicians work very hard at 
allaying such fears and educating their patients." 
Goal: an Infection-free environment 
The best-laid therapeutic plans of the finest oncology 
teams wil l come to nothing if the patient these physi-
cians are attempting to cure or keep alive is not in an 
impeccable clinical setting, free from the dangers of in-
fection and contamination. Although this may be the 
dictum of any well-run clinical unit, the oncology staff 
at the Cancer Center is taking extraordinary steps to 
achieve the optimum infection-free environment for 
cancer patients. 
A t t a c k i n g t h e i n f e c t i o n p r o b l e m . Alexander S. D . 
Effectiveness of radiation therapy in curing Hodgkin's 
Disease is evident from these two photos. In the upper 
photo, a large mass is present in the upper right lobe of 
patient's lung (upper left of photo). In lower photo, a 
normal chest X-ray shows the mass has disappeared 
after a full course of radiation therapy. 
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Spiers, M . D . , an outstanding British oncologist, in 
January, 1976, joined the Section of Medical Oncology 
and is working with section chief Straus to develop in-
novative clinical projects aimed at the infection 
problem shared by oncologists everywhere. 
(Chemotherapy treatment suppresses bone-marrow 
production, thus reducing the number of white blood 
cells, the body's natural infection-fighters.) Spiers 
describes several noteworthy programs to fight infec-
tion now under way in University Hospital's medical 
oncology unit: 
" A particularly interesting project in this area is the 
introduction of a special isolation room on our F-4 
patient unit. The room is being structurally modified 
and is being furnished with a laminar air-flow bed, 
which surrounds the patient with a steady stream of 
sterile bacteria-free air, giving him that sterile air to 
breathe, and at the same time, protecting him from con-
tamination from the environment and from his atten-
dants." 
Spiers explains that the use of the isolation facility is 
being coupled with gastrointestinal decontamination 
through nonabsorbable antibiotics. The antibiotic com-
bination differs from that which has been used in the 
past, and is less expensive and bacteriologically more 
desirable. 
" I n addition," he says, "we are introducing on F-4 
the use of chlorohexidine, which is a very superior an-
tiseptic, completely new in the United States, although 
it has been used in other countries for a number of 
years." 
Another clinical project aimed at the control of 
infection in cancer patients is the development of a 
leukapheresis service in collaboration with the U.S. 
Naval Blood Research Laboratory (which is located 
at the Medical Center) and the Department of 
Hematology. "We are planning to treat cancer patients 
intensively with cytotoxic drugs, which wil l produce 
dangerously low white-cell counts and an increased 
liability to infection," Spiers said. "The approach in 
this study," he explained, "is to treat these patients 
prophylactically, with white-cell transfusions obtained 
from relatives. The white-cell concentrates are obtained 
by filtration—filtering the donor's blood through 
special sterile filters that wi l l remove the white blood 
cells, which subsequently can be washed off and used as 
transfusions to the patient." 
An entirely new venture. Spiers says that although 
white cells have been used extensively in the past for the 
treatment of patients with cancer, infection and low 
white-blood-cell counts, their prophylactic use—that is, 
administering them regularly to patients who have not 
yet developed an infection—is an entirely new venture. 
"The importance of this project," says Spiers, "is that 
i f we can show effective protection by this means, it 
may not be necessary to use extremely expensive isola-
tion facilities, which, in the foreseeable future, could 
only be made available to a very small percentage of 
cancer patients; so i t is possible that leukapheresis, 
which is much less expensive, might be of much wider 
application in treating cancer." 
The leukapheresis project. Spiers says, is being 
carried out under the auspices of the University 
Hospital Blood Bank. He noted in this regard that i f the 
project is successful and spreads elsewhere, 
leukapheresis might someday become a regular part of 
blood-bank services. • 
Bold and innovative use of 
chemotherapy at UH shows 
great value in relieving 
symptoms, gaining remissions 
C H F M O T H F R A P Y , the treatment of patients with potent, cancer-fighting drugs, has taken new directions at the CRC as an important 
therapy after attempts at surgical cure and as a means 
of prolonging life and relieving symptoms for those 
beyond surgical cure. 
University Hospital's Section of Medical Oncology is 
using a powerful three-drug regimen, usually reserved 
for those with advanced disease, for women who have 
undergone surgery for breast cancer and have a good 
prognosis for cure. Only one of the 20 patients who 
received the treatment has had a recurrence of cancer in 
the two and one-half years since the study began, says 
Marc J. Straus, M . D . , chief of medical oncology. 
Without such treatment, the expected recurrence rate at 
two years for this population is between 30 and 40 per-
cent. 
"Over the past two years there have been reports in-
dicating that treating breast-cancer patients with drugs 
that are thought to be most effective for advanced dis-
ease may increase the time to recurrence or potentially 
cure patients who have microscopic amounts of tumor 
that remain after surgery," Straus says. 
Now used on osteogenic sarcoma. Another develop-
ment in the aggressive use of chemotherapy after and 
sometimes before surgery is the treatment of osteogenic 
sarcoma, a bone cancer that occurs most frequently in 
children and young adults. I t is a particularly lethal dis-
ease: Surgical attempts to cure osteogenic sarcoma are 
successful in only 10 to 20 percent of cases. However, 
aggressive chemotherapy combined with surgery has 
reduced the recurrence rate at two years to less than a 
quarter of the rate for surgery alone. 
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A t University Hospital, Alexander S. D . Spiers, 
M . D . , an eminent British oncologist, treats osteogenic 
sarcoma with a combination of drugs that includes 
adriamycin and methotrexate, a drug that is given in 
doses 100 times greater than usual. This particularly 
high dose is followed by an antidote. 
"We haven't had serious adverse effects as yet as a 
result of chemotherapy in any of our osteosarcoma 
patients. I think this has to do with our experience in 
medical oncology—knowing how to monitor patients 
carefully, maximizing doses of drugs at acceptable 
levels of toxicity," says Spiers, a member of the CRC. 
T h r e e r e m a r k a b l e e x a m p l e s . In patients who are 
beyond surgical cure, chemotherapy has been par-
ticularly useful in producing remissions or relieving 
symptoms. Three remarkable examples of the effects of 
chemotherapy, often used in conjunction with surgery, 
radiotherapy or immunotherapy, are in the treatment of 
advanced lung, breast and prostate cancers. 
— A chemotherapy regimen developed by Straus 
has resulted in a 9.3-pcrcent remission rate in patients 
with advanced small-cell lung cancer, one of the 
worst known malignancies. A patient with untreated 
small-cell cancer has a survival expectancy of less 
than three months from diagnosis. 
The three other types of lung cancer, large cell, 
adenocarcinoma and epidermoid—are less responsive 
to therapy. However, 60 percent of patients treated 
for large-cell and adenocarcinoma responded to 
treatment. 
Straus designed the drug protocol based on the 
concepts olThe interaction of two powerful anti-
cancer drugs, Cytoxan and methotrexate, and the 
growth behavior of cells. Although these drugs are 
now commonly used in the treatment of cancer, 
Straus attributes the success of the regimen lo the 
doses and timing of the injections. 
"Lung cancer is a disease that often is not treated 
when it is advanced, but we think that most patients 
with advanced lung cancer can benefit from one of 
the chemotherapy regimens,'' Straus says. 
' R e m i s s i o n ' in c a n c e r - c a r e t e r m s . In cancer care, 
the term "complete remission," means that no 
evidence of the disease can be found upon examina-
tion. Patients who go into complete remission gain an 
additional one to three years of life, Straus says. 
Other patients may achieve a partial remission, in-
dicating that the tumor has been substantially 
reduced. A complete remission is not a cure, since a 
few undetectable tumor cells may remain in the body. 
—The treatment of advanced breast cancer has 
changed markedly with aggressive use of 
chemotherapy. There are now several drugs and 
several combinations of drugs that produce at least a 
60- to 70-percent remission rate. The Section of 
Medical Oncology treats advanced breast cancer with 
CRC member Alexander S. D. Spiers, M.D. 
a three-drug regimen of Cytoxan, methotrexate, and 
adriamycin. Of the first 15 patients treated with this 
protocol, all have responded to treatment and thus 
far remain in remission. 
"Proper treatment with chemotherapy for breast 
cancer, in our opinion, must be very vigorous and use 
a combination of drugs," says Straus. 
— A similar Cytoxan, methotrexate, adriamycin 
regimen has had dramatic results in a preliminary 
study of advanced prostate cancer. Each of the eight 
patients in the study had total amelioration of pain, 
and most experienced a reduction in the size of their 
tumors. Straus emphasizes that many more patients 
must be treated with this regimen before a true 
response rate is known. 
T h e a rsena l i nc reases . The arsenal of anticancer 
drugs and knowledge of chemotherapy increases con-
stantly. In some instances, cancer care is improved by 
using old drugs, such as 5-fluorouracil, in new ways. 
Although 5-fluorouraciI has been used for the past 15 
years in the treatment of gastronintestinal cancers, there 
has been no general agreement as to the best way to ad-
minister it . During the past year, the Section of Medical 
Oncology has studied the effects of extremely high-dose 
infusions of the drug. The results, according to Spiers, 
have been less bone-marrow depression, thus leaving 
the patient better able to fight infection, and in some 
cases, more anti-tumor effect. 
Platinum compounds and a four-drug regimen for 
head and neck cancers are among the new drugs in use 
at the Cancer Center. 
The platinum compounds are distinguished by having 
very little bone-marrow toxicity and by being effective 
against a number of solid tumors. They are now in use 
in the treatment of head and neck cancers and are being 
studied in lung, gastronintestinal and testicular tumors. 
A four-drug regimen for patients with advanced head 
and neck cancers was developed this year by the sec-
tions of medical oncology, otolaryngology and radia-
tion medicine at U H with collaboration from depart-
ments at Boston City Hospital and the Veterans A d -
ministration Hospital. Thus far, the combination has 
been administered to patients with advanced head and 
neck cancers with dramatic responses. A larger study is 
now being planned for patients with recurrent head and 
neck cancers. • S.G. 
Most significant advance 
in surgical oncology: 
joining of specialties 
for systematic treatment 
r • i H E most significant advance in the surgical 
I treatment of cancer in the past decade, in the 
view of CRC surgical oncologist Peter J. Deckers, 
M . D . , has been in the area of perception: the way sur-
geons have changed their attitudes about the role their 
specialty plays, vis-a-vis the several other disciplines 
that are involved in cancer treatment. 
S y s t e m i c na tu re r e c o g n i z e d . "What 1 have seen in 
the past seven or eight years is a decreasing emphasis on 
the massive resection as an attempt to eradicate cancer, 
and an increasing emphasis on the realization that can-
cer, in most instances, is a systemic disease when it is 
first diagnosed and treated," Deckers says. The cancer, 
in those cases, has invaded all parts of the body. 
Although surgery might have removed all visible signs 
of the disease, micro-metastases, small colonies of can-
cer cells that cannot be detected by any known means, 
have escaped from the original tumor site and are look-
ing for a "home" elsewhere in the body. 
"Therefore, to bring really modern, comprehensive 
care to the patient, one has to think about doing good, 
local procedures that eradicate the main bulk of the 
tumor—using surgery, radiation therapy or both—and 
combine those procedures with systemic treatments, 
such as chemotherapy or immunotherapy at a time 
when the patient has a minimal tumor burden or 
minimum residual disease." 
In Deckers's view, there are still a number of sur-
geons who would defend the concept of "a very wide 
and aggressive attack on cancer through surgery," but 
he adds that their number is probably diminishing. The 
change in attitude is truly significant, says Deckers, but 
he adds that it should have been recognized 20 or 25 
years ago. "We had all the data; we just didn't pay close 
enough attention to i t . " 
Deckers and other oncology specialists at the Cancer 
Center speak frequently of "adjuvant therapy,"—the 
use of surgery, radiation, chemotherapy, im-
munotherapy and hormonetherapy to assist one 
another in a systemic attack against the disease. 
Not too many years ago a cancer patient might have 
been treated with several therapeutic modalities, but 
those modes most often were employed in sequence. 
"The patient would be given surgery because it was ac-
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cepted that it worked, that it was useful; so it was done. 
Then, when the symptoms recurred, or showed up in 
other body sites, certain palliative things were done to 
control the symptoms or retard the growth of the dis-
ease, but there was little possibility that those things 
would cure the patient. 
'A b a l a n c e d a t t ack ' p o s s i b l e n o w . "Now, with the 
recognition that cancer is a multidisciplinary disease," 
Deckers says, "we can present a balanced attack against 
the disease. Once you accept the concept that cancer is a 
systemic disease, then you ought to be able to tailor 
your operation so that all women, for instance, may not 
need a radical mastectomy for their breast cancer, but 
instead may have an adequate surgical procedure that is 
less than radical and is combined with good adjuvant 
radiation therapy and chemotherapy to wipe out the 
micrometastases. 
"To me, this systemic approach, this realization of 
the interdisciplinary nature of cancer, is the most 
significant advance in surgical circles in 
years." • O.J.M. 
Radiotherapists join 
in projects combining 
radiation with hormones, 
immunotherapy and drugs 
r • 1 HE ability of radium to shrink tumors became 
I apparent soon after Marie Curie discovered the 
radioactive chemical in 1898. Since then, physi-
cians, scientists and engineers have worked to advance 
the field of cancer care known as radiation medicine. 
Like surgery, radiotherapy is used primarily for 
localized tumors. Radiation therapy works as an an-
tiproliferative agent—it impedes cell division and 
reduces the size of the tumor. In cases of advanced dis-
ease, radiotherapy is effective in ameliorating pain, says 
Merr i l l I . Feldman, M . D . , University Hospital's chief 
of radiation medicine. 
T h e B e t a t r o n ' s e f fec t i veness . The 42-million-
electron-volt Betatron and its sophisticated cobalt units 
allow the Section of Radiation Medicine to provide a 
full range of inpatient and outpatient services. The ef-
fectiveness of the Betatron, used mostly for deep-seated 
tumors, lies in its ability to penetrate deeply. When 
radiation is aimed at a tumor, it first passes through 
healthy tissue, which absorbs some of the energy. The 
beams from the high-energy Betatron, however, slam 
into the body with such intensity that less of the energy 
is absorbed by healthy tissue and more reaches the 
tumor. Healthy tissue survives the dose of radiation and 
recovers, Feldman says. 
The relatively weak X-rays used to diagnose internal 
ailments and detect broken bones range from 35,000 to 
150,000 volts. 
The Betatron represents an endpoint in terms of 
engineering and design skills and penetrating ability, 
although the biological effects of radiation on cancer 
cells and the ways in which chemicals can manipulate 
these effects are the subject of much research, Feldman 
says. 
R e s e a r c h p r o j e c t s u n d e r way . The Section of Radia-
tion Medicine is involved in four research projects and 
is active in several national clinical research study 
groups. The projects include: 
—radiation biology experiments exploring the 
relationship between certain anticancer drugs and 
radiation in killing cancer cells in the laboratory. These 
studies are being conducted by Feldman and Richard 
M . Niles, Ph.D., an assistant professor of surgery and 
biochemistry at the School of Medicine, and a CRC 
member. 
—evaluating a patient's immune response to total 
body irradiation. Total body irradiation is used ex-
perimentally to treat cancers of the blood and lymph 
systems. Co-investigators with Feldman in the project 
are Edgar S. Cathcart,M.D., associate professor of 
medicine; Simon K i m , M . D . , resident in radiation 
medicine; and Donna M . Yonkosky, Ph.D., assistant 
research professor of pathology/medicine. 
—working with the Department of Physics in the 
clinical applications of the Betatron. 
—a pilot study on the use of synthetic androids— 
male hormones—to control bone-marrow depression in 
patients receiving bone-marrow transplants and total 
body irradiation. This study is being carried out by 
Technicians in the Department of Radiation Medicine, 
shown setting up the 43-million-electron-volt Siemens 
Betatron, see some 50 to 60 patients every weekday. 
Technicians in the photo, from left, are Greg Lewis, 
Kathy Herman (taking the role of patient for the photo), 
and Marie Garafolo. 
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Feldman and Michael Bennett, M . D . , associate 
professor of pathology. 
S p e c i a l i s t s p o o l t he i r f i n d i n g s . By cooperating in 
national clinical trials, the CRC and other oncology 
centers throughout the country are able to learn the 
responses of a great number of patients sooner than i f 
they were working independently. "The purpose of 
these groups is to determine what form of surgery, 
radiation therapy and chemotherapy operates to the 
best advantage of the patient. With cancer specialists 
throughout the country pooling their findings, we see 
how a large number of patients respond to a certain 
treatment sooner than i f we waited for one hospital to 
complete its own study," Feldman says. 
The Section of Radiation Medicine participates in: 
—the Radiation Therapy Oncology Group, which 
compares the advantages of one radiotherapy treatment 
program against another; 
—the Primary Surgical Adjuvant Group, which was 
solely devoted to the study of breast cancer, but is ex-
tending its interest into other oncology problems, such 
as those involved in cancer of the colon and rectum; 
—the Eastern Cooperative Oncology Group, which 
began as a chemotherapy group, but which recently ex-
panded its scope of investigation to include the effects 
of combined chemotherapy and radiotherapy on certain 
types of tumors. • S.G. 
Clinical nutrition trials 
study ways to strengthen 
patient's immune response, 
tolerance to chemotherapy 
IT is a paradox of cancer care that many patients die of malnutrition while they are receiving the most sophisticated treatment modern hospitals 
can provide. 
Cancer Center physicians are confronting this 
problem by studying whether an enriched diet ad-
ministered orally or intravenously allows for more ef-
fective anti-cancer treatment and improves the quality 
of life in the adult cancer patient. The Hospital's studies 
on intravenous feeding, two of 10 such trials 
throughout the country, are funded by the National 
Cancer Institute. The School of Medicine has received 
support from Mead-Johnson, a pharmaceutical com-
pany, to study the effects of feeding breast cancer 
patients a complete liquid diet orally or through a naso-
gastric tube. 
T r i p l e o b j e c t i v e s . The objectives of these studies are to 
determine whether proper nutrition can strengthen a 
patient's immune response, increase tolerance to 
chemotherapy by decreasing its side effects, and 
decrease morbidity and mortality by allowing increased 
doses of chemotherapy and radiotherapy. 
Two of the traditional methods of treating cancer, 
drug and radiation therapy, k i l l tumor cells, but they 
also depress the body's natural defense mechanisms, 
thus making the patient more susceptible to infection. 
Other side effects of cancer therapy are nausea and loss 
of appetite, which further weaken the patient. The 
hypothesis behind enriched intravenous and oral 
feeding is that proper nutrition wi l l allow the patient to 
remain stronger and better able to withstand therapy 
regimens that are more potent and of longer duration. 
" I t is ironic that many cancer patients have died of 
malnutrition or the results of malnutrition, such as the 
inability to fight infection or heal wounds, while they 
were in modern hospitals receiving the most 
sophisticated treatment," says William P. Steffee, 
M . D . , Ph.D., director of University Hospital's Clinical 
Nutri t ion Unit, a CRC member and principal in-
vestigator in the intravenous feeding trials. 
A c o m p l e t e l i q u i d d ie t . When a breast cancer patient 
in the trial first begins therapy, she is asked to list 
everything she eats. Her diet is then assessed for 
nutrients and calories. "Most patients do not eat 
enough of the right foods, so we supplement what they 
eat with a complete liquid diet," says CRC member 
Joseph J. Vitale, M . D . , Sc.D., a professor of pathology 
and community medicine at the School of Medicine and 
chief investigator in the oral-feeding studies. I f the 
patient cannot tolerate the taste of the liquid diet, or i f 
she cannot keep it in her stomach, a naso-gastric tube is 
inserted, 'Vitale says. 
Oral nutrition therapy can be administered to in-
patients and outpatients. Intravenous feeding, however, 
can only be given to inpatients and is usually reserved 
for patients with advanced disease. 
The type of intravenous therapy that is being used in 
the research is called total parenteral nutrition (TPN). 
A patient who receives this therapy will have a catheter 
inserted into a major blood vessel, through which he 
wil l receive a highly concentrated solution of nutrients. 
Breast cancer patients who are undergoing 
chemotherapy are the subject of one TPN study, while 
patients with cancer in the pelvic and abdominal 
regions—colon, ovaries, prostate, uterus—and who are 
receiving radiation therapy are the focus of the second 
study. 
A l l o w s fu l l d i e t w i t h o u t e a t i n g . TPN allows cancer 
patients to meet their daily nutritional and caloric re-
quirements without having to eat food. I t is also a way 
of feeding patients whose digestive tracts have been 
obstructed by cancer. 
TPN and the orally-administered liquid diet are 
potentially an improvement over the standard in-
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During rounds on F-4, the UH medical oncology unit, William P. Steffee, M.D., Ph.D., 
discusses a patient's nutritional program with fourth-year medical students Marilyn 6 . 
Mataion and James J. Heffernan and UH Pharmacy staffer Jordan Krigest. 
travenous solution of sugar and water, which contains 
about 400 calories and no nutrients, says Steffee, an 
assistant professor of medicine at the School of 
Medicine. 
The TPN solution contains about 3,000 calories and 
enough amino acids to supply 120 grams of protein. 
The protein supplement is higher than the 80 to 100 
grams usually contained in the American diet in order 
to support healing and replace proteins lost before 
therapy began. The high caloric content is needed 
because the patient is under stress due to a growing 
tumor, Steffee says. Steffee described a malignant 
tumor as a thief, stealing the body's proteins and 
nutrients before non-cancer cells can use them. I f the 
patient does not eat enough, the tumor wil l rob 
nutrients from the patient's organs. One of the purposes 
of the study wil l be to test the belief of some physicians 
that TPN and other methods of nutrition therapy 
"feed" the cancer at the same time they strengthen the 
patient. 
B e n e f i t s v. c o m p l i c a t i o n s s t u d i e d . The TPN study 
will also be aimed at determining whether the benefits 
of this therapy override the five- to 10-percent com-
plication rate of infection and blood clots. The only 
complication of the oral or naso-gastric method is 
irritation from the silastic tube, Vitale says. 
Although the duration of TPN varies, it is usually 
used for four to six weeks while the patient is undergo-
ing chemotherapy or radiotherapy, Steffee says. The 
TPN solution, as well as the amount of the orally ad-
ministered diet, may be changed daily to meet in-
dividual caloric and nutritional needs. 
Working with Steffee and Vitale on these projects are 
Richard Elkort, M . D . , a U H surgical oncologist and 
CRC member, and Merril l Feldman, M . D . , the 
Hospital's chief of radiation medicine. • S.G. 
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In many cases, victim 
of head and neck cancer 
has practically signed up 
for it in his youth 
A young man who smokes heavily, drinks too much, neglects proper nutrition, and keeps up those habits, has practically signed up for cancer 
of the head and neck in his mid-40s. 
M . Stuart Strong, M . D . , chief of otolaryngology at 
University Hospital and a CRC member, explains that, 
unlike many other cancers whose causes are largely un-
known, head and neck cancer is virtually produced by 
these habits, all of which are completely within the 
realm of human choice. 
' A l w a y s t h e s a m e g r o u p . ' "It 's always the same group 
of patients who grow this disease," says Strong, a 
BUSM professor of otolaryngology. "They're almost 
all males; they're all heavy smokers and drinkers, and 
have been for 20 years. I f people didn't smoke or abuse 
drinking, head and neck cancer would almost vanish." 
This particular cancer, he explains, is closely tied to 
liver function and the state of nutrition. I f a person eats 
very well then he can usually tolerate more alcohol than 
if his diet were neglected. Malnutrition tends to weaken 
the person's immune response, a process physicians 
now know contributes to the spread of the disease. 
The staff at University Hospital, Boston City 
Hospital and the Veterans Administration Hospital in 
Jamaica Plain see approximately 200 new head- and 
neck-cancer patients per year. Collectively, the three 
hospitals constitute one of the largest head- and neck-
cancer treatment centers in the Northeast. 
Only about one to two percent of head- and neck-
cancer patients do not fall into the categories of 
smokers and heavy drinkers. "The men who grow can-
cer in the nose and sinuses are very frequently 
woodworkers," Strong says. "We don't know whether 
it is the chemicals they work with all day, or whether 
it's something in the resins that come out of the wood 
when it is being planed, or both. We can cure only 
about one person in 10 who have this woodworker's 
disease." 
S o m e w o m e n p r e d i s p o s e d t o It. Anemic, menopausal 
women can also be predisposed to development of head 
and neck cancer. " I f a women has had anemia for a 
long time, the membranes in her mouth and throat 
become irritated. This type of chronic irritation, even 
when it's not associated with smoking, can eventually 
develop into cancer," Strong explains. 
Cancer in the ear is relatively rare, with only about 
200 new cases developing nationally each year. The site 
of the majority of head and neck cancer is in the mouth 
and the aerodigestive tract. This cancer can include the 
lips and tongue as well as the larnyx and the vocal 
chords, and can possibly involve the lungs. 
In total. Strong says, about 35,000 people each year 
develop some form of cancer of the head and neck. 
The cure rate for head and neck cancer is a dis-
couraging 20 to 25 percent, a figure that, despite treat-
ment advances, has not changed in 20 years. "People 
who come in with a very small head or neck tumor have 
a very good chance of being cured," Strong says. "But 
some have a tumor so big that it's hopeless, and 
really, you can't do much for them but send them 
home. . . .We are rehabilitating people better now; 
they look better, they function better and they feel bet-
ter. But the actual cure rate has not changed." 
No one has al l answers . One reason for the steady 
rate is that so many of the patients also have cancer in 
the lung. "We get them cured of their throat cancer, 
and then they die of lung cancer," the otolaryngologist 
says. "Thus, the secret is a multidisciplinary approach 
at the current state of the art. No one discipline has 
more than a few of the answers." 
A major problem in diagnosis and treatment of head 
and neck cancer is the presence of multiple tumors. Un-
like other types of tumors, which tend to metastasize to 
distant parts of the body, tumors in the head and neck 
usually remain confined to that area. However, physi-
cians have recently found that patients who die from 
the disease die with distant metastases. "Why this is, 
we're not really sure," Strong comments. The 
phenomenon is currently under study. 
T e a m rev i ew of b i ops ies . Biopsies of the tumors are 
conducted, and the results are reviewed by a team 
composed primarily of the otolaryngologist, the 
radiotherapist, the chemotherapist, the oral surgeon, 
the maxillofacial prosthedontist and the plastic 
surgeon. 
Ten years ago. Strong and his colleagues came up 
with a series of three simple drawings of the oral cavity 
and the larynx that are used for recording the results of 
patient examinations. The examining physician marks 




On the side of the sheet, he records the actual measure-
ments of the tumor, and stages the disease in one of 
four progressive categories. 
"Wi th the diagrams and the staging system," Strong 
points out, "anybody can visualize the patient's 
problem, even without seeing the patient. In this way, 
everyone consulting on the case is sure to be discussing 
exactly the same thing." 
Pa t i en t s re ta in u l t i m a t e c h o i c e . As is true with most 
other types of cancer, treatment includes all three dis-
ciplines: chemotherapy, radiotherapy and surgery. 
Patients are actively involved in the development of 
treatment plans. Often, treatment involves certain 
tradeoffs, and the patient retains the ultimate choice 
about the treatment he wil l receive. Strong offers an ex-
ample: "Let's say a patient who has a small tumor on 
his vocal chords is an automobile salesman; he's got to 
have a good voice. We could remove the tumor easily, 
especially with the surgical laser, and he'd be out of the 
hospital in 24 hours and back at work in a week. 
However, he'd be quite hoarse. On the other hand, i f we 
gave him an x-ray treatment, which takes six weeks, he 
may end up with a better voice, but he'd lose his income 
for a month and a half. The patient has to decide what 
is important to him—a hoarse voice or the loss of 
income—and we try to act in accordance with his 
needs." 
Nurses in the hospitals are instrumental in maintain-
ing close contact with the patient. Strong says. "They 
know the patient and can assess the family situation. 
The nurses give us important insight into the patient's 
relationship with the illness," which is important in 
planning the treatment each particular patient is to 
receive. 
This awareness of the patient and the quality of his 
life is permeating all aspects of patient care. "Our 
problem," Strong says, "is that now we can do opera-
tions so big that we wonder about the quality of life 
that wil l be preserved for the person after the 
procedure. I f you take out the entire tongue, jaw and 
the larynx, you can sometimes keep patients alive, but 
you wonder about it . Would that be a great thing for 
your dad or mine? I 'm not sure it would be. The 
philosophy is that these things are not reasonable 
anymore. We've gone to the limit, but now we've 
backed off a little bi t ." 
Thus, although the cure rate for head and neck can-
cer is still low, there is a new concern for the patient 
with head and neck cancer. Specialists in each discipline 
are beginning to work together to develop new ap-
proaches to treatment of the disease, with an emphasis 
on chemotherapy and immunotherapy, while efforts to 
educate the public about the adverse effects of smoking 
are continuing. • N . H . 
Chart used by doctors to keep track of the size and 
location of tumors. 
Use of 'skin flaps' allows 
immediate action on the 
reconstruction of patient's 
head and neck structures 
by Nancy Haslam 
A S recently as a decade ago, men and women who underwent surgery for treatment of head and neck cancer endured life for months, or even 
years, without a nose, a jaw or other structure sacrificed 
to prevent the spread of the disease. 
Reconstruction of the patient's face, which was 
necessarily delayed, was, for the physicians, secondary 
to their major concern of removing the cancer and sav-
ing the patient's life. 
Today, with immediate reconstruction possible 
through the use of "skin flaps," that early attitude 
seems callous. How could a physician be so insensitive 
to another human's need for social acceptability? 
Not u n c o n c e r n e d , b u t l a c k e d t e c h n i q u e s . The fact is 
that the physicians and surgeons were concerned, ac-
cording to Caspar W. Anastasi, M . D . , chief of plastic 
surgery at University Hospital and an associate 
professor of surgery at BUSM. Avenues permitting 
early reconstruction—that is, the technical advances 
and the idea of teamwork—simply had not yet been 
developed. 
"Up until the 1950s," Anastasi says, "surgeons felt 
they might compromise i f they considered reconstruc-
tion. Life, the surgeons thought, was acceptable at any 
cost, no matter what the expense was to the patient in 
terms of mutilation." 
This priority is reflected in the textbooks of the times, 
according to Anastasi, a CRC member. Manuals on 
surgical procedures for head and neck cancer—even 
those published in the mid-'60s—contained little, i f any, 
mention of reconstruction. 
I t wasn't until the late 1950s that surgeons began to 
take positive steps toward early reconstruction, 
Anastasi says. "But, sometimes it was a year before 
they started any reconstruction—sometimes several 
years. People who had undergone surgery walked 
around with all kinds of deformities, waiting for the 
surgeon to say, 'OK, let's go ahead with the reconstruc-
tion.' " 
Fea red ' b u r y i n g ' t u m o r . Surgeons supported this 
delay, Anastasi explains, because they were afraid they 
might hide a tumor by "burying" it under new tissue. 
The delto-pectoral (Bakamjian) flap is one of the flaps 
frequently used in the reconstruction of the skin of the 
head and neck area following the removal of a tumor. 
"Finally," Anastasi says, "the reconstructionists— 
the plastic surgeons—and other surgeons realized that 
reconstruction might be easier for the patient i f they 
worked as a team from the start, designing a plan for 
the removal of the tumor and the early initiation of 
reconstruction." However, he notes, there was still a 
delay of several months between tumor excision and the 
start of reconstruction. 
The massive wounds created by radical head and 
neck cancer surgery often required several complex 
operations involving skin flaps and bone grafts. 
However, new developments in skin-flap techniques 
made reconstruction without delay a reality. The so-
called deltopectoral skin flap, developed by Vahram Y. 
Bakamjian, provides coverage and bulk necessary for 
immediate reconstruction, and permits the surgeon to 
move these structures into place without delay. 
T h e s k i n f l a p is c u L Flaps are peninsula-like sections 
of skin, fat and vessels that are cut on three sides from a 
section of the patient's body. In head and neck 
reconstruction, the flap is usually based in the patient's 
shoulder and chest area. This flap, cut according to the 
defect it is to cover, is brought up from the shoulder 
area, directly to the head and neck. The chest side 
remains attached as a base. The surgeon sutures the free 
sides of the flap, completely covering the wound created 
by the excision of the tumor. In some cases, after the 
skin flap has "taken," the base section, or pedicle, of 
the flap is cut, and the remaining portion of the flap is 
returned to the part of the body from which it 
originated. 
The flap has thus provided the soft tissue necessary 
for head and neck reconstruction. I f bone grafting is 
necessary, it is usually done after the soft tissue has 
been reconstructed. Modifications of this process are 
used for varying forms of head and neck cancer. 
" A n exciting chapter in reconstructive procedures is 
the current utilization of "free flaps," Anastasi says. 
"This technique requires microsurgery to jo in blood 
vessels in free flaps taken from remote areas of the body 
to supply the necessary coverage for reconstruction of 
head and neck defects." 
Looking to the future, Anastasi adds, " I n this field, 
the ultimate would be the day we ggt the problem of 
tissue rejection solved. Then, i f you lose your ear 
because of cancer, 1 can get a cadaver ear and hook it 
up, and your body wil l accept it, not reject it because i t 
is a foreign substance. However, we are still a way from 
that. 
"But what is exciting today," Anastasi says, "is not 
that we have better surgeons. What we do have is a 
more positive and aggressive attitude toward the 
reconstruction and the rehabilitation of the cancer 
patient." • 
Regional Oncology Program 
allows patients to have 
excellent cancer care 
in their own home area 
by Susan Gertman 
FOR many years, the sophisticated field of cancer care was centered almost exclusively at large, metropolitan hospitals that could support an 
array of specialists, equipment and anti-cancer treat-
ments. The patient, his life already disrupted by illness, 
usually had to leave his home area for treatment. 
The situation, however, is changing. A t three 
hospitals in Lastern Massachusetts, ambulatory cancer 
patients leave their jobs for about an hour a week to go 
to a nearby oncology clinic for drug therapy or follow-
up care. The clinics are run by the Regional Oncology 
Program (ROP), an innovative outreach system that 
provides clinical and educational services to community 
hospitals. 
Clinics are now in operation at St. Anne's Hospital, 
Fall River, Mass.; Jordan Hospital, Plymouth, Mass.; 
the U.S. Public Health Service (Brighton Marine) 
Hospital, Brighton, Mass.; St. Luke's Hospital, New 
Bedford, Mass.; and Frisbie Memorial Hospital, 
44 GENTERSCOPE/SPRING-SUMMER/1977 
Rochester, N . H . ROP also conducts seminars describ-
ing the multi-faceted care of cancer patients for physi-
cians at Framingham Union Hospital, Framingham, 
Mass.; and Union-Truesdale Hospital, Fall River; as 
well as St. Anne's Hospital, Jordan Hospital and St. 
Luke's Hospital. 
B e g a n as e d u c a t i c n a l se rv i ce . ROP began as an 
educational and consultative service to community 
hospitals affiliated with University Hospital, says CRC 
member Peter J. Deckers, M . D . , a surgical oncologist, 
and ROP program director and an assistant professor 
of surgery at BUSM. "We found that certain areas 
lacked physicians who practiced primary cancer care. 
We thought it was better for ambulatory cancer patients 
to be treated in their own communities than to travel 60 
or 100 miles to see us in Boston, so we set up oncology 
clinics in their local hospitals." 
ROP is staffed by a team of medical and surgical on-
cologists, radiotherapists, and nurses and social 
workers with special training in the care of cancer 
patients. Working with Deckers on the program's ex-
ecutive committee are Merri l l L Feldman, M . D . , chief 
of radiation medicine at University Hospital, and Marc 
J. Straus, M . D . , the Hospital's chief of medical on-
cology, both associate professors at the Medical School. 
Because treatment is made available in the com-
munity, ambulatory cancer patients and their families 
are able to continue their normal activities with as little 
disruption as possible. Arranging time to come to 
Boston for treatments is a problem not only for the can-
cer patient, but for the family member or friend who 
brings him. 
"Most people around Fall River find it very difficult 
to go to Boston, not only in terms of arranging time 
and transportation, but in terms of cost and worry. 
People think that any problem that cannot be treated 
locally must be very serious, and this frightens them," 
says Sr. Marie Williams, R.N. , a pastoral counselor at 
St. Anne's Hospital, who attends the weekly clinics. 
Y o u t h s tays in h o m e area . A 15-year old boy from 
Southeastern Massachusetts who had a cancerous testis 
surgically removed last summer comes to the oncology 
clinic at St. Anne's once a week. Before he received 
treatment at this clinic, he would have to leave school 
early and his parents would take him on the 75-minute 
drive to University Hospital in Boston. Now, his 
mother picks him up after school and takes him the 
short distance to the clinic. 
In addition to convenience, the local clinics offer sup-
port and camaraderie. "Now I know that I am not the 
only person in this boat," the honor student says. " I 
can look forward to coming here and seeing friends, in-
stead of just coming here and getting sick," a reference 
to the nausea some patients experience after receiving 
anti-cancer drugs. 
Bringing oncology care to the community wi l l result 
in an improved outlook on the disease, says Patricia 
DiMeo, R.N. , an oncology nurse. "Many people in the 
community, lay people as well as medical people, 
equate cancer with death. But, when they see their 
neighbors coming to the clinic from work or school, 
their ideas begin to change," DiMeo says. 
DiMeo is one of seven ROP oncology nurses and 
social workers who conduct workshops in the physical 
and emotional needs of cancer patients for community 
nurses, social workers and paramedical personnel. 
Workshops are now in operation at Pondville Hospital, 
Walpole, Mass., Framingham Union, Jordan, and St. 
Anne's hospitals. 
He lps pa t ien t , t oo . The patient's major gains from the 
workshops is the knowledge that help is always close at 
hand. " I t is important for the patient to know that there 
is someone close to home who can help; that he doesn't 
have to call Boston each time he has a question," 
DiMeo says. 
Most patients do come to Boston, however, at some 
time during their course of treatment for surgery, for 
radiotherapy that is not available locally, or for more 
frequent drug therapy. 
Another facet of ROP is the rehabilitation process, 
which includes the services of social workers, physical 
therapists, nutritionists, vocational counselors and the 
clergy. Deckers explains, "People have to realize that 
cancer is a chronic disease and that the patient wil l 
never be out of a doctor's care. The patient wil l have 
constant questions about his care that a doctor may not 
be able to answer, and a doctor has to be big enough to 
ask for help. 
"That's the reason, I think, that you're finding 
groups around the country incorporating specialists in 
vocational counseling, physical therapy, and the like 
into their cancer activities. They finally have come to 
realize that cancer is a major health problem, and that 
the economic drain on the family and society will be 
greater if a person is not rehabilitated properly and 
helped to become a participating member of 
society." • 
University Hospital second-year surgical resident Ira 
Rutkow, M.D., presents a case at the weekly tumor 
conference. 
Cancer Research Center 
is chosen to conduct 
major NCI study into cost 
of cancer treatment 
A L T H O U G H cancer researchers continually find the means to help cancer patients live longer and more comfortably, little research has been 
done on the cost of bringing these new techniques to the 
patient. What does it cost a patient to live with cancer? 
What does it cost the physician who attends him and 
the hospital that treats him? 
To determine the lifetime cost of caring for cancer 
patients, the National Cancer Institute last year 
launched the first phase of a National Cost of Cancer 
Study (NCOCS). The Boston University Cancer 
Research Center and Abt Associates of Cambridge, 
Mass., bid successfully for the N C I contract to design 
and implement the study. 
CRC members Robert Friedman, M . D . , principal in-
vestigator for the project, and Paul Gertman, M . D . , 
senior investigator, have been working on the survey 
with Abt Associates, a social research firm, since 
December, 1975. They are building on the findings of 
the Third National Cancer Survey, conducted by the 
N C I in 1970. 
Pi lo t s t udy ge ts u n d e r w a y . The survey began this 
spring with a pilot study at University Hospital and 
several other Boston-area hospitals, including U H -
affiliated hospitals. Should the pilot study prove suc-
cessful, a nationwide survey wil l be undertaken in the 
fall of 1977. 
In addition to the direct costs of the disease — as in-
dicated by physician and hospital bills — the NCSOS 
wil l examine the patient's "out-of-pocket expenses," ex-
plains Theresa Concannon, a University Hospital staff 
member. "That includes the cost of transportation to 
the physician's office, special diets, dwelling modifica-
tions, and other costs not usually covered by insurance. 
In addition, we'll try to put that information into the 
proper context by looking at the patient's health status 
and asking, how able is he to carry out the usual ac-
tivities of daily living? Has he lost his ability to earn an 
income, or any other ability? What has been the 
emotional impact of the disease?" The study wil l also 
attempt to evaluate "social" costs of cancer, such as 
disfigurement. 
In many cases, a patient's bills do not reflect the true 
cost of the care he has received. Some physicians and 
hospitals wil l continue to care for a patient even i f he 
cannot afford to pay for their services. " I n a sense, the 
doctor or hospital, in some cases, is subsidizing the 
patient's care," Concannon says. The hidden cost of 
such "free care" wil l also be considered by the NCOCS. 
Pat ien t t o b e p r i m a r y i n f o r m a t i o n s o u r c e . The survey 
will gather information on each patient from more than* 
one source, but the primary source will be the patient 
himself. Investigators are concerned with maintaining 
complete confidentiality. No data will be collected on 
any patient without his full consent; nor will names or 
other identifying information be released with the final 
results of the survey. 
After identifying cancer patients by consulting par-
ticipating hospitals, investigators will ask each patient's 
physician for permission to contact the patient. Hour-
long interviews will be conducted in the patient's home, 
covering the nature and cost of care received during the 
past year, as well as the patient's general and emotional 
health status. "We're not going to conduct any intense 
psychological examinations," Concannon says, "but we 
will ask a few questions about depression and anxiety 
levels." 
NCOCS investigators will not ask patients to "pull 
out every medical record and list of expenditures from a 
ten-year, or even three-year, history of having cancer," 
Concannon says. Instead, patients at different stages of 
the disease will be asked to discuss their previous year's 
experience: One patient will provide information on 
costs incurred during the first year of treatment, and 
another on second-year costs, resulting in "cross-
sectional data." 
T o c o n t a c t 12,000 phys i c i ans . Following a patient in-
terview, investigators will telephone doctors who have 
billed the patient to ask for further information from 
the physician's financial records. The primary physician 
will also be asked to complete a brief questionnaire. 
Over the course of the study, researchers will contact 
more than 12,000 physicians. In some cases, hospital or 
Blue Cross/Blue Shield records may be consulted to en-
sure a "complete and realistic picture" of costs. 
NCOCS researchers will concentrate on major cancer 
body sites which the N C I believes account for 80 per-
cent of the total cost of cancer care in this country. 
Several sites have been further divided into subsites. 
(For instance, more than one type of leukemia will be 
examined.) The study will focus on expenses for 
diagnosis, therapy, rehabilitation and clinical care for 
each type of cancer. 
The NCOCS wil l produce the first clear picture of 
cancer's financial impact, from initial diagnosis to the 
latest treatment, on the patient and the medical field 
alike. (The 1970 Third National Cancer Survey did not 
focus on the patient and his family.) Health planners 
and providers may put this information to what is 
perhaps its most valuable use: finding ways to soften 
that impact. • S.A. 
46 CENTERSCOPE/SPRING-SUMIVIER/1977 
Debbie Lamar, nurses' assistant, (left), and Ann Giuliotti, R.N., (right), assist Robert 
Churchill, a patient in the medical oncology unit. 
vp« ^ Sharing the 
knowledge 
- i i Education, training and outreach by CRC 
Community outreach 
training programs bring 
latest oncology nursing 
ideas to local hospitals 
Disease topics that the nurse is most likely to encoun-
ter in her patients, such as breast, colon-rectal, and 
head and neck cancer, are emphasized. Gribbons also 
discusses radiation therapy, despite the fact that few 
community hospitals have radiation units. "The nurse 
should be able to tell the patient and his family what to 
expect when he gets to the radiotherapy unit at the 
Medical Center," Gribbons explains. Chemotherapy is 
also discussed, since it is being used more frequently in 
the community hospitals. 
T r y i n g t o c h a n g e a t t i t udes . Throughout their train-
ing, nurses most often see those cancer patients who do 
not respond to treatment and thus require hospitaliza-
tion. " I t gives them a negative attitude toward cancer," 
Gribbons says. "We try to make them see that it is not 
necessarily a downhill course. A lot of patients today 
are living much longer and more comfortably." 
The community outreach program brings service as 
well as continuing education to community hospitals. 
In addition to teaching, Gribbons will soon be working 
as a clinical nurse at Jordan Hospital. The program has 
also provided for establishment of chemotherapy 
clinics, such as the one coordinated by Patricia DiMeo 
and staff members at St. Anne's. These units enable 
hospitals to avoid sending all patients to Boston for 
chemotherapy. 
V a r y i n g s tages of i n v o l v e m e n t . A l l of the hospitals 
are at different stages of involvement with the program. 
Those that have been involved for the longest time are 
the most willing to work with new ideas. But Gribbons 
observes that all are more open to discussing cancer to-
day then they were in 1969. "One of the first things we 
did at Jordan Hospital, which just joined the program, 
was to start a workshop. Eight years ago they probably 
wouldn't have been ready for that right from the start." 
Gribbons finds the community nurses' willingness to 
implement new services "refreshing." She plans to in-
troduce new activities, focusing on the needs of the 
patient's family and the use of community resources. 
"We hope that the groups will eventually outgrow their 
need for us," she says. "Our ultimate goal is to give 
them the expertise to carry on by themselves." • 
S.A. 
f • ^ R A I N I N G nurses to work with cancer patients is 
I a major goal of the Medical Center's community 
.M^ outreach program, which began in 1969 as part 
of the B U M C Regional Medical Program. The 
program "aims at fostering regional collaboration be-
tween community hospitals and medical centers," Moz-
den explains. Groups of physicians, nurses and social 
workers work with community hospital staff members. 
Carol Gribbons, R.N. , brings continued education 
about cancer to nurses at Framingham Union, 
Pondville (Walpole), Brockton, Jordan (Plymouth), and 
St. Anne's (Fall River) hospitals. She will soon be 
working at Frisbie Memorial Hospital in New 
Hampshire as well. 
' Le t nu r ses iden t i f y t he i r needs . ' Gribbons has 
organized courses, workshops, panel discussions and 
monthly conferences at the hospitals, in collaboration 
with the inservice education department of each com-
munity hospital. "Our basic approach since the begin-
ning has been to let the nurses identify their needs," 
Gribbons explains. "We've never felt that we could go 
into a hospital and say, 'Okay, here we are and this is 
what we're going to do.' " 
The courses cover general information on cancer, 
from malignant cells to the treatments available and the 
nursing implications. "For the most part, during their 
basic education nurses do not see cancer as a complete 
entity, from beginning to end," Gribbons says. Joan 
Roover, a social worker, takes part in the training 
program, dealing with such psycho-social problems as 
the patient's reaction to a diagnosis of cancer or to a 
change in body image after surgery. 
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Oncology training program 
provides unique means for 
teaching about cancer, 
a disease without borders 
by Sue Aucella 
CA N C E R has presented a unique problem to educators at medical schools and teaching hospitals. A disease without borders, i t is too 
large to be easily categorized, and is almost indefinable. 
The medical student's traditional classroom view of 
cancer has been incomplete; his clinical view, one of 
despair. 
Nearly ten years ago, however, the faculty of the 
School of Medicine developed a unique solution: a mul-
tidisciplinary approach to oncology training for medical 
students, postgraduate fellows, postgraduate medical 
students, house staff, nurses and social workers. 
O r i g i n a t e d s p e c i a l o n c o l o g y c o u r s e . BUSM 
originated the concept of a special course on cancer, 
which most medical schools have yet to offer, according 
to Peter Mozden, M . D . , chief of surgical oncology at 
B U M C and principal investigator for the education and 
training project. "Instead of setting time aside in the 
curriculum for teaching about cancer, most schools 
assume that each department wil l cover its own area: 
thoracic wi l l teach lung cancer; gastrointestinal, cancer 
of the stomach and colon; obstetric-gynecological, 
uterine cancer. But it's a disease that crosses 
disciplines—it can't be pigeon-holed. What department 
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would cover breast cancer, for instance?" 
A t BUSM, students are given "an opportunity to 
view cancer as a distinct disease, rather than just as a 
part of other disease syndromes or as a subsection of 
various other courses," explains Richard Elkort, M . D . , 
^n assistant professor of surgery at the School of 
Medicine. Thirty curriculum hours are devoted to can-
cer within the interdisciplinary Biology of Disease 
course for second-year students. The course, which 
Mozden says "pulls together all the loose strings of all 
the departments," deals with cancer in relation to other 
clinical problems, providing the student with a max-
imum amount of basic information about the disease at 
one time. The National Cancer Institute, which is 
currently funding the education and training program 
at B U M C , has described the course as a model for 
other medical schools to follow. 
12 d e p a r t m e n t s i n v o l v e d . There are 12 departments 
and 30 faculty members involved in the training 
program. The number of students interested in on-
cology training has increased steadily since the program 
began in 1967. "More residents are interested in i t , " 
Elkort says, "and more and more people are interested 
in becoming surgical oncologists, as evidenced by the 
sharp increase in the number of fellowship applicants 
over the past two years." 
First- and second-year students receive what Elkort 
terms "classical" information about cancer through 
several general courses. During the third and fourth 
years, students may elect courses in both medical and 
surgical oncology. They may also serve on the medical 
or surgical oncology units at University Hospital for 
two- to four-week periods. 
Residents are rotated through the "White" Surgical 
Service at U H for surgical oncology training because it 
has a higher concentration of cancer patients than the 
Hospital's "Red" and "Blue" surgical services. 
Although the house officers are there for surgical ser-
vice, they work with patients who are also receiving 
chemotherapy and radiotherapy as part of their treat-
ment. 
' N o - m a n ' s l a n d be fo re . ' The training of specialists in 
clinical cancer was "a no-man's land" until B U M C 
began training postgraduate physicians, Mozden says. 
" B U M C is responsible for the training of the majority 
of oncologists in Massachusetts, outside of the Boston 
area." Six postgraduates are involved in the program at 
a time, training to specialize in medical or surgical on-
cology, or in radiation therapy. 
The program also attracts board-qualified or board-
certified surgeons who wish to continue their training as 
surgical oncology fellows. The two-year program deals 
with special surgical techniques, such as regional perfu-
sions or supraradical surgery of the type that a resident 
doesn't usually see, Elkort says. "Beyond that, we aim 
to make them competent chemotherapists and to 
familiarize them with the language of radiotherapy, so 
that as practicing oncologists they can coordinate all 
three modalities of treatment—surgery, radiotherapy 
and chemotherapy—on the basis of first-hand 
knowledge of each." 
Faculty members involved in the oncology training 
program try to convey more than information and 
techniques to their students: They try to convey a sense 
of hope. "We point out that the prognosis for most can-
cer patients is better than it is for those with advanced 
heart disease, uncontrollable diabetes and a variety of 
other conditions not associated with the morbid aspects 
that people associate with cancer," Elkort says. 
O n e ou t of th ree su rv i ves . Currently, one out of three 
cancer patients survives the disease. A "tremendous" 
number of treatments have been developed during the 
last 10 to 15 years, but they have not yet been made 
available to every cancer patient, Elkort says. " I f all 
patients could be treated with modern techniques, at 
least one out of two would be saved, and that's not a 
bad batting average for a disease that we still under-
stand so little about." 
Elkort believes, most students and hospital staff 
members have a "distorted view" of the cancer patient, 
because only failing patients are hospitalized. "The 
bulk of our patients are followed in the office as out-
patients who live at home, leading quite normal lives, 
surviving despite the disease," he said. "We hope to in-
crease the exposure of students, house officers and 
nurses to this type of cancer patient." 
University Hospital nurses have developed their own 
inhouse oncology training program, largely taught by 
several oncology nurses. The "pioneering" program, as 
Mozden describes it, is repeated several times a year 
and places special emphasis on working with the family 
of the patient. "The nurses are very gung-ho," Mozden 
said, "and the program is thriving." 
P r o g r a m s at S O N a t t rac t m a n y . Boston University 
School of Nursing also offers high-quality programs in 
oncology nursing, attended by nurses from all across 
the United States and Europe. (Only 11 nursing schools 
in the nation have developed oncology education 
programs, all funded by the N.C.I . ) The training con-
sists of a one-week course in general concepts, a three-
week clinical course combining clinical practice and 
theory, and a masters'-level summer course. "Many 
nurses also expressed a need to know more about 
chemotherapy, so we have conducted two three-day 
chemotherapy workshops," says CRC member Jeanne 
Valencius, R.N. , M.S., principal investigator/instructor 
at SON. "To date, 473 nurses have attended the 
programs." 
The one-week course teaches concepts that can be ap-
plied to the care of any cancer patient, including car-
cinogenesis, nutrition, pathology, prevention and detec-
tion, and psycho-social needs. Pain control, home care 
and rehabilitative needs are also discussed. 
The three-week course, which uses the resources of 
University Hospital and the Dana Center (the out-
patient clinic of the Sidney Farber Cancer Institute), 
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deals with more specialized aspects of adult oncology 
training and requires the nurse to define a problem 
related to cancer care within her health agency or com-
munity. With the help of faculty members and fellow 
students, she wil l propose a solution and put her idea 
into action. "She can actually accomplish a change," 
Valencius says, "such as initiating ongoing screening 
clinics or in-service programs." 
The four-credit masters'-level elective, which is 
"more in-depth than the other programs," is offered for 
six weeks during the summer. "The major thrust of the 
program is to analyze current research efforts in on-
cology, define the gaps in nursing theory and practice, 
and develop new nursing approaches to patient care 
problems," Valencius says. "This, we hope, wil l 
stimulate dynamic and creative leadership in oncology 
nursing." 
Patient Gladys C. Collins discusses her case with Peter Mozden, M.D., 
head of cancer training and education program, and medical students 
William Shalen and Dennis Sprecher. 
Role as pa t i en t a d v o c a t e . The masters' program also 
emphasizes the role of nurse as patient advocate, es-
pecially in relation to the use of investigational treat-
ments. "The nurse is responsible for seeing that the 
patient knows and understands his options, and isn't 
neglected i f he should opt for no treatment — which 
sometimes happens," Valencius says. The nurse should 
also understand her own legal responsibilities. 
The great strides made in cancer research during the 
last decade demand that medical schools and teaching 
hospitals keep in step. Among the first to meet the need, 
the CRC, B U M C and BUSON continue to produce 
medical professionals with a current and comprehensive 
knowledge of cancer care. • 
^•j^ People and programs 
mm-
The officers, committees and members of the CRC 
The officers 
Sidney R. Cooperband, M . D . , director 
The director, with the approval of the Steering Com-
mittee and the dean of the School of Medicine, has recent-
ly appointed the following persons as associate directors 
of the Cancer Center: 
Frederick Moolten, M . D . 
Associate Director, Carcinogenesis Program 
Vice Chairman, Scientific Evaluation Committee 
Member, Steering Committee 
Peter Mozden, M . D . 
Associate Director, Cancer Education and Training 
Vice Chairman, Education and Training Committee 
Member, Steering Committee 
Marc Straus, M . D . 
Associate Director, Clinical Research Programs 
Vice Chairman, Clinical Oncology Research 
Committee 
Member, Steering Committee 
Herbert Wotiz, Ph.D. 
Associate Director, Membership 
Vice Chairman, Membership Committee 
Member, Steering Committee 
Merri l l Feldman, M . D . 
Associate Director, Radiotherapy and Radiobiology 
Programs 
Member, Steering Committee 
Sidney Kibrick, Ph.D. 
Associate Director, Biohazards Program 
Vice Chairman, Biohazards Committee 
Member, Steering Committee 
Fitzroy Kennedy 
Associate Director, Administration 
Member, Steering Committee 
The committees 
A set of steering and advisory committees for the 
Cancer Research Center has been established, whose 
relationships to the individual scientists in the research 
program are described below. Policy-making decisions 
are carried out by the director with the advice and 
guidance of these committees. 
The Steering Committee 
Sidney Cooperband, M . D . , chairman; director, Cancer 
Research Center and member of the Departments of 
Microbiology and Medicine 
Merri l l Feldman, M . D . , Department of Radiation Therapy 
Leonard Gottlieb, M . D . , Department of Pathology 
Fitzroy Kennedy, associate director. Cancer Research Center 
Sidney Kibrick, M . D . , Departments of Pediatrics and 
Microbiology 
Frederick Moolten, M . D . , Department of Microbiology 
Peter Mozden, M . D . , Department of Surgery 
Marc Straus, M . D . , Department of Medicine 
Herbert Wotiz, Ph.D., Department of Biochemistry 
These men, ail senior members of the faculty in their 
respective departments and all committed to research efforts 
in cancer, represent the broad spectrum of academic interest 
in cancer wi thin the Medical Center. They wi l l carry in -
creasing responsibility in the Cancer Center as the organiza-
tion grows and the division of labor becomes more clearly es-
tablished. A number of them already direct committees of the 
Cancer Research Center. 
The Scientific Evaluation Committee 
Sidney Cooperband, M . D . , chairman; director, Cancer 
Research Center 
Frederick Moolten, M . D . , vice-chairman, Department of 
Microbiology 
Arthur Albert, Ph.D., Department of Mathematics 
(Statistics) 
Michael Bennett, M . D . , Department of Pathology 
Lllen Berkowitz, Ph.D., Department of Biochemistry 
Laurence Corwin, Ph.D., Department of Microbiology 
Robert Lckner, Ph.D., Departments of Microbiology and 
Pathology 
Richard Llkort, M . D . , Department of Surgery 
Vinay Kumar, M . D . , Department of Pathology 
Hugues Ryser, M . D . , Department of Pathology 
Alexander Spiers, M . D . , Department of Medicine 
Herbert Wotiz, Ph.D., Department of Biochemistry 
This committee, which meets biweekly, was formed in late 
1974 in response to the need for a clinical body which could 
(1) hear suggestions for clinical oncology research proposals 
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and review them, and (2) integrate the needs of basic scien-
tists with those of clinicians in terms of developing protocols 
and procuring patient samples for studies. The committee 
also performs the valuable function of providing formal 
liaison wi th the Departments of Medicine, Surgery, and 
Radiotherapy at the Medical Center and wi th sections at the 
Boston City and Veterans' Administration hospitals. In addi-
t ion to physicians, oncology nurses and staff members of the 
Regional Oncology Program and other interested persons at-
tend meetings. 
The Biohazards Advisory Committee 
Sidney Cooperband, M . D . , chairman; director, Cancer 
Research Center 
Sidney Kibrick, M . D . , vice-chairman, Department of 
Microbiology 
Hugues Ryser, M . D . , Department of Pathology 
Belton Burrows, M . D . , Section of Nuclear Medicine 
Jacob Spira, Ph.D., Department of Physics 
Asher Kelman, M . D . , Ph.D., Departments of Microbiology 
and Radiotherapy 
Diana Hannon, R.N., records a patient's medication order. 
William McNary, M . D . , Department of Anatomy 
Peter Theran, D . V . M . , Section of Animal Sciences 
Because of existing viral oncology programs and expected 
growth in this area, this committee was formed in late 1975 to 
oversee the development of a biohazards program. Since its 
formation, a Medical Center biohazards committee has also 
been established, and it is now formulating plans for a 
Medical Center program, of which the CRC Committee wi l l 
be a part. 
The At-Large Scientific Review Committee 
A basic tenet of both the University and the Cancer 
Research Center administration (reflected in the CRC 
Charter) is the need for peer review at regular intervals to i n -
sure as much as possible the excellence of the Center's per-
formance. This committee wi l l be composed of scientists and 
professionals of outstanding reputation and competence in 
cancer research drawn from the scientific community at 
large. Its purpose wi l l be to make an annual review of the 
CRC and its programs for quality, scientific merit, and per-
tinence (as defined by the director of the Medical Center), 
after which it wi l l report and make recommendations to the 
director concerning the status of the Center. The committee 
wil l have no less than five members, one of whom shall be 
designated as chairman by the medical center director. 
Members of this committee have not yet been appointed. 
This committee reviews all grant proposals of the Cancer 
Research Center's staff members before their submission for 
funding. Its principal goal is to improve the quality of grant 
applications, but it also acts as a screening mechanism, 
eliminating duplications of effort and coordinating the 
research efforts of investigators who may have complemen-
tary methodology and technology in their labs. During the 
past year the committee has reviewed six grants, approved 
four of them, and rejected two. Of those approved, all were 
returned for revision before approval. (See Table 5.) 
Grants and contracts are submitted two to four weeks 
before deadline and are sent out to two primary reviewers 
(who may or may not be members of the committee, depend-
ing on their expertise). The grants and the analyses are 
brought before the ful l committee a week later for detailed 
discussion. Based on this discussion and vote, the grant is 
either accepted, rejected, or returned for revision. The com-
mittee meets on the second Tuesday of each month, but more 
frequently during February-March, June-July and October-
November, depending on the work load. 
The Training and Education Committee 
Sidney Cooperband, M . D . , chairman; director. Cancer 
Research Center 
Peter Mozden, M . D . , vice-chairman. Department of Surgery 
Stanley Robbins, M . D . , Department of Pathology 
This committee has conducted a survey of cancer educa-
tion and training wi th in the University, the first to be con-
ducted wi th in the institution. It has recently completed phase 
1, the fact-finding phase. It is intended that the committee 
wil l now begin the task of formulating new programs at all 
levels of education and training. 
The Hospital Advisory and Administrative Advisory Com-
mittee 
These committees are called for by the Charter, but they 
have not been activated yet. Their members wi l l be appointed 
in the near future. 
The Clinical Cancer Research Committee 
Sidney Cooperband, M . D . , chairman; director. Cancer 
Research Center 
Peter Deckers, M . D . , Department of Surgery, University 
Hospital and Boston City Hospital 
Richard Elkort, M . D . , Department of Surgery, University 
Hospital 
Jack Evjy, M . D . , Department of Medicine, University 
Hospital 
Merri l l Feldman, M . D . , Department of Radiation Medicine, 
University Hospital 
Mark Janis, M . D . , Department of Medicine, University 
Hospital 
Peter Mozden, M . D . , Department of Surgery, University 
Hospital 
Alexander Spiers, M . D . , Department of Medicine, Universi-
ty Hospital 
Marc Straus, M . D . , vice-chairman, Department of Medicine, 
University Hospital 
Nurse practitioner Jody Parmeiee (center) and Debbie Lamar, nurses' assistant (ieft), 
with Nathaniel Redman, a patient on the medical oncology floor. 
The members Associate Members 
Arthur Albert, Ph.D., professor of mathematics. College of 
Liberal Arts 
Caspar Anastasi, M . D . , associate professor of surgery 
Alison Badger, Ph.D., associate professor of microbiology 
Robert Baratz, Ph.D., assistant professor of anatomy 
Michael Bennett, M . D . , associate professor of pathology 
Ellen Berkowitz, Ph.D., assistant professor of biochemistry 
Leonard Berman, M . D . , associate professor of pathology 
Seiwyn Broitman, Ph.D., professor of microbiology 
Sati Chattoraj, Ph.D., associate professor of biochemistry 
Sidney Cooperband, M . D . , professor of medicine and 
microbiology 
Laurence Corwin, Ph.D., professor of microbiology 
Peter Deckers, M . D . , assistant professor of surgery 
Robert Eckner, Ph.D., assistant professor of microbiology 
and pathology 
Richard Elkort, M . D . , assistant professor of surgery 
jack Evjy, M . D . , assistant professor of medicine 
Merr i l l Feldman, M . D . , associate professor of radiology 
Robert Friedman, M . D . , assistant professor of medicine 
Alphonse Callitano, M . D . , assistant professor of surgery 
Paul Certman, M . D . assistant professor of medicine 
Leonard Cottlieb, M . D . , professor of pathology 
Waun K i Hong, M . D . , assistant professor of medicine 
Marc lanis, M . D . , Assistant professor of medicine 
Eva Kashket, Ph.D., associate professor of microbiology 
Asher Kelman, M . D . , Ph.D., assistant professor of 
microbiology 
Sidney Kibrick, M . D . , professor of pediatrics and 
microbiology 
Edward Kondi, M . D . , assistant professor of surgery 
Vinay Kumar, M . D . , assistant professor of pathology 
Stanley Leong, M . D . , research associate in surgery 
Thomas Louis, Ph.D., assistant professor of mathematics, 
College of Liberal Arts 
Frederick Moolten, M . D . , associate professor of 
microbiology 
Peter Mozden, M . D . , associate professor of surgery 
Richard Niles, Ph.D., assistant professor of surgery and 
biochemistry 
Carl Olsson, M . D . , professor of urology 
Marianne Prout, M . D . , assistant professor of medicine, 
Boston City Hospital 
Arnold Reif, D.Sc, professor of pathology 
Stanley Robbins, M . D . , professor of pathology 
Hugues Ryser, M . . D . , professor of pathology and 
pharmacology 
Samuel Shapiro, M . D . , associate professor of medicine 
F. Marott Sinex, Ph.D., professor of biochemistry 
Alexander Spiers, M . D . , associate professor of medicine 
H . Eugene Stanley, Ph.D., professor of physics and 
physiology. College of Liberal Arts 
William Steffee, M . D . , assistant professor of medicine 
Marc Straus, M . D . , associate professor of medicine 
M . Stuart Strong, M . D . , professor of otolaryngology 
Jorge Tello, M . D . , clinical instructor of medicine, Boston 
City Hospital 
Judith Vaitukaitis, M . D . , professor of medicine 
Jeanne Valencius, R.N. , M.S., instructor of continuing 
education. School of Nursing 
Joseph Vitale, M . D . , professor of pathology 
Pamela Watson, B.S., M.S., assistant professor of 
enterostomal education, School of Nursing 
Herbert Wotiz, Ph.D., professor of biochemistry 
Norman Zamcheck, M . D . , professor of pathology 
Marvin Adner, M . D . , assistant professor of medicine, 
Framingham Union Hospital 
Donna Barnard, M . D . , instructor of medicine 
Karolyn Barrett, R.N., instructor of continuing education, 
School of Nursing 
Linda Christensen, R.N., instructor of continuing education. 
School of Nursing 
Frank Coco, M . D . , assistant professor of medicine, 
Framingham Union Hospital 
Harvey Finkel, M . D . , assistant professor of medicine 
Sebastian Cenna, Ph.D., associate research professor of 
medicine 
Sumner Hoffmann, M . D . , professor of community medicine 
Raymond Koff, M . D . , associate professor of medicine, 
Boston Veterans Administration Hospital 
Mary Jane Kurtz, Ph.D., postdoctoral fellow in biochemistry 
Elinor Levy, Ph.D., instructor of microbiology 
Norman Lichtin, Ph.D., professor of chemistry, College of 
Liberal Arts 
Leah Lowenstein, M . D . , professor of medicine and 
biochemistry 
Fnzio Muller, Ph.D., assistant professor of biochemistry 
Sara Rothman, Ph.D., assistant professor of microbiology 
Flihu Schimmel, M . D . , associate professor of medicine, 
Boston Veterans Administration Hospital 
Eva Vavrousek-Jakuba, Sc.D., assistant professor of 
pathology 
John Wysocki, M . D . , assistant professor of surgery 
Fitzroy Kennedy, associate director for administration 
of the Cancer Research Center. 
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Legal signs 
(Continued from page 11) 
Courts will rightfully expect that 
hospitals will adopt procedures that in-
sure that the representations of their em-
ployees regarding death and burial of 
patients are accurate, and where 
promises are made, that they are carried 
out. Patients and their relatives trust 
hospitals and their employees, and 
neither courts nor juries are likely to be 
terribly sympathetic when that trust Is 
flagrantly violated. 
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In Print 
Olli P. Helnonen, M.D., Samuel 
Shapiro, M.S., F.R.C.P., and Dennis 
Slone, M.D., ali associate professors 
of medicine, Birth Defects and Drugs 
in Pregnancy. Publishing Sciences 
Group, Inc., 1977. 516 pp. $75. Pre-
sents data from a prospective study 
of drugs used by more than 50,000 
women, between 1958 and 1965, in 
relation to birth detects identified in 
their chi ldren, includes material that 
should be of interest to scientists 
concerned with all aspects of 
teratology, and particularly to 
epidemiologists engaged in exploring 
birth detects, whether from the 
perspective of hypothesis generation, 
or f rom that of hypothesis testing. 
Chalm M. Rosenberg, M.D., Ph.D., 
associate professor of psychiatry 
(and Anthony E. Raynes, M.D.), 
Keeping Patients In Psychiatric Treat-
ment. Baliinger Publishing Co., 1976. 
167 pp. $15. The authors analyze 
obstacles in the path of adequate 
psychiatric care and propose specific 
actions to improve patient retention 
and ensure a more effective use of 
the treatment system. Their overview 
of the system tor providing psy-
chiatric treatment includes factors 
that influence the decision to accept 
or reject treatment, the costs to 
health systems, and a critical evalua-
tion of the relevant literature from the 
United States and other countries. 
George J. Annas, J.D., director of the 
Boston University Center tor Law and 
Health Sciences, and Leonard H. 
Glantz, J.D., and Barbara F. Katz, 
J.D., staff attorneys. Informed Con-
sent to Human Experimentation: The 
Subject's Dilemma. Baliinger 
Publishing, 1977, 384 pp. $17.50. A 
report prepared tor the National 
Commission tor the Protection of 
Human Subjects of Biomedical and 
Behavioral Research. It recommends 
that researchers be strictly required 
to obtain voluntary, competent, in-
formed consent before conducting 
research on human subjects, and that 
they further be required to disclose 
information on procedures and risks 
whether or not the experiment is 
designed to benefit the subject. 
Richard W. Chaikin, D.D.S., M.Sc.D., 
BUSGD '65, Elements of Surgical 
Treatment in the Delivery of 
Periodontal Therapy. Quintessence 
International, 1977. 300 pp. $54. A 
text tor the general practitioner and 
periodontist with chapters on 
diagnosis, gingivectomy, principles of 
suturing, flap design, implantology, 
eiectrosurgery, and the use of assis-
tants during periodontal surgery. 
With illustrations and photographs. 
Harold L. Goldberg, M.D., an 
associate clinical professor of psy-
chiatry, (and Alberto DIMascio, Ph.D.) 
Emotional Disorders: An Outline 
Guide to Diagnosis and Phar-
macological Treatment Medical 
Economics Book Division, 1977.144 
pp. $8.95. A book designed to assist 
physicians, medical students, nurses, 
pharmacists, and others in dealing 
with the most common psychiatric 
problems amenable to drug therapy. 
It deals with selection of appropriate 
medication, doses, scheduling, dura-
t ion, and termination, and is based on 
the practical experience of the 
authors and the latest citations from 
the literature. 
Commentary 
(Continued from page 4) 
would become the meaningful f igure, 
rather than the per-diem cost at one 
university hospital or one community 
hospital, reflecting a more equitable 
means of distributing tertiary-care 
costs throughout the system served 
by the academic medical center 
without lowering the quality of care. 
Although all member hospitals in 
the multi-hospital system, including 
the urban teaching hospital, would 
lose some autonomy, they would all 
greatly benefit from the development 
of a coordinated health-care system. 
All patients would benefit by receiv-
ing the appropriate level of high-
quality care wherever they were 
treated within the system. 
Tertiary care would need to remain 
predominantly, but not exclusively, 
within the academic medical center, 
but certain community hospitals in 
the system would also develop into 
academic campuses with some 
tertiary-care capability and with ma-
jor commitments to medical-student 
and house-staff education. Ali of the 
community hospitals within the 
system would place an increased 
emphasis on education, especially in 
the areas of continuing medical 
education and patient education. The 
patient would be the beneficiary, 
receiving high-quality, humane care 
wherever hospitai treatment was ren-
dered. 
Spur to planning efforts. The multi-
hospital system would provide tor 
greater planning by health-care in-
stitutions within a region, leading to 
reduced duplication of tertiary ser-
vices, which, in turn, should lower the 
aggregate cost of health care within 
the area served by the system. 
The multi-hospital system not oniy 
could serve to alleviate the fiscal 
crisis in the academic medical center, 
but also, by contributing to more 
rational health planning and more 
equitable distribution of health man-
power, would be truly consonant with 
the needs of the country as they are 
expressed in the current national 
health-planning effort. 
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(Effective Oct. 1,1976, unless 
otherwise noted) 
Richard L. Cardiff: Assistant 
Professor of Prosthetic Dentistry, ef-
fective Nov. 1, 1976. 
Karabasz Chinn: Instructor in 
Public Health and Community Den-
tistry. 
Stephen R. Cohen: clinicai instruc-
tor in prosthetic dentistry, effective 
November 1, 1976. 
Alan Gauchman: Instructor in 
Public Health and Community Den-
tistry. 
Jose M. Guarino: clinical instructor 
in prosthetic dentistry, effective 
January 1,1977. 
Robin Lawrence: Lecturer in Public 
Health and Community Dentistry. 
Madalyn Mann: Instructor in Public 
Health and Community Dentistry, ef-
fective Aug. 1, 1976. 
Ellen S. Nayduch: Lecturer in 
Public Health and Community Den-
tistry. 
Michael A. Segal: Clinical Instruc-
tor in Prosthetic Dentistry, effective 
Nov. 1, 1976. 
Joseph Steinhurst: Lecturer in 
Public Health and Community Den-
tistry. 
George B. Wenckebach: clinicai in-
structor in prosthetic dentistry, effec-
tive January 1, 1977. 
School of Medicine 
Appointments 
(Effective Nov. 1,1976, unless 
otherwise noted) 
William J. Adelson: Ciinical Instruc-
tor in Pediatrics. 
Gordon C. Blanchard: Instructor in 
Pathology. 
Herbert E. Bradley: Assistant 
Clinical Professor of Pediatrics, effec-
tive Dec. 1,1976. 
Stanley H. Ducharme, Jr.: Assistant 
Clinical Professor of Rehabilitation 
Medicine, effective Dec. 1,1976. 
Jane H. Ferguson: instructor in 
Pediatrics, effective Dec. 1,1976. 
Maureen J. Giovannini: Assistant 
Professor of Socio-Medical Sciences 
and Community Medicine, effective 
Dec. 1, 1976. 
Wayne A. Gonnerman: Assistant 
Professor of Biochemistry, effective 
Dec. 1, 1976. 
Richard Graham: Instructor in 
Radiology, effective Dec. 1, 1976. 
Sonya Hamlin: Adjunct Assistant 
Professor of Socio-Medical Sciences 
and Community Medicine, effective 
Dec. 1, 1976. 
Richard A. Hochman: Clinical In-
structor in Medicine, effective Dec. 1, 
1976. 
John M. Kareta-Smart: Clinical 
Professor of Socio-Medical Sciences 
and Community Medicine, effective 
Dec. 1,1976. 
Amy E. Kumar: Assistant Research 
Professor of Medicine. 
Raj Kumar: Assistant Research 
Professor of Medicine. 
Elinor M. Levy: Instructor in 
Microbiology. 
Simon Locke: Lecturer on 
Neurology. 
Daniel McCauley: Instructor in 
Obstetrics and Gynecology, effective 
Dec. 1, 1976. 
Nagi A. S. Mohammed: Assistant 
Clinical Professor of Radiology. 
Patricia E. Meyer: Clinical Instruc-
tor in Medicine. 
Theodore L. Munsat: Lecturer on 
Neurology. 
Jane S. O'Hern: Associate 
Professor of Psychiatry. 
Sreko Pogacar: Instructor in 
Neurology, effective Dec. 1,1976. 
John A. Renner, Jr.: Associate 
Professor of Psychiatry, effective 
Dec. 1,1976. 
Steven L. Rosen: Clinical Instructor 
in Neurology, effective Dec. 1,1976. 
Neil B. Ruderman: Professor of 
Medicine, effective July 1,1976. 
Joseph Ruggieri: Assistant 
Professor of Pathology. 
Ascher J. Segal!: Professor of 
Socio-Medical Sciences and Com-
munity Medicine, effective Dec. 1, 
1976. 
Richard J. Sohn: Assistant 
Professor of Biochemistry, effective 
Dec. 1, 1976. 
Peter G. Str ingham: Clinical in-
structor in Pediatrics. 
Kotaro Suzuki: Associate Professor 
of Obstetrics and Gynecology; and 
Associate Professor of Pediatrics, ef-
fective Dec. 1, 1976. 
Donna M. Yonkosky: Assistant 




Changes In Title 
(Effective Nov. 1,1976, unless 
otherwise noted) 
Nathan S. Birnbaum: To Assistant 
Clinical Professor of Prosthetic Den-
tistry. 
Donald Downing: To Professor of 
Biochemistry and Nutritional 
Sciences; and Research Professor of 
Dermatology. 
Jon T. Kapaia: To Chairman, 
Department of Pedodontics. 
Fred H. Naimon: To Assistant 
Professor of Prosthetic Dentistry. 
Frank Cppenheim: To Associate 
Professor of Oral Biology. 
Michael A. Rubin: To Assistant 
Clinical Professor of Prosthetic Den-
tistry, effective Dec. 1,1976. 
Robert L. Soper: To Assistant 
Ciinical Professor of Prosthetic Den-
tistry. 
Gerald Udler: To Assistant Clinical 
Professor of Pedodontics, effective 
Oct. 1,1976. 
School of Medicine 
Changes in Title 
(Effective Dec. 1,1976, unless 
otherwise noted) 
Mohammed Akbarian: To Assistant 
Clinical Professor of Medicine. 
Richard A. Bloomtield: To 
Associate Clinical Professor of 
Medicine, effective July 1,1977. 
Sidney Brodie: to assistant clinical 
professor of pediatrics, effective 
March 1, 1977. 
Athanasios P. Flessas: To Adjunct 
Associate Clinical Professor of 
Medicine, effective July, 1, 1977. 
Marvin P. Fried: to assistant 
professor of otolaryngology, effective 
July 1, 1977. 
Allen H. Greenfield: to clinicai in-
structor in psychiatry, effective March 
1, 1977. 
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Mary C. Howell: to assistant clinical 
professor of pediatrics, effective 
March 1,1977. 
Joseph S. Incze: To Lecturer on 
Pathology. 
John L. Jainchili: to assistant 
professor of medicine and 
sociomedical sciences and com-
munity medicine, effective March 1, 
1977. 
Muhammed A. Khan: To Assistant 
Professor of Medicine. 
Yhu-Hsiung Lee: to instructor in 
pediatrics, effective July 1,1977. 
Robert J. Master: To Instructor in 
Medicine; and Assistant Clinical 
Professor of Socio-Medical Sciences 
and Community Medicine. 
Lillian E. C. McMahon: to instructor 
in pediatrics, effective March 1,1977. 
Joseph More: to clinicai instructor 
in psychiatry, effective March 1,1977. 
Norman L. Paul: To Associate 
Clinical Professor of Neurology, ef-
fective July 1, 1977. 
Stephen I. Pelton: to assistant 
professor of pediatrics, effective July 
1,1977. 
Sara W. Rothman: To Assistant 
Research Professor of Microbiology. 
Thomas D. Sabin: to associate 
professor of neurology and psy-
chiatry, effective March 1, 1977. 
Stanley M. Shapshay: to assistant 
professor of otoiaryngology, effective 
July 1,1977. 
Philip J. Stone: To Assistant 
Professor of Biochemistry, effective 
Nov. 1, 1976. 
David W. Teele: to assistant 





ECOG cancer control program. M. 
Straus. Frontier Science and 
Technology Research Foundation. 
$19,000. 10/26/76-10/25/77. 
New England Regional Spinal Cord 
Injury System. M. Freed. DHEW. 
$250,000. 6/30/76-6/30/77. 
Metabolic adaptation to starvation: 
An animal model. M. Goodman. NIH. 
$49,028. 6/30/76-5/31/77. 
Cellular kinetics of ciinical cancer 
chemotherapy. M. Straus. NIH. $200,-
424. 6/30/76-6/29/77. 
Glucose and amino acid 
metabolism in skeletal muscle. N. 
Ruderman. $61,135. 7/1/76-6/30/77. 
Quantitative histochemical and 
biochemical studies of human mus-
cle. R. Feldman, F. Romanul. 
Muscular Dystrophy Association. 
$46,989.7/1/76-6/30/77. 
Optimal nutritional support as an 
adjunct to cancer therapy in the 
adult—abdomen and pelvis 
malignancies undergoing high-
dosage treatment. W. Steffee. NIH. 
$82,077. 9/30/76-9/30/77. 
Optimal nutritional support as an 
adjunct to cancer therapy in the 
adult—carcinoma of the breast. W. 
Steffee. NIH. $82,827. 9/30/76-
9/29/77. 
Clinical metabolic research unit. J. 
Meiby. NIH. $174,585. 12/1/76-
11/30/77. 
Drug treatment of stenosing 
primate athrosclerosis. D. Kramsch. 
NIH. $64,382. 1/1/77-12/31/77. 
School of Graduate 
Dentistry 
Health professions student loan. H. 
Goldman. DHEW. $22,659. 7/1/76-
6/30/77. 
Workshop on early detection and 
prevention of dental disease in pre-
school and preadolescent chi ldren. 
A. Jong. DHEW/PHS. $10,000. 
9/30/76-9/29/77. 
School of Medicine 
Research training in nephrology. N. 
Levinsky. NIH. $31,293. 7/1/76-
12/31/76. 
The metabolic regulation of mem-
brane permeability. A. Gorman. NIH. 
$37,490. 9/1/76-8/31/77. 
Enrollment and retention of 
minorities. S. Roman. PHS. $211,079. 
7/1/76-6/30/77. 
The nature of pellet induced 
tolerance. J. Cochin. National 
Academy of Science. $11,132. 
10/1/76-9/30/77. 
Iodine metabolism of the thyroid 
gland. I. Rosenberg. NIH. $90,752. 
9/1/76-8/31/77. 
Neuropsychopharmacological 
studies of attention. C. Kornetsky. 
NIMH. $141,775. 9/1/76-8/31/77. 
Postdoctoral fellowship. P. Knapp. 
NIMH. $16,600. 8/1/76-7/31/77. 
Role of the arterial wall in 
atherosclerosis. W. Hollander. NIH. 
$578,599. 9 /1/76-8/31/77. 
Mechanism of angiotensin action 
on target issues. P. Brecher. NIH. 
$20,339. 9/1/76-8/31/77. 
Fe l lowship-Dr . Fairen. A. Peters. 
C. A. King Trust. $19,250. 10/1/76-
9/30/77. 
Lite problems and alcohol use in 
an urban population. N. Scotch. NIH. 
$89,587.8/1/76-7/31/77. 
Endocrine and metabolic response 
to shock and trauma. R. Egdahl. NIH. 
$153,680. 9/1/76-8/31/77. 
Characterization of membrane 
transfer in receptor sites. A. Sullivan. 
NIH. $25,000. 7/1/76-6/30/77. 
Cardiovascular disease and evolv-
ing diabetes mellitus. J. O'Sullivan. 
NIH. $158,352. 9/1/76-8/31/77. 
Chemistry of human proteins and 
glycoproteins. K. Schmid. NIH. $12,-
311. 10/1/76-9/30/77. 
Methodology of outpatient drug 
research. S. Fisher. NIMH. $255,238. 
9/1/76-8/31/77. 
Studies of cultured human 
fibroblasts in diabetes mellitus. C. 
Silbert. American Diabetes Associa-
t ion. $10,000. 9/1/76-8/31/77. 
Health professions student loan. J. 
Sandson. DHEW. $82,429. 7/1/76-
6/30/77. 
Indirect cost awards. NIH. $69,739. 
Behavioral factors in car-
diovascular diseases. C. Jenkins. 
NIH. $92,248. 9/1/76-8/31/77. 
Lung elastic tissue. C. Franzblau. 
NIH. $26,591. 9/1/76-8/31/77. 
Investigation of HBS tactoid forma-
tion. E. Simons. NIH. $33,582. 9/1/76-
8/31/77. 
Long term training in rehabilitation 
medicine. M. Freed. DHEW. $38,480. 
7/1/76-6/30/77. 
Feasibility study tor a model com-
prehensive stroke center program. R. 
Feldman. DHEW. $50,662. 9/30/76-
9/29/77. 
Objective focusing fundus camera. 
R. Laing. NIH. $21,701. 9/17/76-
8/31/77. 
Evaluation of the safety and ef-
ficacy of psychosurgery. M. Orzack. 
NIH. $149,250. 9/29/76-6/28/77. 
Immunogenetic regulation in 
autoimmune brain disease. M. 
Moore. NIH. $37,701. 9/1/76-
8/31/77. 
Postdoctoral fellowship. W. Hood. 
NIH. $14,500. 7/1/76-6/30/77. 
Multidisciplinary cancer center: 
Core grant. S. Cooperband. NIH. 
$155,343. 9/30/76-9/29/77. 
Program project: New approaches 
to tumor immunotherapy. S. Cooper-
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band. NIH. $31,852. 11/1/75-1/31/77. 
New careers training. L. Peters. 
NIMH. $127,270. 7/1/76-6/30/77. 
Etiologic and prognostic factors in 
breast cancer. H. Wotiz. NIH. $161,-
630. 9/30/76-9/29/77. 
Program in rheumatology. A. 
Cohen. NIH. $19,528. 7 /1 /76-
6/30/77. 
Roxbury Court alcoholism screen-
ing and referral program. J. Wells. 
NIH. $101,883. 10/1/76-9/30/77. 
Life problems and alcohol use in 
an urban population. N. Scotch. NIH. 
$10,608. 8/1/76-7/31/77. 
Physical chemistry of biologically 
active lipids. D. Small. NIH. $204,712. 
9/1/76-8/31/77. 
Indirect cost awards. NIH. $330,-
659. 
University Hospital anatomic 
pathology services. L. Gottlieb. 
Boston City Hospital and University 
Hospital. $303,500. 10/1/76-9/30/77. 
Hottman-LaRoche unrestricted 
grant. D. Slone. Hottman-LaRoche. 
$20,000. 11/1/76-open. 
Salary support tor F. i. Harosi. B. 
Kaminer. NIH. $52,158. 10/1/76-
9/30/78. 
Chemistry of human proteins and 
glycoproteins. K. Schmid. NIH. $84,-
457, 12/1/76-11/30/77. 
Educational and training program 
in communi ty health. H. Levine. Com-
monwealth of Massachusetts Depart-
ment of Mental Health. $27,953. 
9/1/76-6/30/77. 
Immunobiology of transplacental 
carcinogenesis. M. Bennett. 
American Cancer Society. $113,984. 
1/1/77-12/31/78. 
Polyunsaturated tatty acids and 
cancer. L. Corwin. American Cancer 
Society. $100,000. 1/1/77-12/31/78. 
Pulmonary research fellowship. G. 
Snider. P. B. Francis Foundation. 
$16,740. 7/1/77-6/30/78. 
Lymphocyte proliferation inhibitory 
factor. S. Cooperband. NIH. $10,749. 
10/1/75-11/30/76. 
General clinical research center. J. 
Sandson. DHEW/PHS. $105,360. 
10/1/75-11/30/76. 
Indirect cost awards. NIH. $72,823. 
Maintenance and service 
contract—Naval Blood Research Lab. 
R. Jordan. U. S. Navy. $67,300. 
10/1/76-9/30/77. 
Application of cellular kinetics to 
clinical cancer chemotherapy. M. 
Straus. University Hospital. $75,340. 
7/1/76-6/30/77. 
Type-A behavior and ventricular 
ectopy: A relationship for sudden 
death. F. Pirzada. American Heart 
Association. $10,000. 12/1/76-
11/30/77. 
Boston University Aphasia 
Research Center. H. Goodglass. NIH. 
$142,943. 12/1/76-11/30/77. 
Contractile and elastic properties 
of cardiac muscle. R. McLaughlin. 
NIH. $59,179. 12/1/76-11/30/77. 
General clinical research center. J. 
Sandson. NIH. $556,889. 12/1/76-
11/30/77. 
Antimicrobial agents and the cell 
surface. D. Feingold. NIH. $42,372. 
12/1/76-11/30/77. 
Studies in the neuropsychology of 
attention. A. Mirsky. NIMH. $31,860. 
12/1/76-11/30/77. 
Penetration of macromolecules 
into mammalian cells. H. Ryser. NIH. 
$54,180. 12/1/76-11/30/77. 
Response of the lung to injury. C. 
Franzblau. NIH. $415,246. 12/1/76-
11/30/77. 
Endocrine and pulmonary 
response to hemorrhagic shock. R. 
Egdahl. U.S.Army. $81,825. 10/1/76-
9/30/77. 
Long term training in rehabilitation 
medicine. M. Freed. HEW. $27,347. 
7/1/76-6/30/77. 
Molecular mechanisms of platinum 
and ruthenium drugs. A. Kelman. 
NIH. $56,738. 12/1/76-11/30/77. 
Lymphocyte proliferation inhibitory 
factor. S. Cooperband. NIH. $65,996. 
12/1/76-10/30/77. 
Indirect cost awards. NIH. $169,-
425. 
Effects of steroid hormones on 
subaceous gland secretions and on 
development of acne. P. Pochi. NIH. 
$54,184. 12/1/76-6/30/77. 
Training program in endocrine and 
metabolic research. J. Melby. NIH. 
$37,525. 1/1/77-12/31/77. 
Bristol fellowship in infectious dis-
eases. W. McCabe. Bristol Labs. 
$14,500.7/1/77-6/30/78. 
Arterial metabolism diabetes and 
artherogenesis. A. Chobanian. NIH. 
$66,308. 12/1/76-11/30/77. 
Acute and long-term clinical tox-
icity of drugs. H. Jick. NIH. $309,328. 
1/1/77-12/30/77. 
Health change in air-traffic con-
trollers. R. Rose. FAA. $504,192. 
1/1/77-12/31/77. 
Cognitive deficits related to chronic 
alcoholism. N. Butters. NIH. $69,099. 
1/1/77-12/31/77. 
Applied pulmonary physiology. E. 
Gaensler. NIH. $31,860.1/1/77-
12/31/77. 
Pathophysiology of myocardial 
ischemia. W. Hood. NIH. $55,560. 
1/1/77-12/31/77. 
Autonomic nervous system func-
tion in bronchial asthma. A. Mathe. 
NIH. $40,000. 1/1/77-12/31/77. 
Indirect cost awards. NIH. $650,-
207. 
Diet microflora and induction of 
colonic carcinoma. S. Broitman. NIH. 
$33,143. 1/1/77-12/31/77. 
Ultra structure and organization of 
the sensory cortex. E. White. NSF. 
$79,800. 1/1/77-6/30/79. 
Synovial membrane and related 
connective tissues. A. Cohen. NIH. 
$84,439. 1/1/77-12/31/77. 
Pathogenesis and complication of 
hypertension. A. Chobanian. NIH. 
$766,484. 12/1/76-11/30/77. 
Proposal tor drug teratology study. 
D. Stone. FDA. $24,801. 1/1/77-
1/3/78. 
Framingham Heart Study cohort. 
T. Dawber. NIH. $264,366. 6/29/75-
9/30/78. 
Research training in nephrology. N. 
Levinsky. NIH. $80,455. 1/1/77-
12/31/77. 
Immunobiology of amyloid. A. 
Cohen. Hartford Foundation. $78,-
311.2/1 /77-1/31/78. 
Indirect cost awards. NIH. $363,-
001. 
Hypertension, shock and edema: 
renal aspects. E. Alexander. NIH. 
$70,011. 2/1/77-1/31778. 
Chronic alterations in tissue 
metabolism aftershock. N. Ryan. 
NIH. $41,994.2/1/77-3/31/78. 
Synthesis of bile pigments in plants. 
R. Troxler. NSF. $48,100. 1/15/77-
6/30/78. 
Research fellowship—Dr. Alan Tall. 
D. Small. Medical Foundation. $13,-
500.7/1/77-6/30/78. 
Immunologic mechanisms of 
glomerular injury. W. Couser. NIH. 
$25,000. 2/1/77-1/31/78. 
The structure and projections of the 
cochlear nuclei. W. Warr. NIH. $39,-
981.3/1/77-2/28/78. 
Experimental optic neuropathies. S. 
Lessen. NIH. $55,521. 4/1/77-3/31/78 
Medical Foundation research 
fellowship. M. Pozen. Medical Foun-
dation. $13,500. 2/1/77-1/31/78. 
Normal and pathological human 
brain function. M. Berman. NIH. $25,-
000.4/1/77-3/31/78. 
Program project—New approaches 
to tumor immunotherapy. S. Cooper-
band. NIH. $126,136. 2/1/77-1/31/78. 
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Alumni News 
Michael J. Halberstam, '57: "My friends must think I'm oniy writing. 
ALUMNI PROFILE 
A writer, yes — but a 
physician first of all 
by Mary Hager 
WASHINGTON, D.C.—Michael J. 
Halberstam,.BUSM '57, would like his 
fr iends to know that he is "alive and 
well and practicing medicine"—and 
that "I intend to keep doing so as long 
as I'm healthy." 
For most physicians, such a state-
ment would be totally unnecessary. 
But Halberstam is not like most 
physicians. For years he has pursued 
two careers, employing both his 
medical and his journalistic talents. 
His bylines are numerous and visible, 
in the Atlantic, New York Times 
Magazine, New England Journal of 
Medicine, American Medical News, 
Today's Health, tor starters; recently 
he was named co-editor of Modern 
Medicine. So visible has been his 
writing career, in tact, that "what dis-
Mary Hager, a free-lance writer, lives in 
McLean, Va. 
turbs me is that people only know me 
because i have a byline. My friends 
must think I'm only writ ing." 
Solo and streamlined. This last, most 
assuredly, is not true, tor Halberstam 
maintains an active solo practice in 
internal medicine, specializing in car-
diology, in Washington, D.G. He does 
admit, though, to having streamlined 
his practice a bit to accommodate the 
writ ing, cutting out the "junky s t u f f -
like allergy shots and college en-
trance physicals tor nonpatients— 
and not taking "diff icult" patients 
anymore. Among the latter he places 
strangers who call f rom phone 
booths demanding to be seen "right 
now," tor "they tend to be impulsive 
and unreliable, usually insistent," he 
explains. "Someone who is really sick 
will go to an emergency room." 
He finds he is also taking fewer 
young patients. "Medically, there's 
not much wrong with them. It's 
usually depression and tension. I 
don't do much tor them, and they 
don't tee! much better, but they get 
the same bill. It's the least satisfying 
type of encounter." 
As a solo practitioner, Halberstam 
takes his own calls, except when he is 
out of town; then a colleague, who is 
also in solo practice, covers tor him. 
Halberstam finds that taking the calls 
does not interfere with his after-hours 
writ ing. "My patients are very con-
siderate," he says. "They never call at 
night or on weekends unless it is 
serious or acute." 
Natural path to medicine. Becoming 
a doctor was a natural path tor 
Halberstam. His father was a doctor, 
and Halberstam recalls going to the 
hospital with him when he was a boy. 
He grew up wanting to be a doctor, 
tor he saw being a doctor as "the only 
thing that's tun." 
But, as he says this, he realizes 
"that is not entirely true, because i 
always thought journalism seemed 
like an easy way to earn a living." And 
since his younger brother David was 
beginning to make something of a 
name tor himself in the journalism 
world, there must have been a 
familial tug there, too. 
The desire to be a doctor won tor a 
very practical reason. "I knew I could 
always write it I became a doctor," he 
explains, "but I couldn't be a doctor it 
I wrote." 
Even his path toward becoming a 
doctor was marked by a devotion to 
two professions. While classmates at 
Harvard who planned to become 
physicians were tending their test 
tubes and doing dissections, 
Halberstam spent his undergraduate 
years majoring in history—taking the 
minimum of tour science courses re-
quired tor medical school—and 
working daily on the Harvard Crim-
son. Many colleagues on the 
Cr/mson—such men as Anthony 
Lewis and J. Anthony Lukas of the 
New York Times—have since won ac-
claim in journalism. 
The 'wisdom to accept' h im. When it 
came t ime to apply tor medical 
school, Halberstam found his 
humanities background and jour-
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nalistic talents were not in great de-
mand. He was accepted at BUSM, 
and "I have always been grateful to 
the School," he says. "They had the 
wisdom to accept me." 
The writing continued sporadically 
during his BUSM years and became 
serious when, while doing his military 
stint with the Public Health Service, 
he had a number of articles pub-
lished, one a piece about Alaska 
in Holiday Magazine. It was a handy 
way to supplement his meager in-
come, so he continued writing during 
his residency in Burl ington, Vt., and 
wrote on during a cardiology 
fellowship at George Washington 
Medical School in 1962. Then, an arti-
cle won a prize, he was contacted by 
Medical Economics, and the second 
career took oft. 
"The whole thing has snowballed 
since then without much plan to it," 
he says. "I never really thought I'd be 
doing this." 
Part of the snowballing can be ex-
plained by the tact that, as a physi-
cian who can also write, he has 
become "everyone's token practicing 
physician." When a symposium or 
magazine issue is devoted to a 
health-care issue and someone 
decides a practicing physician ought 
to be represented, Halberstam often 
gets the call. 
Airs physicians' feelings. Halberstam 
has used this " token" position to 
become an articulate and effective 
spokesman tor the practicing physi-
cian. "I tee! very strongly that the 
medical profession that is written 
about is very different from the 
medical profession that exists," he 
says. "It is written about by nonphysi-
cians or by physicians who have 
never practiced." With a tew excep-
tions, he says, the writing is both 
biased and uninformed. 
"I kept reading articles (about 
medical care and health) that had ab-
solutely no relationship to the realities 
experienced in my own practice," he 
recalls. "I didn't have to be too bright 
to say, 'Why don't i write about it and 
say how it really is?' " And, he adds, 
"I was right. There was a vacuum." 
Since he still sees enormous gaps, 
he has tried to get more doctors in-
terested in writ ing, with some 
success. Whenever a physician calls 
him with a story idea—which happens 
with increasing frequency— 
Halberstam suggests the physician 
write it himself. "They always say Tm 
not a wr i ter , ' " he says. "Doctors are 
really reluctant to write, but they can 
tell a story concisely and pungently. 
All they have to do is write it down." 
Despite his dedication to medical 
writ ing, Halberstam does not think of 
himself as a "medical writer." From 
high school English on, though, he 
recalls "I was always told to 'write 
about what you know about,' and the 
one thing I know about is medicine." 
Likes the Challenge. But he has also 
written about other things, sex and 
sports and cities, tor instance. He 
recently completed a political novel, 
and he thinks "it is a good idea to 
write about something you don't 
know about, to make things up. 
to do research." 
With much of his writ ing, Halber-
stam's intention is "to make people 
think, to make people realize the 
issues are not as simple as Ralph 
Nader or John Knowles makes them 
appear." He likes the challenge of 
writing tor the New York Times 
Magazine because it is so widely read 
by the thoughtful people who can 
change social policy. 
Halberstam looks forward to his in-
creased responsibilities with Modern 
Medicine, which he has served as a 
senior editor tor a number of years. 
He plans to continue soliciting and 
reviewing manuscripts, and editing 
and writ ing, mostly long-distance, 
since the magazine is published in 
Minneapolis. 
Since he has managed to do this 
and keep up with his practice and his 
other writ ing, in addition to f inding 
t ime tor tennis and rowing and his 
family—he has two sons, now 14 and 
15—tor a number of years, he doesn't 
expect lite to be much different. Ex-
cept, he laments, he doesn't find 
much time tor skiing anymore. 
Between them, Michael and David 
Halberstam (with a straight face 
Halberstam says, "i taught my 
younger brother to write") have kept 
the family name in the public eye tor 
a number of years. But he admits he 
and David have both been panicked 
by the byline of "Yitta Halberstam" 
that turned up recently in Parade 
Magazine. 





More than 200 alumni, students 
and guests attended the annual 
meeting and banquet of the BUSM 
Alumni Association at the Copley 
Plaza Hotel, Boston, on May 14. 
Howard A. Rusk, M.D., director of the 
Institute of Rehabilitation Medicine at 
New York University Medical Center, 
was the principal speaker. 
Rusk, internationally known as a 
pioneer in rehabilitation medicine, 
spoke with enthusiasm of the great Howard A. Rusk, M.D. (second from rigfit), guest speaker at tfie annual dinner of ttie BUSM Alumni Association, is greeted by (from left) P. Antfiony Penta, '51, Dean Jofm I. 
Sandson, and Murray Freed, '52. 
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strides that have been made in that 
field over the past two decades. He 
said, "It someone had asked me 15 
years ago what could be done tor a 
youngster who suffered a broken 
neck, I would have said that getting 
15 percent back into some kind of 
useful lite would be rather good. 
. . . Now, two three-year retrospec-
tive studies of 130 children with 
broken necks have been carried out. 
The first, begun six years ago, 
showed that 53 percent were back in 
school or doing some kind of gainful 
work. Last year, the second study 
came out, covering the next three 
years, and it showed that 83 percent 
were able to lead productive lives." 
UH doing 'great work. ' Rusk paid 
tribute to University Hospital's New 
England Regional Spinal Cord Injury 
Center as a place "where great work 
is being done." He also said he was 
proud that he had had a hand in 
getting Murray M. Freed, M.D., UH 
chief of rehabilitation medicine, into 
the field, "where he is one of the out-
standing people today." 
The Alumni Association elected the 
following slate of new officers tor the 
coming year: Alan S. Cohen, '52, 
president; P. Anthony Penta, '51 , first 
vice-president; Peter E. Pochi, '55, 
second vice-president; Job E. Fuchs, 
'44, secretary; Edward Spindeil, '53, 
assistant secretary; Lester F. 
Williams, Jr., '56, treasurer; Donald T. 
Devine, '50, assistant treasurer; and 
Barry M. Manuel, '58, auditor. 
Directors appointed. Appointed to 
the board of directors were Donna R. 
Barnard, '65, and Martin B. Levene, 
'50, tor terms expiring in 1978; Arnold 
L. Berenberg, '46, and Judith L. 
Vaitukaitis, '66, tor terms expiring in 
1979; and Elizabeth C. Dooling, '65, 
and Murray M. Freed, '52, tor terms 
expir ing in 1980. 
The alumni banquet culminated a 
weekend of alumni activity that in-
cluded a Friday evening gathering of 
the Class of 1952, this year's 25-year 
class, and a Saturday luncheon tor all 
returning alumni at the School. 
Nearly halt of the Class of 1952 at-
tended the Friday dinner at the Castle 
on the Charles River campus. On 
Saturday, BUSM Dean John I. 
Sandson addressed the aiumni on 
issues in medical education, and 
hosted a reception and luncheon. 
Faculty raise $100,855 
in answer to challenge 
A to ta l of 241 S c h o o l of M e d i c i n e facu l ty m e m b e r s have c o n t r i b u t e d 
to the Schoo l ' s " C h a l l e n g e " d r i ve , ra is ing $100,855 for the S tuden t 
Revo lv ing Loan F u n d . 
T h e A l u m n i Assoc ia t i on had cha l l enged the facu l ty to ra ise $100,000 
by Dec. 3 1 , 1976, to m a t c h the Assoc ia t i on ' s p l e d g e to the loan f u n d . 
T h e m o n e y tha t w a s ra ised wi l l a l low the Schoo i to of fer s tuden t loans 
at m o r e f avo rab le in terest ra tes than those tha t are cu r ren t l y ava i lab le . 
" T h e o u t c o m e w a s g o o d . W e d id mee t the cha l l enge , " sa id B U S M 
Dean J o h n I. S a n d s o n , M.D. S a n d s o n also c o m m e n t e d on t h e h igh 
ra te of pa r t i c ipa t ion by the fu l l - t ime facu l ty , and sa id he t h o u g h t It w a s 
unusua l to r a facu l ty to be so respons i ve to s u c h a d r ive . 
The following persons had 
contributed to the fund as of 
June 10, 1977: 
William Adams 
Elsa J. Aguiiera 
Joel J. Alpert 
Bernhard Anderson 
Gaspar W. Anastasi 
Marvin Bacaner 
Madeleine Bachta 
Edgar E. Baker 
David A. Ballen 
Michael Bennett 
Patricia Berger 
Robert L. Berger 
Ellen M. Berkowitz 
Leonard D. Berman 
Daniel S. Bernstein 
David B. Bernard 
Mr. & Mrs. John Betjemann 
Charles M. Bliss 
Richard A. Bloomtield 
Leon R. Briggs, Jr. 
Jerome S. Brody 
Seiwyn A. Broitman 
Padralc Burns 
Belton Burrows 
Edwin S. Busch 
John J . Byrne 




SatI C. Chattoraj 
Aram V. Chobanian 
Sanford Chodosh 
John P. Cocchlarella 
Joseph Cochin 
Jay D. Coffman 
Sanford J . Cohen 
Bentley P. Colcock 
Francis L. Colpoys 
Sidney Cooperband 
Constance C. Cornog 
Laurence Corwin 
Frank F. Davidson, Jr. 
Thomas Dawber 
Peter J. Deckers 
Donald T. Downing 
Kenneth Edelln 
Richard H. Egdahl 
Joseph Egharevba 
Timothy H. Elsaman 
Richard J. Elkort 
Peter A. Engel 
Alvin Esslg 
J. Worth Estes 
David Faxon 
David S. Feingold 
S. Edwin FIneberg 
Seymour Fisher 
Murray Freed 






Leonard S. Gottlieb 
Jeffrey B. Gould 
Kenneth M. Graham 
William A. R. Greer 
Inta A. Grots 
Lauran D. Harris 
Gerald Hass 
John A. Hayes 
Paul J . M. Healey 
Sanford D. Hecht 
Frederick W. Hehre 
William Hollander 
Will iam B. Hood, Jr. 
BenI M. Horvath 
David C. Hueter 
Beldon A. Idelson 
Joseph S. Incze 
Franz J. Ingelflnger 
Lenworth Jacobs 
BImal P. Jain 
John L. Jalnchell 
Ophelia S. James 
Jewel Foundation 
Lorraine M. Josof 
B. Kaminer 
Samuel Kaplan 
Eva R. Kashket 
Alan S. Katz 
Paul Kaufman 
Herbert L. Kayne 
Ambrose F. Keeley 
M. David Kelleher 
Charles J. Kensler 
M. Anees Khan 
Sidney Kibrick 
Mohandas M. KInl 
Jerome O. Klein 
Michael D. Klein 
Peter H. Knapp 
James B. Knight 
Raymond S. Koff 
Edward Kondl 
Lewis F. Kornfeld 
Constantlne Kostas 
Philip Kramer 
Dieter M. Kramsch 
Robert Krane 




Eugene G. Laforet 
Knowles B. Lawrence 
Robert Leach 
Melvin Leeds 
Howard M. Leibowltz 
Herbert M. Levenson 
Robert M. Levin 
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Howard B. Levine 
Irving M. Levine 
Paul A. Levine 
Ruth R. Levine 
Sol Levine 
Norman G. Levinsky 
Robert D. Lille 
Frank W. LoGerfo 
Ernest Lowe 
Leah M. Lowenstein 
Irving M. Madoff 
David T. Mahoney 
Barry Make 
Alice T. Marston 
Masslk Family Charitable 
Fund of the Combined 
Jewish Philanthropies 
Owen R. Mathleu, Jr. 
A.G. Matolsty 
John F. McCahan 
Daniel McCauley 
H. Louis McCombs 
Will iam F. McNary 
Jaime D. Mejistenkler 
James O. Menzolan 
Joseph C. Merrlam 
Herbert Mescon 
Patricia H. Moffatt 
Richard Morri l l 
John L. Morrison 
Robert Moylan 
Richard S. Nelman 
Lawrence A. Norton 
Bernard E. O'Brien 
John F. O'Brien 
John F. O'Connor 
Carl A. Olsson 
Ann R. O'Meara 
Oncology & Hematology 
Associates (combined gift 
of Donna R. Barnard, 
Jack T. Evjy, & Harvey E. 
Finkel) 
Santiago Parades 
G. Richard Paul 
Edward W. Pellkan 
P. Anthony Penta 
Ervin Phillips 
Peter E. Pochi 
Burton J. Polansky 
Peter R. Polgar 
Alberto L. Politoff 
Michael W. Pozen 
Joel Rankin 
Glusepplna Raviola 
Robert M. Reece 
Arnold E. Relt 
Jonathan Reynolds 
Arnold Robbins 
Stanley L. Robbins 
Charles W. Robertson 
Chalm M. Rosenberg 
Henry N. Rosenberg 
Isadora N. Rosenberg 
George Rosenthal 
Henry L. Rosett 
N. Paul Rosman 
Leonard S. Ross 
Nell B. Ruderman 
Thomas J. Ryan 
Hugues Ryser 




Daniel S. Sax 
Karl Schmid 
Charles J. Schwartz 
Robert Schwartz 
Norman A. Scotch 
Jerome Shapiro 
Irving A. Shautter 
George G. Shipley 
Tsuranobu Shirahama 
Roy M. Shulman 
Benjamin Slegel 
Steven M. Sllberstein 
Elizabeth R. Simons 
F. Marott SInex 
M.B.SIroty 
James C. Skinner 
Donald M. Small 
L.Kent Smith 
R. H. Smithwick 




Alexander S. D. Spiers 
Martin L. Splvack 
Gerald Stechler 
William P. Steffee 
J. S. Strauss 
M. Stuart Strong 
Philip B. Sullivan 
Kotaro Suzuki 
Thomas M. Sweeney 
Lllla Talarico 
Carter B. Tallman 
Herbert M. Teager 
Jorge Tello 
M.P.Thakur 
H. Emerson Thomas 
Judith Vaitukaitis 
Joseph J. Vitale 
Pantel S. Vokonas 
Ladlslav Vollcer 
Carol T. Walsh 
Raymond J. Walther 
George W. Waring, Jr. 
Ph i l i ps . White 
Philip A. Wolf 
Herbert H. Wotiz 
John P. Wysocki 
Norman Zamcheck 
An alumnus for 50 years, New York resident George 
Levine, M.D., BUSM '27, and fiis wife taik with Dean 
John i. Sandson, M.D., at the Saturday Aiumni Associa-
tion luncheon in the Hiebert Lounge. 
Members of the class of 1952 gather on the staircase of 
the Castle at the Charles River Campus on Aiumni 
Weekend. They are ieft to right: (first row) Leonard J. 
Cibiey, Aivin N. Eden, Henry H. Frenkei, Murray M. 
Freed, outgoing president of the Aiumni Association; 
(second row) Nicholas A. Giosa, Frank J. Gualtieri, Alan 
S. Cohen, E.D. Anguio; (third row) Seymour A. A. 
DiMare, Sidney Chason, Herbert L. Sperling, Wiiiiam J. 
Shaprio; (fourth row) Juan A. Noguera, Arthur H. 
Levere, Carl Nelson, Joseph Steg; (fifth row) H. Leon 
Taylor, Robert J. Hambiin; (top row) Charles J. 
Schissei, Wiiiiam J. Cummings. 
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Alumni provide BUSM with ongoing support 
Listed below are the names of aiumni who through their generous finan-
cial support to the School earned membership in the Dean's Club, the An-
niversary Club or the Century Club. Membership in these clubs is offered 
for only one year at a time, and many of these members have supported the 
School for years through annual renewal of their gift. 
Dean's Club membership is open to ali alumni who, through their annual 
gift of $1,000 or more, express their desire to serve as committed and in-
formed advocates of BUSM. Anniversary Club members are aiumni who 
contribute $500 or more to the Annual Fund, and membership in the Cen-
tury Club, which continues to rise dramatically each year, is open to alumni 
who have contributed from $100 to $499 to the Fund. 
DEAN'S CLUB 
A s of A p r i l 30 
Lou is J . A i e l l o ' 3 5 
M i n o r u A r a k i '53 
Rosa l ie M e i s s n e r - A u s t e r '65 
* M a r v i n B. Bacane r '53 
Dona ld Ba rkan '45 
J o h n H. Bechte l '50 
A r n o l d B l a k e ' 5 0 
Wa l te r J . B r o d z i n s k i ' 6 4 
L e o n a r d J . C i b i e y ' 5 2 
Mar t i n J . Coyne '69 
Wi l l i am F. C roske ry '37 
A n d r e w B. C r u m m y , Jr. '55 
T i m o t h y L. C u r r a n '39 
N o r m a n W. Elton '26 
Wi l l i am Frank l in '46 
M u r r a y M. Freed '52 
Henry H. Frenke i '52 
Cha r l es E. G i lpa t r i ck '46 
Phi l ip T. G o l d e n b e r g '46 
Jef f rey H. Har r is '50 
Peter F. Je f f r ies '60 
M ichae l J . Kannan '33 
Phyl l is Ko teen '42 
Dav id H. K r a m e r '60 
Mar t i n B. Levene '50 
Ethel Lev ine 
S. J . L loyd '42 
B r u c e W. L o w n e y '68 
J o s e p h E. M a g a r o '61 
Ju l ian Mande l l '48 
" L i f e t i m e M e m b e r s h i p 
Bar ry M. M a n u e l '58 
Benne t t Mi l le r '51 
G e o r g e H. N i p ' 4 5 
V i n c e n t s . O ' H a r a ' 5 7 
Helen A. Papa loanou '53 
*P . A n t h o n y Penta '51 
A n t h o n y V. P o r c e l l i ' 5 5 
Frank Ratner '47 
G i lbe r t J . R o s e ' 4 7 
Felix R. Rosenha in '53 
Wi l l i am J . S h a p i r o '52 
Steven P. Shea r i ng '64 
E d w a r d Sp inde i l '53 
N o r m a n S. S tea rns '47 
J a c o b Swar tz '46 
B e r n a r d To ln i ck '43-A 
J e r o m e D. W a y e '58 
( A s of J u n e 15) 
J e a n n e F. A r n o l d '61 
A r n o l d L. B e r e n b e r g '46 
Rache l Ha rdw ick Bu rgess '25 
R. C l e m e n t Dar l ing '53 
A r n o l d G o l d e n b e r g '54 
M a l c o l m G o r d o n '48 
T h e o d o r e B. Green f i e l d '44 
Rober t J . H a m b i i n '52 
Marv in B. K r ims '51 
* R o c c o S. M a r i n o '42 
S a n f o r d W. Udls '44 
A lan D. We ine r '52 
ANNIVERSARY CLUB 
( A s of J u n e 15) 
Rober t L. Berger '56 
Na than L. F Ineberg '30 
J a m e s E. F i tzgera ld '54 
G e o r g e Lev ine '27 
Juan A. Nogue ra '52 
V incen t J . Russo '64 
Char les J . Sch isse i '52 
Frances Hayward Sm i th '43 
CENTURY CLUB 
(As of Apr i l 30) 
George H. Abbot '60 
Anonymous 
Peter Ald in '64 
Albert A. Apshaga '49 
Gordon D. Arnold '43-B 
Edward R. Asregadoo '51 
Guy B. Atonna '33 
J. Paul Bablneau '64 
Thomas C. Bagnoll '64 
Cambiz C. Baher '67 
David A. Ballen '67 
Arnold J. Bajek '53 
G. Robert Baler '50 
Arthur Barnes'55 
Armando Barreto '53 
G. Curtis Barry '63 
Marshall S. Bedlne '67 
William H. Beekley '66 
John Belsky '34 
Salvatore L. Benlvegna '42 
Fred Benton '45 
Jeffrey L. Berenberg '68 
H. Arthur Berson '31 
Bernard J. Berstein '72 
Abraham I. Binder '40 
David W. Bishop '46 
Nadya Konlkov Blelsch '50 
Harold P. Blum '53 
S. Arthur Boruchoff '51 
George K. Boyd '55 
James G. Boyd '39 
Robert D. Boynton '45 
George 0. Branche, Jr. '48 
Donald C. Brody '56 
Hope N. Brown '59 
Robert S. Burroughs '64 
Robert J. Carey '54 
Andrew C. Carr '61 
Muriel Case-Downer '29 
David F. Casey '62 
Marlon Macdonald Castagno 
'43-A 
William J. Cates '58 
Daniel S. Chaffin '55 
Edmond E. Charrette '62 
John J. Chlarenza '58 
Yl-Chuan Ching '58 
William A. Christmas '65 
Otto L. Churney '28 
A. B. Clachko '51 
John P. Cloherty '62 
Charles T. Cloutler '65 
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Paul B. Cohen 7 1 
Richard M. Cohen 7 1 
Samuel Cllve Cohen '35 
Gerald M. Col l ins'41 
John F. Connell '33 
George M. Connor '35 
Mark H. Cooley '60 
Robert P. Cote '67 
Robert H. Cowing '51 
Lois B. Crowell '38 
Catherine K. Culllnan '47 
David A. D'Alessandro '66 
A. Edward D'Andrea '60 
Mildred P. Davis'50 
Peter J. Deckers '66 
Alain de La Chapelle '65 
Frank Peter de Luca '33 
Peter N. De Sanctis '62 
Albert A. DesChenes '41 
Donald T. Devine '50 
Lester S. Dewls '61 
Caroline Howe Dilmaghani '64 
Lawrence H. Doollttle '26 
Frederick G. Doran '55 
Alcid F. DuMals '40 
Donald S. Dworken '55 
AlvIn N. Eden '52 
Marlon WIer Elliott '55 
Richard O. Elliott '56 
George Entwisle '48 
Michael J. Esposlto '49 
Max Faber '29 
Joseph Factor '31 
Jacob Felderman'35 
George Ferre '31 
John A. Ferris '45 
Abraham M. Flering '29 
Edward M. Fine '72 
George G. FIshman '69 
Alice M. Fleming '50 
Barbara Herman Fleming '69 
Edward W. Forbes '69 
Beverly A. Foss '54 
Howard Frankel '64 
Robert S. Frankel '47 
Richard D. Frary '56 
Vincent J. Frascatore '52 
Albert L. Freedman '51 
Carl G, Freese, Jr. '53 
Fredric D. Frigoletto, Jr. '62 
George E. Garcia '61 
Gerald E. Gaull '55 
Frank C. Gazzanlga '59 
Louis M. Geller '53 
Angelo L. Gentile '29 
George E. Ghareeb '62 
Harold M. GInzburg '68 
Nicholas Giosa '52 
Ira S. Goldenberg '51 
Harry S. Goldsmith '56 
Leon M. Golub '45 
Sydney Grace '36 
Edward V. Grayson '67 
Leonard A. Greene '60 
David T. Greenleaf '65 
Michael A. Greenwald '68 
Robert J. Griffin '48 
David B. Gurland '65 
Manuel Guzman Acosta '46 
Bernard M. Halbstein '35 
George A. Haslotis '65 
Gerald B. Healy '67 
David G. Heller '68 
Lester K. Henderson '69 
John A. Hermos '65 
Michael G. HIrsh '63 
Victor Hochberg '63 
Judith E. Hogg '70 
E. Michael Holden '68 
Saul C. Holtzman '43-A 
Will iam H. Horton '40 
Richard E. Hunter '44 
Harry M. lannotti '66 
Malcolm G. Idelson '53 
Arnold M. Illman '60 
Don E. Ingham '51 
James P. Johnson '55 
Israel M. Kamens '35 
Edward P. Kane '51 
OnnI C. Kangas '54 
Warren Kantrowltz '60 
Harold Karlln '42 
Seymour A. Kaufman '48 
Sumner Kaufman '44 
Abraham Kaye '42 
James A. Kearney '64 
Donald L. Kelley '58 
Thomas A. Kelley, Jr. '61 
Francis C. Kennedy '34 
Patricia J. Kennedy '61 
James D. Kenney '56 
Paul J. Kllloran '54 
Howard S. King '56 
Oskar Klausenstock '53 
Elaine Kohler '64 
Stanley H. Konefal '47 
Samuel J. Kowal '36 
Edward E. Krukonis '63 
John M. Kurkjian '58 
Hamer Lacey '53 
Laurence A. LaGattuta '61 
Eliot Landsman '50 
Robert C. Lawlor '55 
Ruth M. Lawrence '64 
Wallace B. Lebowltz '56 
KIrsten D. Lee '69 
Thomas C. Lee '53 
Jeffrey A. Lempert '69 
Henry H. Lerner '34 
Arthur H. Levere '52 
Paul A. Levine '68 
Harold D. Levy '59 
Jerome A. L'Heureux '34 
Dennis B. LInd '66 
George I. LItman '64 
Olga A. G. Litt le'35 
Peter A. Lodewick '67 
Donald R. Lombard '58 
Stephen R. LoVerme '46 
Lillian Luksis '49 
George 1. Lythcott '43-A 
Daniel L. Macken '60 
Forrest N. Maddix, Jr. '45 
George D. Malkaslan, Jr. '54 
Saul Malklel '44 
Edward H. Malone '43-A 
Martin C. Manin '54 
John R. Marcaccio '64 
Ethel Brown Margolls '63 
A. V. Mariano '59 
Richard M. Marks '51 
Herbert L. Martin '50 
J. Jay Matloff '43-B 
Jorge W. Mayoral-Blgas '51 
Robert L. McAuley '59 
John F. McGinn '58 
John M. Mclver '39 
Robert W. McLean '49 
Francis J. McMahon '42 
John F. McManus '36 
Mark S. MIchelman '67 
Steven Abbott Miller '70 
Clifford K. MIrlkltanI '44 
Isabel S. Money '40 
Evan E. Mortimer '73 
Marlon K. Moulton '38 
Carlos Munoz-Mellowes '53 
John D. Murphy '60 
Doris B. Nagel '64 
Robert M. Namlot '60 
Roy W. Nelson '38 
Morton B. Newman '56 
Bertha Offenbach '36 
Noboru OgamI '51 
Peter Oliver '57 
Radamee Orlandl-Gomez '53 
Thomas H. O'Shea'54 
Harold L. Osher '47 
Paul I. Ossen '43-B 
Nicholas Padls'31 
Otto C. Page '44 
Chris G. Palacas '64 
Joseph F. Palmlerl '40 
Frank Pettlnga '52 
Peter E. Pochi '55 
Carol C. Pohl '67 
Stephen J. Poor, III '65 
Theodore A. Potter '38 
Lawrence A. Putnam '28 
John J. Quinn '50 
Francesca M. RacloppI '41 
Rober to . Ralnle '43-B 
Hilda Ratner '34 
Benjamin Reder '39 
Ph i l i ps . Rellly '59 
Wayland R. Rice '34 
Norrls H. Robertson '31 
Dirk Romeyn '62 
Henry N. Rosenberg '30 
Gerald Rosenblatt '59 
Herbert L. Rothman '66 
Maurice R. Ruben '39 
Jordan S. Ruboy '55 
Flore R. Rullo '54 
Rondall W. Rutherford '31 
Leonard E. Safon '56 
Louis M. Sales '35 
Roberta Apfel Savltz '62 
Luclan A. Sawlckl '48 
Louis J. Schelnman '75 
Harold S. Schell '70 
Rolf G. Scherman'56 
Mario J. Scuico '60 
John H. Selby'44 
Herman Sellnsky '24 
George H. Semel '63 
Robert M. Seymour '64 
Charles J. Shagoury '43-B 
Jay R. Shapiro '57 
Leonard A. Sharzer '67 
Ethan M. Shevach '67 
David M. Shor '29 
Richard L. Simmons '59 
James J. SIragusa, Jr. '49 
Duane L. Smith '64 
Kenneth B. Snell '59 
Monica Harnden Snyder '33 
Robert F. Sommer '61 
Pauline G. Spear '40 
Herbert L. Sperling '52 
Robert E. Stanton '55 
Joseph Steg '52 
George E. Sullivan '36 
Irving M. Swartz '28 
Edward D. Swiss '55 
Toshlhlsa Takel '62 
Richard C. Taylor '39 
Leonard B. Thompson '31 
Richard H. Thorp '60 
John W. Towne '62 
Henry M.Trask '43-A 
Guy N. Turcotte '51 
John Urban '71 
Judith L. Vaitukaitis '66 
James D. Vllllotte '63 
Emil Von Arx, III '67 
Peter A. Vrees '65 
William W. Walner '36 
Joseph S. Wallace '46 
Arthur B. Wein '39 
Norman Welnstein '53 
Charles A. Welch'72 
Percy T. Whitney '30 
Joseph E. WIttIg '29 
R. Peter WIttmann '72 
Gary J. Wolf '74 
Arnold Wong '59 
Kinsman E. Wright, Jr. '64 
Herbert M. Wyman '63 
Joshua Wynne '71 
Henry M. Yager '66 
Konstantine K. Yankopolus '73 
Lawrence A. YannuzzI '64 
Thomas J. Zaccheo '62 
Philip E. Zanfagna '34 
Leo P. Zentgraf '38 
Alan Zlskind '57 
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(As of June 15) 
Crawford W. Adams '42 
Dwight M. Akers '53 
Stephen J. Alphas '55 
Fred A. Anderson '40 
Nell E. Anderson '48 
Ruth M. Anderson '40 
Anonymous 
Betty J. Bamforth '47 
Howard C. Beane '57 
Martin A. Berezin '37 
Richard J. Blocker '67 
Embrle J. Borkovic '32 
Francis H. Boudreau '62 
Leonard Bouras '59 
Martin L. Bradford '42 ' 
Fairy P. Brown '21 
Will iam Farrar Brown '47 
Paul M. Burke '49 
John L. Carrlgan '68 
Pletro Castelnuovo-Tedesco '52 
Joseph R. Cataldo '58 
Jose Chaves-Estrada '26 
Herbert Y.H.ChInn '44 
Jay D. Coffman '54 
Alan S. Cohen '52 
Roger M.Co le '47 
Maurice H. Connors '57 
Norman D. Corwin '57 
Elmer L. Crehan '43-B 
Seymour A. DIMare '52 
Melvin R. Dixon '53 
Elizabeth C. Dooling '65 
Saul K. Dopkeen '39 
Leo Dugas '33 
Sidney Elgner '37 
Ruth M. Ell is'52 
Richard K. Forster '63 
Frederick L. Fox '68 
Job E. Fuchs '44 
Antonio R. Gasset '66 
Ralph A. Goddard '57 
Jacob Gottler '42 
Maurice E. Green '37 
Arthur S. Gr iswold '50 
Frank J. Gualtieri '52 
MIchlhIko Hayashlda '53 
Marvin J. Hoffman '47 
Alexander P. Hyde '52 
Beldon A. Idelson '60 
Nell D. Jackson '62 
John T. Kaemmerlen '54 
Will iam L. Kasdon '70 
Jeanne D. Keller '55 
Robert F. Kenerson '65 
Gay Bong Kim '22 
Robert M. K im'60 
Burton 1. Korell tz'51 
Roger L. LeMaIre '62 
Ernest W. Lowe '53 
Edward W. Luka '58 
William P. Luke '55 
Charles Mahanor, Jr. '54 
Frank I. Marcus '53 
Samuel L. Marnoy '17 
Francis C. Mason '54 
Lulgl MastrolannI, Jr. '50 
Marlon Dallas MastrolannI '22 
Joseph C. Merr lam, Jr. '51 
Herbert Mescon '42 
Richard C. Newell '56 
David F. C'Brlen '40 
Carl A. CIsson'63 
William A. C'Shea'49 
Henry T. Cyama '57 
Clement E. Papazlan '57 
Nicholas T. Phillips '44 
Joel S. Rankin '57 
Iver S. Ravin'40 
Richard J. Rlhn '51 
Kenneth J. RItter '58 
Nicholas D. Rlzzo '44 
Enid K. Rutledge'29 
Peter L. Saplenza '43-A 
Albert V. Saradarlan '29 
S. Albert Sarklslan '43 
Max G. Sherer '50 
Anna Sllverman-Boruchoff '49 
John J. Slattery'29 
Ladlslaus B. Slysz '27 
Will iam E. Smith '65 
M. Jerome Strong '56 
David T.W. Sung '70 
Charles E. Teebagy '64 
Ellsworth A. Twible '47 
Anthony D. Vamvas, Jr. '46 
Joseph P. Van Der Meulen '54 
Francis E. Wanat '63 
Donald O. Ward '47 
Eugene P. Whittler '52 
Roland P. Wilder '36 
Konstantine G. Yankopolus '42 




LOUIS P. LEUNG writes f rom Hong Kong, 
"Before the second world war, I was work-
ing in a mission hospital in the interior of 
East China about 200 miles from 
Shanghai. When the fighting spread to 
near our work, we were forced to 
evacuate. I took my family and fled to the 
southern part of the country. Finally we 
came to Hong Kong. Three years later, 
this Island fell into Japanese hands. We 
had to steal to the Interior of the country 
again until the war was over. After the war, 
I came out to the coast city, Canton, and 
started a practice of my own. I got along 
fairly well with a hope to recover gradually 
what I have lost during the war days. My 
practice went on smoothly for several 
years; then suddenly the Communists oc-
cupied the city of Canton and we had to 
get away from that city. We again came to 
this British island. Hong Kong, for shelter. 
Being a (medical school) graduate from 
U.S.A. i was not eligible to practice 
medicine on this Island. I am about 85 
years old now, and living with my sister-in-
law." 
1924 
HARALAMBIE G. CICMA, a der-
matologist who had practiced medicine in 
Providence, R.I., since 1926, died on 
March 24, 1977, at Massachusetts 
General Hospital, Boston, after an extend-
ed illness. Born in Greece, Dr. Cicma im-
migrated to the United States in 1913 
where he first settled in Newport, N.H. 
Before coming to BUSM, he attended 
Boston University and Harvard Medical 
School. A pioneer in the research and 
development of crude coal-tar prepara-
tions for the treatment of skin diseases, he 
established the first dermatological clinic 
and was appointed chief of dermatology 
of the Homeopathic Hospital (now the 
Roger Wil l iams General Hosp.) in 
Providence. He retired from the post in 
1969 after 40 years of service. During 
World War 11, Dr. Cicma served as der-
matologist for Medical Advisory Board No. 
3 of Rhode Island and was recognized for 
professional service with numerous 
awards and citations. A member of the 
Massachusetts and Rhode Island Medical 
Societies and the American Medical 
Association, Dr. Cicma is survived by his 
wife, a son, and three daughters, including 
the wife of R. Clement Darling BUSM 'S3 
of Boston, Mass. 
1925 
HARRIS E. BOWMAR of North Scituate, 
Mass., received his 50-year citation f rom 
the American Medical Association this 
year, and NICHOLAS J. CAPECE of 
Mllford, Mass., recently received his 50-
year pin for a half century in American 
medicine. Capece Is still in active practice 




L.B. SLYSZ writes f rom New Britain, 
Conn., "50 years of general practice and 
still work ing hard. The demand for 
general practice is high. My grandson, 
Joseph Melna, is entering BU as a 
f reshman." 
IRVING H. UVITSKY, l iving in Bridgeport, 
Conn., retired f rom practice in November, 
1976. 
1928 
LAWRENCE A. PUTNAM of Holyoke, 
Mass., retired in 1970 and spends his 
summers at Orr 's Island, Maine. 
1929 
ANGELO L. GENTILE writes f rom New 
Haven, Conn., that he is still in active prac-
tice and hopes to attend "our Fiftieth." 
ENID K. RUTLEDGE retired as professor 
of pathology emeritus f rom University of 
Colorado Medical School and Center, 
Denver, in June, 1968. She served as 
medical director of the Employee Health 
Service at Presbyterian Medical Center 
for 6y2 years until full ret irement In July, 
1976. She comments, "It's great to be 
free—to sleep ad lib, to relax, to be 
domest ic mildly, to enjoy the organ as the 
mood strikes, to read, and especially to 
share hours with fr iendly neighbors and 
closest fr iends of many years. Soon I hope 
to broaden my horizons, work ing with and 
^ for the bl ind. Greetings to my 
classmates!" 
1930 
NATHAN L. FINEBERG of Newton Cen-
ter, Mass., has been appointed for four 
years as trustee of the Boston Medical 
Library in the Francis A. Countway Library 
of Medicine, 
CARL V. LENDGREN writes from 
Torrance, Calif., "After 46 years of prac-
tice, I have been forced to retire because 
of health reasons. Illness has depleted my 
economic resources, but not my interest 
in and fond recollections of BUSM. Best 
wishes to my classmates and all you 
neophytes." 
1931 
GEORGE FERRE is now fully retired and 
living on Silver Acres, his farm near Ocala, 
Fla. 
NICHOLAS PADIS writes f rom 
Philadelphia, Pa., that in August, 1976, he 
delivered a paper titled "The Legacy of 
Byzantine Medic ine" at the International 
Congress of the History of Medicine in 
Quebec, Canada. 
LEONARD B. THOMPSON of Gardner, 
Mass., is also retired now. 
1934 
MARGARET R. SIMPSON of Gape 
Elizabeth, Maine, has been retired for two 
years now. 
PHILIP E. ZANFAGNA and his wife, of 
Methuen, Mass., attended the 10th annual 
meeting and postgraduate course of the 
American Associat ion for Clinical Im-
munology and Allergy In Tucson, Ariz., 
Nov. 28 to Dec. 2, 1976. As president of 
the northeast region, Zanfagna was chair-
man of one of the sessions, at which the 
most recent treatment of allergic skin dis-
eases was discussed. He is also a mem-
ber of the American Academy of Allergy, 
the American College of Allergy, the New 
England Society of Allergy, and the 
American Association for the Study of 
Headache. 
EDWIN Y. STANTON of Great Neck, N.Y., 
has been in the practice of otolaryngology 
for 38 years. His son, GARY, graduated 
this June f rom BUSM. 
1935 
BERNARD M. HALBSTEIN writes, "I have 
just completed 25 years as director of the 
Department of Orthopaedic Surgery at 
Monmouth Medical Center in Long 
Branch, N.J. I continue in active practice, 
but now without administrat ive burdens." 
OLGA GAVRILUK LITTLE writes f rom 
Will lmantic, Conn., "I 'm still actively in-
volved in practice, despite joining 
Medicare. I'm serving as medical director 
of Natchaug Psychiatric Hospital, Inc., 
Wil l lmantic." 
1936 
WILLIAM W. WAINER is now serving in 
the Emergency Department at Holy Gross 
Hospital, Fort Lauderdale, Fla. 
After 40 years of ob-gyn practice in 
Maiden, Mass., ROLAND P. WILDER is 
retiring to Chatham, Mass., in July. He 
writes, "In good health, but want to enjoy 
the Cape." 
1937 
SIDNEY EIGNER is semi-ret ired and en-
joys living in Surfside, Fla. 
SAMUEL E. PAUL has been working as a 
psychiatrist for the Fresno County Mental 
Health Department, Fresno, Calif., since 
Nov. 15, 1976. He also does some 
teaching, and liaison with family medicine 
units at Valley Medical Center, Fresno. 
1940 
DONALD L. ANDERSON of Greene, 
Maine, husband of DOROTHY SPERLING 
ANDERSON, also BUSM '40, died March 
26, 1977, of acute bilateral viral 
pneumonia at Central Maine Medical Cen-
ter. At the t ime of his death, he was 
president-elect of Maine Medical Society 
and vice-president-elect of the staff of 
Central Maine Medical Center, where he 
was urologist in chief. Besides his wife, he 
Is survived by three daughters, three sons, 
his mother and one brother. 
RUTH M. and FRED A. ANDERSON write 
f rom Norwich, Conn., that their son, Frank 
L. Anderson, graduated f rom Tufts Uni-
versity this spring and will enter BUSM in 
the fall. 
ALCID F. DUMAIS is chief of staff at Jef-
ferson Hospital in Louisville, Ga. 
1942 
MARTIN L. BRADFORD writes f rom 
Norwood, Mass., "Al l five kids are 
marr ied, all with kids. So now we have 
eight grandchi ldren. My wife and I play a 
lot of tennis and still ski whenever and 
wherever there's snow—and fish for tuna 
in the summer. Still cutt in' and sewin' l " 
1943-A 
COL. SAUL C. HOLTZMAN writes, "Com-
pleting a challenging and rewarding active 
duty tour with U.S. Army, Europe. Next 
year, back to private practice of psychiatry 
in St. Petersburg, Fla. Found several BU 
alumni in Europe. Best wishes to 
everyone." 
1943-B 
EDNA H. SOBEL of Bronxvil le, N.Y., 
writes, "Stil l in pediatric endocrinology, 
director of that Division in the Department 
of Pediatrics, Albert Einstein College of 
Medicine; professor of pediatrics, trying to 
keep up-to-date for teaching endocrine 
pathophysiology to our students." 
MELVYN JOHNSON of Providence, R.I., 
is a psychiatric consultant to the Rhode 
Island School for the Deaf and has been 
appointed chairman of the statewide Con-
ference for Coordinating Services to the 
Deaf. He also serves as associate clinical 
professor of psychiatry at Brown Univer-
sity Medical School. 
ROBERT 0. RAINIE of Concord, N.H., is 
governor-elect for AGP from New 
Hampshire. 
1944 
FRANKLIN A. MUNSEY writes f rom Pago 
Pago, American Samoa, "Tropical 
breezes, sailing and snorkel ing, tare and 
coconuts and a little medicine and, so, not 
too bad a life." 
SUMNER KAUFMAN of Islip, N.Y., sends 
this report on his chi ldren: son Gary, prac-
ticing dentistry; daughter Adine, teaching 
at Skidmore College; son Peter, 
graduat ing dental school; son Paul, stu-
dent at Harpur College. 
1945 
After 30 years In family practice in 
Fitchburg, Mass., FRED W. BENTON has 
relocated to Sunrise, Fla. 
DONALD W.S. STIFF of Monte Serene, 
Calif., was awarded a certif icate of 
fel lowship by the American College of 
Radiology during its annual meeting in 
Houston, Texas, in Apri l . Born in Bristol, 
England, Dr. Stiff is affiliated with the 
Good Samaritan Hospital and Valley 
Medical County Hospital, San Jose, Calif. 
RUDOLF TOCH is now serving as presi-
dent of the medical staff at Milton Hospital 
in Milton, Mass. An instructor In pediatrics 
at Harvard University Medical School and 
an assistant professor at Tufts, Dr. Toch 
lists among his professional memberships 
the A.M.A., the Massachusetts Medical 
Society, the American Academy of 
Pediatrics, the American Association of 
Cancer Research and the American 
Society of Hematology. In addit ion to his 
other activities, Dr. Toch is chairman of 
the Advisory Committee of the Milton 
Visiting Nurses and chairman of the Milton 
Red Gross Blood Program. Around the 
Milton public schools, he Is known as the 
"footbal l doctor" for his role as school 
physician. 
1946 
STEPHEN R. LOVERME writes f rom Glen 
Ridge, N.J., "My son, STEVE, JR., is 
senior resident in neurology in Denver, 
Colo., and hopes to start a fellowship at 
the Veterans Administrat ion Hospital in 
Boston in July, 1977. He graduated f rom 
BUSM in the class of '73 (six-year medical 
program). Son #2, Paul, graduated f rom 
BU's College of Liberal Arts also in '73 and 
is now a junior at New Jersey College of 
Medicine after spending three years In 
Guadalajara, Mexico. Another son, Bill, Is 
in Mexico in his third year of medical 
school in Guadalajara, and we hope he 
will be ab le to transfer to an Amer ican 
medical school next summer. Our fourth 
chi ld, a daughter, Mary Lou, is now a 
senior in the physical therapy department 
67 
at Ithaca College. She will be doing a 
clerkship In Boston this summer—in fact, 
it seems that all the chi ldren are drift ing 
back to our 'home town. ' " 
JOHN W. MOSES is now associate direc-
tor of medical affairs at Akron City 
Hospital, Chic. He served previously as 
director of medical education at Mount 
Carmel Mercy Hospital and Medical Cen-
ter In Detroit, Mich. He has held staff ap-
pointments with Albany Veterans A d -
ministration Hospital, New York; Harper 
Hospital, Detroit; and Rehabilitation In-
stitute Metropol i tan, Detroit. He also had a 
private practice in internal medicine in 
Detroit. 
STANLEY H. OATH, BUSM '46, and 
NORMAN S. STEARNS, BUSM '47, have 
been awarded the medal of meritorious 
merit by the Crder of St. Lazarus of 
Jerusalem in appreciat ion of their con-
•fribution to teaching and research in the 
field of aging. Dr. Oath is currently an 
associate clinical professor at Tufts Uni-
versity, Boston, and Dr. Stearns is direc-
tor of Continuing Education at the School 
of Medicine, Tufts. 
1947 
In the past 12 years, SETRAG A. 
ZACARIAN of Longmeadow, Mass., has 
been the author of three books and some 
30 papers on cryosurgery for skin cancer; 
he has also invented several cryosurgical 
instruments for the treatment of malignant 
tumors. 
BETTY J. BAMFORTH is currently assis-
tant dean for Student Affairs at the Univer-
sity of Wisconsin Medical School in 
Madison. 
ROGER M. COLE is in his 28th year of 
microbiological research at the National 
Institutes of Health. His family is living in 
Bethesda, Md., and four of his five 
chi ldren are now through college, "none in 
medicine—yet." 
MARVIN J. HOFFMAN of Rochester, N Y , 
has been elected vice chairman of the 
board of directors of First Federal Savings 
and Loan Associat ion, "the largest savings 
and loan association in New York state." 
Patients have established the Marvin J. 
Hoffman Scholarship at the University of 
Rochester School of Medicine. His son, 
Wil l iam Yanes Hoffman, is graduat ing 
f rom the University of Rochester School of 
Medicine this year; he has a surgical 
residency at the University of California at 
San Francisco. 
1948 
ANTHONY R. GABRIEL writes, I con-
t inue as a staff psychiatrist (assistant at-
tending) at Bellevue Hospital Center, Psy-
chiatric Division, New York, and also in the 
private pract ice of psychiatry in New York 
City." 
1949 
MITCHELL R. ZAVON has been appoint-
ed medical director of the Corporate En-
vironmental Health Department of Hooker 
Chemicals and Plastics Corp. In Niagara 
Falls, N.Y. He will have responsibil i ty for 
the development of policies, programs, 
and procedures for protection of em-
ployees f rom adverse health effects that 
might be associated with their work, and 
the prevention of possible harmful tox-
icological effects of company processes 
or products on human health and the en-
vironment. During the past 26 years Zavon 
has worked in the areas of occupational 
and environmental health, toxicology, 
pesticides, food protection and public 
health, and has had experience in drug 
research and animal and human research 
related to occupational and environmental 
problems. He is board-cert i f ied in oc-
cupational medicine and in industrial 
hygiene and has published extensively in 
the fields of radiat ion, pesticides, and oc-
cupational health. 
June Jackson Christmas was presented 
with the 1976 Award for Excellence in the 
Field of Public Health of the American 
Public Health Association. Christmas, the 
subject of an Alumni Profile in the winter 
issue of Centerscope, is commissioner of 
the New York City Department of Mental 
Health and Mental Retardation. 
1950 
G. ROBERT BALER of Brockton, Mass., 
served as president of the New England 
Dermatological Society, 1975-1976. He 
writes, "My wife Nancy and I, together with 
her sister and brother-in-law, Drs. 
Blossom and George Sanger, are donors 
of the Hall of Medicine, which was 
sculpted by Nancy's mother, Doris Appel , 
and now graces the lobby of BUSM." 
MICHAEL ROHMAN writes from White 
Plains, N.Y., that his daughter, Lisa, is to 
marry in August, 1977, and that his wife, 
Joelyn, is an experienced and busy travel 
agent. 
LUIGI MASTROIANNI, Wil l iam Goodell 
Professor and chairman of the Depart-
ment of Cb /Gyn at the University of 
Pennsylvania School of Medicine in 
Philadelphia, is the current president of 
the American Fertility Society. 
MAX G. SHERER writes f rom Bethesda, 
Md., "Four chi ldren: Debbee, 23, is in 




BUSM alumni giving: 
A special report 
The S e p t e m b e r issue of 
Centerscope wi l l be d e v o t e d to 
a spec ia l repo r t on the A l u m n i 
Assoc ia t i on ' s A n n u a l Fund 
c a m p a i g n , a d r i ve tha t is 
m a r k e d by a s t rong s h o w i n g of 
loyal ty and new r e c o r d s in 
g iv ing . 
medical social worker; David, 19, a junior 
at Emory Univ.; Daniel, 14, in junior high 
school and producing school movies. 
Leah, wife, age undetermined—piano 
player and devoted chum. I am to lecture 
at Hebrew University in Jerusalem on July 
1, on diabetes." 
1951 
EDWARD R. ASREGADOO of Danville, ; 
Calif., is chief of ophthalmology, Per-
manente Medical Group. Divorced now, 
Dr. Asregadoo has four chi ldren: Ray-
mond, 19, in London; Lura, 17, a high 
school senior; Steven, 13, in junior high; 
Edward, 11, in grade school. Asregadoo 
does research in addit ion to maintaining 
an active practice. His hobbies include 
tennis, swimming and travel. 
HARRY W. FRITTS, JR., professor and 
chairman of the Department of Medicine, 
School of Medicine of the State University 
of New York at Stony Brook, has been ap-
pointed to the National Heart, Lung, and 
Blood Advisory Council of the National 
Heart, Lung, and Blood Institute in 
Bethesda, Md. The NHLBI is a bureau of 
the National Institutes of Health, one of six 
agencies composing HEW's Public Health 
Service. As a Council member, Fritts will 
take part in the evaluation of NHLBI 
programs concerned with cardiovascular, 
blood, and lung diseases and will make 
recommendat ions to the director of 
NHLBI and the director of NIH concerning 
direct ions, goals, and priorit ies of these 
programs. His term of service runs 
through October, 1980. 
JORGE W. MAYORAL-BIGAS of Ponce, 
P.R., wrote in January, "I was sorry to 
miss the recent alumni meeting at San 
Juan where Dean and Mrs. John I. 
Sandson were present. However, I had the 
unexpected visit of the 'f lu' at home." 
A. B. CLACHKO of Teaneck, N.J., is now 
chairman of the Medical Board of Hacken-
sack (N.J.) Hospital. He is in group prac-
tice; the newest member of his group is 
his son, MARC A. CLACHKO, BUSM '71. 
EDWARD P. KANE of Claremont, N.H., 
sends word that he has been elected to 
fellowship in the American College of 
Radiology, conferred Apr i l , 1977, in 
Houston, Texas. Also, a third man was 
recently added to his radiology group, 
which now covers five hospitals. He also 
built and opened a new office in February, 
1977, in Charlestown, N.H. 
RICHARD J. RIHN writes from Pinole, 
Calif., "After 17 years in an old converted 
bui lding, I recently moved to a new 
medical bui lding. Pioneer with a male 
nurse practit ioner. Oldest daughter, Sally, 
In nursing school and an CR tech. Son, 
Dan, graduated and employed by 
Northrop Corp. Youngest girl still In 
col lege." 
1952 
ROBERT WALKER BAIN was ordained to 
the Sacred Order of Priests May 26 in St. 
Stephen's Episcopal Church, 
Westborough, Mass. by the Right Rev. 
Alexander D. Stewart, Episcopal Bishop of 
the Diocese of Western Massachusetts. 
DIANE W. CROCKER assumes the chair-
manship of the Department of Pathology 
at the University of Tennessee Center for 
the Health Sciences In Memphis on July 1, 
68 CENTERSCOPE/SPRIN&-SUMMER/1977 
1977. She has just completed her fourth 
year as professor of pathology at the Un-
iversity of Southern California School of 
Medicine and as surgical pathologist and 
chief of Anatomic Pathology Data 
Processing at the Los Angeles County 
General Hospital. Dr. Crocker will be the 
first woman chairman at the University of 
Tennessee Medical School and the 
second woman chairman of pathology in 
the country. 
1953 
RADAMEE ORLANDI-GOMEZ of Rio 
Piedras, P.R., informs us that he Is now 
working as a ful l- t ime anesthesiologist at 
the San Juan Veterans' Administrat ion 
Hospital. In 1976 he underwent a double 
coronary bypass operat ion at Hines VA 
Hospital in Chicago. It was such a success 
that he was able to start ful l - t ime work two 
months after surgery, completely symp-
tomless and without medicat ions. His wife, 
Ali, and their two boys are doing fine. The 
eldest son is in his second year of dental 
school at Indiana University. The younger 
boy is in his second year of high school. 
Cr iandi-Gomez Is looking forward to the 
25th reunion of the Glass of 1953 next 
year. 
MALCDLM G. IDELSDN of Boston, 
Mass., obtained specialty board certif ica-
tion in gynecology-oncology in November, 
1976. 
ARNOLD J. BAJEK writes f rom Summit , 
N.J., that his daughter Paula is a pre-med 
student at BU and hopes to enter BUSM in 
1978. 
THDMAS C. LEE, currently associate 
professor of surgery at Georgetown Uni-
versity In Washington, D.C., presented a 
paper entitled "Hyperparathyroid ism, A 
Report of 200 Gases" at the Southern Sur-
gical Associat ion, in December, 1976, at 
Palm Beach, Fla. 
NDRMAN WEINSTEIN is now a senior at-
tending physician in pediatr ics at 
Bridgeport Hospital, Conn., and is assis-
tant clinical professor of pediatrics at Yale 
Medical School, New Haven. 
THEDDDRE J. MEDREK has been named 
corporate medical director—clinical 
research for Becton, Dickinson and Com-
pany, Rutherford, N.J. He has been with 
the company since 1969. He is a 
Diplomate of the National Board of 
Medical Examiners and a member of the 
faculty of New York University Medical 
School . He and his family reside in 
Hackensack, N.J. 
1954 
CLIFTDN F. MDUNTAIN, professor of 
surgery and chief of the Section of 
Thoracic Surgery, University of Texas 
System Cancer Center, M. D. Anderson 
Hospital and Tumor Institute in Houston, 
Texas, was recently elected president of 
the International Association for the Study 
of Lung Cancer. 
PAUL M. LERNER reports f rom Ashevil le, 
N.C., that he has been in the practice of 
urology for 16 years with four other board-
certif ied urologists. For the year 1977, he 
was elected chief of staff of St. Joseph's 
Hospital (270 beds). Despite a myocardial 
infarction eight years ago, he is still going 
strong. "Every day is a birthday." 
FRANCIS C. MASDN writes from 
Westwood, Mass., that at age 5 1 , he is 
happy, healthy, and working hard. He has 
six chi ldren. 
JDSEPH P. VAN DER MEULEN of Rolling 
Hills Estates, Calif., has been appointed 
vice president of medical affairs for the 
University of Southern California. He will 
also continue in his position as professor 
and chairman of the Department of 
Neurology. 
1955 
WILLIAM Y.W. AU has moved to the Uni-
versity of Arkansas Center for Medical 
Sciences as chief of clinical pharmacology 
and professor of medicine and phar-
macology. He is busily involved in in-
itiating and establishing a teaching, 
research and service program in clinical 
pharmacology in Little Rock, Ark. 
GEDRGE K. BDYD last July was appoint-
ed clinical assistant professor of 
pediatrics, Section on Developmental and 
Reproductive Medicine, Brown University 
Medical School, Providence, R.I. 
GERALD E. GAULL is professor of 
pediatrics at Mt. Sinai School of Medicine, 
New York, N.Y., and chief of the Division 
of Human Development and Genetics, 
New York State Department of Basic 
Research in Mental Retardation. He was 
married in September, 1976, to Dr. Sin 
von Reis Altschul. 
JOHN B. LITTLE of Brookl ine, Mass., has 
been appointed professor of radiobiology 
in the Department of Physiology at Har-
vard Medical School, Boston, Mass. 
Al though his interests have ranged over a 
number of scientific areas. Little is Well 
known for his work with polonium 210, a 
radioactive element, as one possible car-
cinogenic agent in tobacco. He has 
publ ished more than 100 articles, papers 
and abstracts in a wide variety of journals 
and other publications on subjects 
primari ly concerned with the effect of 
radiation on cells. He is also lecturer on 
radiology at Harvard Medical School and 
consultant in radiology at the 
Massachusetts General Hospital. 
GORDDN W. GRITTER moved to New 
Zealand in 1976 and is now senior consul-
tant in psychiatry at Porirva Hospital, 
Wel l ington; he also teaches in the Clinical 
School of Ctago University. 
PAUL KAUFMAN of Waban, Mass., works 
for the BUSM Division of Psychiatry as 
director of the Medical Student Psychiatry 
Program. He is in the private practice of 
psychiatry as well. 
1956 
WALLACE B. LEBDWITZ Is currently 
program director in cardiology, St. Vin-
cent's Medical Center, Bridgeport, Conn., 
and assistant clinical professor of 
medicine, Yale University School of 
Medicine, New Haven. 
HARDLD G. REISS, director of the out-
patient psychotherapy clinic at Worcester 
(Mass.) State Hospital, has been appoint-
ed director of psychiatric training at the 
hospital. He has been a psychiatrist at the 
hospital since 1959 and became director 
of the outpatient clinic in 1967. He is a 
diplomate of the American Board of Psy-
chiatry and Neurology, a member of the 
Boston Psychoanalytic Society and In-
stitute, and psychiatric consultant for the 
Jewish Family Service tor the past 12 
years. 
LEDNARD E. SAFDN and his wife, Jean, 
of Needham Heights, Mass., celebrate 
their 25th wedding anniversary in August, 
1977. They have two sons—Brad, 18, a 
freshman at Lafayette College in 
Pennsylvania, and Todd, 13, an eighth 
grader. Safon was appointed in June, 
1976, an assistant clinical professor in ob-
gyn at Harvard Medical School, Boston, 
Mass. He enjoys a very active private 
practice. 
1957 
MICHAEL HALBERSTAM has been 
named Dr. Irvine Page's new "co-
editorial ist" on the magazine Modern 
Medicine. The appointment was an-
nounced in the Jan. 1,1977, issue of the 
magazine. Halberstam is an internist-
cardiologist who practices in Washington, 
D.C., and is a member of the Institute of 
Medicine. (See alumni profi le, pg. 60.) 
JAY R. SHAPIRD of Kensington, Md., is 
the director tor Medical and Educational 
Affairs at the Greater Southeast Com-
munity Hospital, Washington, D.C. 
RALPH A. GDDDARD writes from Encino, 
Calif., "I am still in the private practice of 
chi ld, adolescent and adult psychiatry. 
For the past 12 years I have been the 
medical director of the Psychiatric Clinic 
of the Crippled Children's Society of Los 
Angeles, Calif. My wife and five chi ldren 
are fine and we all send our best wishes to 
our fr iends f rom BUSM." 
JDHN F. D'CDNNDR, JR., of Dedham, 
Mass., has been cited tor distinguished 
medical achievements by being named a 
fellow of the American College of 
Radiology. The College awarded him a 
certif icate of fel lowship during its annual 
meeting and convocation in Houston In 
Apri l . He Is affiliated with Boston City and 
University Hospitals in Boston, and Ken-
nedy Memorial Hospital in Brighton. 
1958 
DDNALD L. KELLEY retired f rom the U.S. 
Navy Medical Corps with the rank of cap-
tain on Cot. 1, 1976. He Is now in the 
private practice of general and thoracic 
surgery in Woodstown, N.J. He was re-
cently elected mayor of South Harrison 
Township, N.J. 
JDHN M. KURKJIAN is associate surgeon 
at Massachusetts Eye and Ear Infirmary in 
Boston. He was recently appointed chief 
of otolaryngology at Symmes Hospital in 
Arl ington, Mass. 
RALPH D. PDWELL, JR., recently became 
chief of the pathology service at the 
Veterans Administrat ion Hospital and 
associate professor, department of 
pathology. College of Medicine, University 
of Kentucky, Lexington, Ky. 
JDSEPH R. CATALDD writes, "Have gone 
from Green Beret Army doctor to quiet, 
retired life of family practice. Living with 
family in Alexandria, Va. and enjoying the 
serene slow pace of 80 hours and seven 
days a week. Ch, for the good ol' school 
days." 
1959 
LEDNARD BDURAS is living in 
Swampscott, Mass., with wife, Ann, and 
their two daughters, 10 and 12. He is In his 
13th year at Lynn Hospital as radiologist, 
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with special interest In interventional 
radiology, and teaches regularly at Boston 
City Hospital and at BUSM as an associate 
clinical professor of radiology. 
1960 
LEONARD A. GREENE Is chief of the 
department of ob-gyn, W. W. Backus 
Hospital, Norwich, Conn. His wife, Joan, is 
a registered nurse and is teaching fifth 
and sixth grades. They have four chi ldren: 
Wil l iam Lamar, 13; David, 9; Robert, 7; 
and Deborah, 5. 
RONALD A. SCHWARTZ of Somerset, 
Mass., has been named town physician in 
Somerset. He Is a practicing physician 
specializing in internal medicine in Fall 
River, Mass. 
WARREN KANTROWITZ, a clinical In-
structor of medicine at BUSM, has been 
appointed administrator for ambulatory care 
and special services at University Hospital. 
In this role, he will have responsibility for 
the Hospital's Evans Medical Clinic, 
Emergency Room, all Hospital outpatient 
departments, and ambulatory psychiatric 
services. Kantrowltz completed his In-
ternship and residency at University Hospi-
tal, and served as the Hospital's chief res-
ident in medicine In 1966. 
1961 
GEDRGE E. GARCIA writes that he Is 
"pract ic ing and teaching in Boston and 
enjoying It. Lois is concentrat ing on her 
golf and tennis. Suzanne is a sophomore 
at Virginia Commonweal th University, ma-
jor ing in physical educat ion. Paul Is in-
terested in everything, especially sports." 
BURTON WHITE interned at Los Angeles 
County General Hospital fol lowing 
graduat ion f rom BUSM. Then he did a 
residency at Massachusetts Mental Health 
Center in Boston f rom 1962 to '65. He 
served In the Air Force in the Phil ippines 
f rom 1965 to '67. Then he worked in com-
munity mental health and was director of a 
center in San Mateo County, Calif., 
through 1973. Since 1973, he has been in 
the private practice of general psychiatry 
in San Mateo, Calif. 
RICHARD H. LITNER writes f rom Maiden, 
Mass., "I continue with my solo practice of 
general and pediatric surgery and retain 
teaching posit ions at BUSM and Harvard. 
In my spare (?) t ime, I am engaged as a 
coach in the Belmont Mite Ranger Hockey 
Program (ages 6-8). Sandy and I grow 
older raising chi ldren Meryl (age 17), Jill 
(13) and Scott (7) as well as a St. Bernard 
and a cocker spaniel. 
DENNIS J. SANIDAS, a specialist in 
radiology and nuclear medicine, was elec-
ted president of the Tobey Hospital staff in 
Falmouth, Mass., at its 1977 annual 
meeting. After serving as a commissioned 
officer in the U.S. Army and spending two 
years In diagnostic and therapeutic 
radiology at Fitzslmmons General 
Hospital In Denver, Colo., Dr. Sanidas 
returned to this area In 1967. Since then, 
he has been on the staff of Tobey, 
Falmouth, and Barnstable County 
Hospitals, and a consultant at Otis Air 
Force Base. 
1962 
PETER N. DE SANCTIS is still practicing 
urology at Columbia-Presbyter ian Medical 
Center in New York, N.Y., and is chief of 
urology at the Helen Hayes Hospital, 
Haverstraw, N.Y. 
1963 
VICTOR HOCHBERG has been In clinical 
practice in neurology in Hol lywood, Fla., 
since 1967. He was made a fellow of the 
American College of Physicians in 1975. 
WILLIAM C. GENTRY, JR., writes f rom 
Bloomington, Minn., "My academic career 
f lourishes as associate professor of der-
matology at the University of Minnesota. 
In March, I had a great visit and did some 
snorkel l ing in the reefs off Biscayne Bay 
(Miami, Fla.) with NORMA and DICK 
FORSTER (BUSM '63) and their chi ldren, 
in conjunct ion with a CME teaching 
assignment in Fort Lauderdale, Fla." 
1964 
EDWARD PAUL ANDERSEN was marr ied 
in December, 1976, to Pauline Estelle 
Theroux, a graduate of St. Joseph's 
Hospital of Nursing, Providence, R.I. An -
dersen served his internship and 
residency at Rockland Hospital, Dallas, 
Texas. Following a honeymoon In Hawaii 
and San Francisco, Calif., the couple is 
living in Cumber land, R.I. 
CAROLINE HOWE DILMAGHANI writes 
from Tabriz, Iran: "I will not receive a tax 
deduct ion for this contr ibut ion, but I am 
very grateful to BUSM for a fine educa-
t ion. My husband, as dean of 
Azarabadegan Medical School, and I, as 
assistant professor of pediatrics, are Im-
mersed in the complex problems of f inan-
cing and educating doctors and students. 
We are well settled here, and two of our 
three sons attend Iranian schools." 
JDHN R. MARCACCID of Warwick, R.I., 
was marr ied two years ago and now has a 
son, aged 10 months. Marcaccio is prac-
ticing urology in Providence and is on the 
faculty of Brown University School of 
Medicine. 
VINCENT J. RUSSD writes, "I am in the 
practice of surgery with classmate 
PUTNAM P. BREED. He lives In Hampton 
Falls, N.H., while I live In Newburyport , 
Mass., with my wife, Sheila, and four 
chi ldren." 
CHRIS G. PALACAS of Detroit, Mich., is 
currently enjoying the practice of 
hematology at Sinai Hospital of Detroit 
and Is assistant professor in medicine at 
Wayne State University In Detroit. 
KINSMAN E. WRIGHT, JR., formerly with 
the Methodist Hospital in Houston, Texas, 
moved to Chattanooga, Tenn., in March 
and wrote: "I am leaving the ivy-covered 
tower for private practice today. Am look-
ing forward to a new adventure." 
DUANE L. SMITH is currently employed 
by the Department of State and Is located 
in Kathmandu. 
1965 
ALAIN DE LA CHAPELLE of New York 
City Is engaged In the hospital and office 
practice of psychiatry in New York City 
and is on the teaching staff at New York 
Medical College. 
Word has reached us of the marr iage of 
SHIRLEY MCMAHDN last July to 
Yesugey Oktay in Duxbury, Mass. She Is 
currently an instructor In pediatrics at 
Harvard University and at Beth Israel 
Hospital in Boston. Her husband is 
associated with Badger-American Incor-
porated and is teaching structural 
engineering at Northeastern University. 
They are residing in Marblehead, Mass. 
ROSALIE MEISSNER-AUSTER writes 
f rom Washington, D.G.: "Going back for 
another internship/residency, this t ime in 
family medicine, beginning 7 /1 /77. Hus-
band, also a psychiatrist, doing same. 
Program is three years long and at the 
moment have no plans beyond that. 
Believe we've finally decided what we 
want to do when we grow up." 
From Isllp, N.Y., RONALD C. SULLIVAN 
informs us that he is part of a four-man 
group practice in otolaryngology featuring 
DDMINICK SAMPDGNA, 65, and others 
He was board-cert i f ied in 1973. He and his 
wife, Nancy, enjoy life with their four 
chi ldren (two girls, two boys) and one sail 
boat. 
CHARLES T. CLDUTIER assumed the 
directorship of the U.S. Navy Clinical In-
vestigation Program in Bethesda, Md., on 
Nov. 1, 1976. 
BENEDICT D. T. DALY has been appoint-
ed a surgeon on the ful l- t ime staff of the 
New England Medical Center Hospital, 
Department of Cardiothoracic Surgery, 
in Boston, and director of the Department 
of Cardiothoracic Surgery at St. 
Elizabeth's Hospital in Boston's Brighton 
section. Daly was an assistant professor of 
anatomy at BUSM and served as an assis-
tant visiting surgeon on the staff of Univer-
sity Hospital prior to joining NEMCH. 
DAVID B. GURLAND of Tucson, Ariz., has 
been in the private practice of general 
psychiatry since 1971. He was board-
certif ied in Apri l , 1973, and is now medical 
director of a private mult idiscipl inary 
mental-health outpatient clinic. He has 
two chi ldren, Jeffrey, 9, and Janice, 8. 
PETER A. VREES is living in New Hamp-
shire with his wife and four chi ldren, and 
practices general surgery in Exeter, N.H. 
1966 
MICHAEL A. BLEICHER Is currently chief 
of the Division of Pediatric Surgery at the 
Mount Sinai Hospital, New York, N.Y., and 
assistant professor of surgery at the 
Mount Sinai School of Medicine. 
DENNIS B. LIND writes f rom Honolulu, 
Hawaii, " I 'm enjoying a busy private prac-
tice in psychiatry, both in the office and in 
Gueen's Hospital. I'm also a clinical in-
structor at the University of Hawaii School 
of Medicine In psychiatry and f ind that 
rewarding. Wish I could get to more B.U. 
activities, but find it's not exactly next 
door. Good luck In alumni dr ive." 
JOHN M. NIGRO Is currently a member of 
a four-man emergency-room group prac-
tice at the Cardinal Gushing General 
Hospital In Brockton, Mass.; he is also a 
member of the board of directors and 
secretary of the Massachusetts Chapter of 
the American College of Emergency 
Room Physicians. He is also active in 
emergency medical services in the greater 
Brockton area. 
STEPHEN J. RICHMAN is currently 
clinical Instructor in ophthalmology at 
Brown University Medical School in 
Providence, R.l. 
CARDL (MILCHENSKI) and HERBERT L. 
RDTHMAN had another lovely daughter 
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on August 4 ,1976. Ttie baby was named 
Victoria Ann. 
DAVID H. ZORNOW writes: "We moved to 
Danville, Va., in September, '76, where I 
have joined a group of four other 
urologists and two nephrologists. Iva had 
our third child in January, and we now 
have two girls and a boy." 
1967 
JEFFREY B. CRANDALL has completed 
internal medicine residency, two years in 
Public Health Service (National Health 
Service Corps), two years ful l- t ime faculty 
at George Washington University School 
of Medicine, two years internal medicine 
practice In Morehead, Ky., and is now 
relocating with his wife and four chi ldren 
to Cedar Falls, Iowa. 
J. M. HIEBERT of Charlottesvil le, Va., is 
an assistant professor of plastic surgery at 
the University of Virginia, Charlottesvil le, 
and Is director of the burn center and 
microvascular laboratory. 
ROBERT P. COTE writes f rom Sanford, 
Maine, "I am active in a primary care in-
ternal medicine practice with two other in-
ternists, all board-cert i f ied, and seeking a 
fourth; all about same age. Anyone in-
terested, please get in touch. " 
LEONARD A. SHARZER writes f rom 
Portsmouth, Va., "The peripatetic Shar-
zers have finally settled in Tidewater," 
where Sharzer is on Eastern Virginia 
School of Medicine's faculty in the Depart-
ment of Plastic Surgery, and is director of 
the Plastic Surgery Research Lab. The 
Sharzers have two daughters, Jessica and 
Rebecca. 
STUART E. SIEGEL has been appointed 
associate professor of pediatr ics and 
coordinator of pediatric oncology at the 
University of Southern California School 
of Medicine, and head, division of 
hematology-oncology. Children's Hospital 
of Los Angeles, Calif. 
EMIL VDN ARX, i l l , writes, "Anna. Jurea 
and I are currently in Afghanistan, working 
for the Department of State in an eight-
bed hospital-dispensary which is fully 
equipped with ORs, ERs, etc. I'm the 
overall M.D., with a staff of six, plus one 
other M.D. (G.P.) and a surprisingly large 
consult ing group f rom various govern-
ment and volunteer agencies. We love it." 
STEPHEN M. SCHWARTZ has received 
the American Heart Association's Career 
Investigator's Award. A member of the 
faculty of the University of Washington's 
Department of Pathology, Schwartz 
received his Ph.D. in experimental 
pathology from the University of 
Washington after graduat ing f rom BUSM. 
His father, Robert Schwartz, M.D., is an 
assistant clinical professor of communi ty 
medicine and medicine at BUSM. 
RICHARD B. CHASET has announced the 
opening of an office for plastic and 
reconstructive surgery at the Wachusett 
Professional Center in Fitchburg, Mass. 
He is associated with the Burbank, Henry 
Heywood Memoria l , Leominster and 
Nashoba Communi ty Hospitals. He was 
recently discharged f rom the Navy, where 
he was a commander and held the posi-
tion of chief, plastic surgery, at the Naval 
Regional Medical Center, Philadelphia, 
Pa. 
1968 
DAVID G. HELLER writes from Hingham, 
Mass., "I f inished orthopedic training at 
Carney Hospital in Dorchester In 1973. 
Spent two years in the Army at Ft. Polk, 
La. In practice at Carney and Quincy 
Hospitals since July, 1975. Living in 
Hingham with wife, Nancy, and two 
chi ldren, Mindy and Kim." 
STEVEN R. KDHN has moved his office to 
235 Prospect Ave., Hackensack, N.J. 
PAUL A. LEVINE of Northborough, Mass., 
joined the ful l-t ime staff at University 
Hospital in the section of cardiology as of 
July 1, 1976. He received an appointment 
to BUSM as assistant professor of 
medicine as of Oct. 1,1976. 
BRUCE W. LDWNEY is entering his fourth 
year in the practice of vascular and 
general surgery at the Doctors Office 
Building at the Medical Center. He was 
recently appointed director of surgery at 
Northeastern University Health Services 
and at the Eunice Kennedy Shrlver Center 
for Mental Retardation in Wal tham, Mass. 
GERALD H. MARGDLIS writes f rom 
Needham, Mass., "Our second daughter, 
Sarah Kate, was born August 22, 1976." 
ERIC BIRKEN of Fairport, N.Y., has start-
ed his practice in otolaryngology at Clifton 
Springs, N.Y., in the Finger Lake region of 
New York state. 
1969 
EDWARD W. FDRBES of Wharton, N.J., 
has completed general surgery residency 
this year at St. Vincent's Hospital, New 
York City, and has started practice in 
Wharton. He spent two years in the Army 
at the Pentagon, f rom 1971 to 1973. 
MICHAEL ALBDM has been promoted to 
assistant clinical professor of dermatology 
at New York University Medical Center. He 
is also chief of the chemosurgery unit (for 
specialized skin cancer surgery) at New 
York's Bellevue Hospital Medical Center. 
A contr ibut ing editor of the Journal of 
Dermatologic Surgery, he writes a feature 
article for each issue. 
RDBERT A. DYE of Boston writes, "I am 
actively involved in developing an in-
patient cardiac rehabil itation program for 
both chi ldren and adults with heart dis-
ease at the Massachusetts Rehabilitation 
Hospital. In addit ion, I am working with my 
colleagues at Massachusetts General 
Hospital in the development of a similar 
program for outpatients. I heard an ex-
cellent abstract on cardiac rehabil itation 
at the November American Heart Associa-
tion meeting in Miami, delivered by my 
friend and BUSM '69 classmate, WILLIAM 
FRISHMAN, M.D., of New York City." 
GEORGE G. FISHMAN, marr ied to Ellen 
Ogintz, is director of the psychiatric clinic 
at Beth Israel Hospital in Boston. 
WILLIAM R. GRACE has been named to 
the new post of chief of oncology research 
in the Department of Medicine of St. Vin-
cent's Hospital and Medical Center of New 
York City. Grace, who served on the St. 
Vincent's house staff f rom 1969 to ' 71 , for 
the past year had been an instructor in 
medicine at Dartmouth Medical School 
where he also held a fellowship in 
hematoiogy/oncoiogy at the Dartmouth-
Hitchcock Medical Center. From 1971 to 
'74 he was a research associate in im-
munology, experimental immunology divi-
sion, of the Naval Medical Research in -
stitute, Bethesda, Md., serving s imul-
taneously as a member of the Navy 
Medical Corps with the rank of lieutenant 
commander. During two of these years, he 
was codirector of the institute's bone 
marrow transplant unit. 
JON C. LOCHNER writes. "Jan and i have 
moved Amy, age 5, Joshua, age 1 Vz, and 
my dermatology practice to Syracuse, 
N.Y. i am in solo practice and a visitant at 
the new dermatology teaching program at 
S.U.N.Y. Upstate Medical Center." 
ELIHU L. SUSSMAN of New York City 
marr ied Geraidine Ducce, a nurse at 
Bellevue Hospitai, in July, 1976. He is still 
practicing general pediatrics in the same 
location and was promoted in September, 
1976, to assistant professor of pediatrics 
at the New York University Medical Cen-
ter. 
ROBERT J. SZARNICKI is finishing up his 
commitment as senior registrar in 
pediatric thoracic and cardiovascular sur-
gery at the Hospital for Sick Children in 
London, England. He will be moving to 
San Francisco, Calif., this summer to join 
the staff of Presbyterian Hospitai in 
partnership with J. Donald Hill, M.D. Their 
practice will include both adult and 
pediatric thoracic and cardiovascular sur-
gery. He adds, "Just this past month i 
learned that I passed my boards in 
thoracic surgery. What a relief!" 
1970 
In November, 1976, the Lahey Clinic an-
nounced the appointment of FRED A. 
CECERE as an associate in the Depart-
ment of internal Medicine, Section of 
General Medicine. Gecere had served his 
internship at University Hospitai and was a 
resident at Wiii iam Beaumont Hospitai in 
Ei Paso, Texas, and Brooke Army Medical 
Center in San Antonio, Texas. Before his 
appointment to the Clinic, he was chief of 
the Department of Medicine at Cutler 
Army Hospitai at Fort Devens, Mass. He is 
living in Waltham, Mass., with his wife and 
two chi ldren. 
BRIAN P. MURRAY f inished his residency 
in anesthesia at Massachusetts General 
Hospitai, Boston, after a six-month 
fellowship in medical education and has 
begun the private practice of anesthesia 
at Santa Barbara Cottage Hospital in 
Santa Barbara, Calif. 
HAROLD S. SCHELL writes from West 
Trenton, N.J., of his " two beautiful 
daughters, one fine wife, one-half of a 
practice and a $20,000 malpractice 
premium." 
1971 
RAYMOND and NANCY ( 73) 
ANTHRACITE of San Antonio, Texas, 
write: "Nancy will begin a fellowship in in-
fectious disease at the University of Texas 
at San Antonio. Raymond will complete 
his fel lowship in pulmonary disease at 
Wiiford Hail USAF Medical Center and will 
begin with Brook AFB Schooi of 
Aerospace Medicine." 
MARTIN M. BRESS of Holiister, Calif., 
was certif ied by the American Board of In-
ternal Medicine in July, 1976, and was 
elected one of five directors of the 
Holiister Community Hospitai in a general 
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election last November. He is currently in-
volved in a campaign to raise $1.5 mill ion 
to expand hospitai services and to build a 
n e w l C U / C C U . 
CARL J. BROTMAN is practicing adoles-
cent and adult psycti iatry in Belmont, 
Mass. 
PAUL COHEN, M.P.H. (UC Berkeley), is 
now in the National Health Service Corps 
In Brownsvil le, Calif., doing pediatr ics and 
general family practice. 
Last fai l, NANCY L. SPRINGE was 
appointed an instructor in medicine at 
Harvard Medical Schooi and a clinicai 
assistant in medicine at Massachusetts 
General Hospitai in Boston. She 
previously interned for three years at 
Montef iore Hospitai, N.Y. In 1974, she 
returned to Boston to begin a two-year 
fel lowship in pulmonary medicine at MGH. 
Since 1974, she has been a clinical and 
research fellow in medicine at Harvard 
Medical and MGH. Her main area of in-
terest and research is occupational lung 
diseases, and she has lectured exten-
sively on her research in chronic beryll ium 
disease, which occurs among some 
workers in the electronics and aerospace 
industries. Last year at an international 
conference on occupationai diseases in 
Oslo, Norway, Sprince and P. infante, 
M.D., presented an abstract summariz ing 
their investigations on beryll ium and its 
possible cancer-producing role. 
On December 5, 1976, ELIZABETH B. 
WOOD became the bride of Terence 
Murphy, M.D., of Brookl ine at a ceremony 
in Br ighton, Mass. Both are ciinical in-
structors at Tufts University Schooi of 
Medicine. They plan to continue to prac-
tice internal medicine at 1560 Beacon St., 
Brookl ine, Mass. 
JOSHUA WYNNE, currently complet ing 
his cardiology training at the Peter Bent 
Br igham Hospitai in Boston, will be stay-
ing on next year in a staff posit ion. He pre-
viously spent two years in Korea (1973-75) 
fuifi i l ing a Berry Plan commitment and 
travelled in the Far East. While in Korea, 
he learned to fly and is now a private pilot. 
GREGORY BINUS and his wife, Alexan-
dra, announce the birth of Seth's and Ari 's 
brother, Jonathan Gabriel , on Apri l 9, 
1977. They are living in Newton Centre, 
Mass. 
STEPHEN G. GREEN writes f rom Cardiff-
by-the-Sea, Calif., " i will finish tour of duty 
with USN in June, 1977. We plan to 
relocate in the Worcester, Mass., area. 
Looking forward to a change of pace, and 
return to civilian l ife." 
1972 
JAMES BRASIC is currently a psychiatric 
resident at Barnes Hospitai in St. Louis, 
Mo. 
ARTHUR E. BRAWER presented a paper 
enti t led, "Acute Monocytic Arthr i t is" at the 
December, 1976, meeting of the American 
Rheumatism Association in Miami Beach. 
Brawer was formerly an arthrit is fellow at 
the Medical Center. He currently practices 
rheumatology in Long Branch, N.J. 
JDYCE EASTER completed a residency 
in psychiatry at University Hospitai last 
summer and entered private practice in 
psychiatry at 76 Cypress St., Brookl ine, 
Mass. She also was appointed ciinical 
director of the North End (Boston) Health 
Center, associate professor of psychiatry 
at Harvard Medical Schooi, and member 
of the medical staff at the Carney Hospitai, 
Boston. 
ERIC G. HDNIG moved in January, 1977, 
from Grady Memorial Hospitai, Atlanta, 
Ga., to Johns Hopkins University School 
of Medicine, Balt imore, Md., on a National 
Pulmonary Faculty Training grant. 
ROBERT F. MEENAN writes, "Lynda and i 
had a baby girl on June 30,1976, and 
named her Molly. We will be returning to 
Boston in August; 1977, and i will be work-
ing at BCH in rheumatology." 
STEPHEN R. SMITH of New London, 
Conn., was appointed to serve on the 10-
member state public health council by 
Gov. Ella T. Grasso in December, 1976. 
The council is the highest pol icy-making 
body for the state Department of Health. 
At age 28, Smith is the youngest physician 
ever to serve on the council. Before his 
appointment, he had been involved in in-
vestigative work, assessing quality of care 
in nursing homes in Connecticut. He is 
currently an assistant professor of family 
medicine at the University of Connecticut 
Health Center, Farmington. 
R. PETER WITTMANN of Cambr idge, 
Mass., is a member of the American 
College of Emergency Physicians. He will 
be entering the U.S. Air Force (Berry Plan) 
in July, 1977. 
1973 
STEPHEN H. GDLDBERGER writes f rom 
Westminster, Calif., that he ran into his 
classmate, BYRDN ADKI, in Sausalito, 
Calif., last spr ing. 
KDNSTANTINE K. YANKDPDLUS, who 
is practicing obstetr ics-gynecology in Fort 
Myers, Fla., writes, "Practice is most en-
joyable here in sunny south Florida. Try-
ing to get PHIL SHARP and JIM ZUGER 
down here." 
EVA RICARDI MAUER is currently living 
in Pasadena, Calif., and working as a 
pediatrician for the Los Angeles County 
Department of Public Health. 
MICHAEL J. STRDNGIN has just com-
pleted his chief residency in obstetr ics 
and gynecology at the New York Hospitai-
Corneii Medical Center in New York City. 
He will be joining a busy group practice in 
New York City with teaching appointments 
at the New York Hospitai and Cornell 
Medical Schooi and Lenox Hill Hospitai. 
He and his wife, Sharon, have been 
marr ied for six years and have two 
chi ldren, Jason and Julie. 
1974 
DAVID J. CHRDNLEY writes f rom 
Narragansett, R.i., "Finishing PL3 at 
Rhode Island Hospitai—taking orders 
f rom one-year-old son, Courtney David!" 
DDRDTHY CHASE has joined North River 
Medical Associates in Hanover, Mass., as 
family practit ioner. The group now en-
compasses family practice, internal 
medicine and surgical consultation. Dr. 
Chase is also presently an instructor at 
BUSM. 
1975 
Word f rom JDSEPH L. JDRIZZD is that 
he is currently enjoying his first year of 
residency in the dermatology program at 
the North Carolina Memorial Hospital at 
Chapel Hill, N.C. 
MARY KRAFT is finishing her second year 
as a surgical resident at University 
Hospital. As of July 1, she will embark on 
an anesthesiology residency at 
Massachusetts General Hospitai. 
1976 
Word has reached this office of the 
marr iage last August of JEFFREY R. 
BREITER to Ronni Sue Frohiioh, who 
earned her master's degree in speech 
therapy at Boston University. The couple 
is living in North Yonkers, N.Y. while he in-
terns at Montefiore Hospitai in New York 
City. 
SGD CLASS NOTES 
1963—Dral Surgery 
HARDLD L. MALLDN of Flint, Mich., was 
the recipient of a special Odyssey House 
Award for work with drug addict ion. 
1969—Dral Surgery 
R. DAVID SELDIN has opened a new of-
fice in Newark, N.J., with practice limited 
to orai and maxiiiofaciai surgery. 
1971—Orthodontics 
GEDRGE GINSBERG, now living in West 
Hartford, Conn., announces the birth of 
his daughter, Alison Beth Ginsberg. 
1975—Orthodontics 
BRIAN H. MILLER is practicing or thodon-
tics at 93 Union Street, Newton Center, 
Mass., and at 66 McGrath Highway, 
Quincy, Mass. 
NECROLOGY 
Emerson F. Hird '10 
Lillian Moore Lawford '11 
Clifton B. Leech '19 
Haraiambie G. C icma '24 
Arthur R. Daviau '24 
Anthony W. Devito'25 
Roland D. C iapp '27 
Edna Waick-Sedgewick '29 
Harold Burger '30 
Daniel Hoizman '30 
Robert E. Rice '30 
George A. Crepeau '34 
Harry L. Benson '36 
W. Nelson Thompson '39 
Donald L. Anderson '40 
Donald G. Mi l ler '40 
Charles L. Tuttie '41 
John T. Konecki '43-A 
Milton Berkowitz '53 
Caroline Pottenger Fry '53 
Jenaro Suarez '22 
John S. Martin '25 
Bruno G. DeFusco'32 
Raymond B. Cof f in '35 
Melvin D. Roseman'41 
72 CENTERSCOPE/SPRING-SUMMER/1977 
S i n c e 1 8 1 2 , The New England Journa l of Medic ine has 
played its role in medical c ircles—report ing the progress 
of medic ine to physicians and medical students t h rough -
out the wo r l d . 
me new Eneland Jeurnai oi Medicine 
10 SHATTUCK STREET, BOSTON, MASSACHUSETTS 02115 
Boston University 




Course Announcements 1977-1978 
1 Advanced Course in Oncology /Septem-
ber 28-30,1977/Howard Johnson's, Cam-
bridge, MA/16 hrs. 
2 Neurology for the Non-Neurol-
oglst /October 12,1977/Howard Johnson's, 
Cambridge, MA/7 hrs. 
3 Pediatric Radiology In the General 
Hospital /October 19-21,1977/Dunfey's 
Hyannis Resort Hotel, Hyannis, Cape Cod, 
MA/16y2 hrs. 
4 Recognit ion and Management ot Medical 
Emergencies /October 20-21,1977/Howard 
Johnson's, Cambridge, MA/12 hrs. 
5 The Crisis in Stress Research: A Cri t ical 
Reappraisal ot the Role ot Stress in Hyperten-
sion, Gastrointestinal Illness, Female 
Reproductive Dystunction /October 20-22, 
1977/Boston University Medical Center, 
Boston, MA/17 hrs. 
6 Learning Disabi l i t ies /November 19, 
1977/Hyatt Regency Hotel, Cambridge, 
MA/6y2 hrs. 
7 Board Review in Internal Medicine /Tues-
days, January 10-June 13,1978, 7-10 
p.m./Boston University Medical Center/69 
hrs. 
8 Topics in Uro-Oncology /January 23-26, 
1978/The Village at Smuggler's Notch, Jeffer-
sonvllle, VT/19 hrs. 
9 Current Cl inical Pediatr ics /January 30-
February 3,1978/The Village at Smuggler's 
Notch, Jeffersonvllle, VT/19 hrs. 
10 Controversies in Internal Medicine/ 
F e b r u a r y 6 -9 , 1 9 7 8 / T h e V i l l age at 
Smuggler's Notch, Jeffersonvllle, VT/19 
hrs. 
11 Acquired Diseases ot the Heart /Apri l 11 -
16,1978/Sonesta Beach Hotel, Bermuda/30 
hrs. 
All courses are fully accredited by ttie American 
Medical Association for Category 1 credits toward 
tfie Physician's Recognition Award (hour-for-hour). 
AAFP accreditation granted where applicable. 
For further Information please contact: Donna 
Marcy, Department of Continuing Medical Educa-
tion, Boston University School of Medicine, 80 E. 




City State Zl p 
I am Interested In Boston University School of 
Medicine Department of Continuing Medical 
Education programs (circle number below): 
1 2 3 4 5 6 7 8 9 10 11 
Detach and mall to Ms. Donna Marcy at the 
above address. 
